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Abstract
The human HepG2 (hepatoma) cells can be induced to convert into pancreatic 
cells following introduction of an activated form of the pancreatic transcription factor 
Pdx1 (Xlhbox8Vp16). In this study, further investigations were carried out to elucidate 
the cellular and molecular basis of this conversion and to determine whether the 
transdifferentiated (3-cells are functional. The results showed that (1) both pancreatic 
exocrine cells and endocrine cells are induced; (2) the hepatic phenotype is 
suppressed and (3) requirement for the transgene is transient during 
transdifferentiation of liver cells into pancreatic-like cells. The transdifferentiated cells 
are functional based on (1) expression of the (3-cell functional markers prohormone 
convertase 1/3 and C-peptide; (2) insulin mRNA expression is increased after 
treatment with GLP-1 and betacellulin; and (3) insulin secretion is elevated after a 
glucose challenge.
To verify whether transdifferentiation can also occur in primary cultures of 
hepatocytes, an in vitro culture system for differentiated rat hepatocytes was 
established using a chemically-defined medium (Keratinocyte serum free medium 
supplemented with dexamethasone, epidermal growth factor and pituitary gland 
extract (KDS)). KDS was able to maintain primary rat hepatocytes for up to 28 days in 
culture without significant loss of liver-specific properties based on the maintenance of 
morphological appearance, expression of liver proteins and liver-enriched 
transcription factors and certain hepatic functions including glycogen storage, 
ureagenesis and xenobiotic metabolism. Cultured rat hepatocytes can be also 
converted into insulin-producing cells by introducing the transgene Xlhbox8Vp16. A 
more mature (3-cell phenotype (increased expression of (3-specific genes (e.g. 
sulphonylurea receptor and potassium channel Kir6.2)) was seen when additional 
pancreatic transcription factors (Neurogenin 3, Nkx2.2 and Nkx6.1) were introduced in 
the cells. These studies suggested the hepatocytes are a potential source of (3-cell for 
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1 .A Endoderm development and 
organogenesis of liver and pancreas
An important goal for developmental biologists is to understand the steps that 
allow a single fertilised egg to become a sophisticated organism. This information also 
has important therapeutic implications since it might allow us to produce specific cell 
types at will (regenerative medicine). The basic processes for creating lower (worms 
or flies) and higher (frog, fish, chick, mouse and human) animals are similar (Wells 
and Melton, 1999). Briefly, a fertilized egg progresses through the formation of the 
germ layers and body axes (gastrulation and axis patterning), formation of individual 
organs (organogenesis), and cytodifferentiation to eventually generate a functional 
organism.
During early development, embryonic cells are divided into the three germ layers 
(mesoderm, endoderm and ectoderm) through a series of cell movements termed 
gastrulation. The ectoderm generates the cells of the nervous systems and skin; the 
mesoderm generates the cells of the connective tissue, muscle, and the circulatory 
system; and the endoderm gives rise to gastrointestinal organs (oesophagus, 
stomach, intestines), respiratory tract (lung and trachea), liver and endocrine glands 
(such as thyroid and pancreas) (Tam and Behringer, 1997). Compared to our 
knowledge of ectoderm and mesoderm development, the mechanisms underlying 
endoderm development are more poorly understood. This lack of information is due to 
a number of reasons. First, most endoderm-derived organs are positioned internally, 
thus defects associated with endodermal development are rather difficult to observe 
directly. Second, functions of the endoderm-derived organs including gas exchange, 
digestion, nutrition absorption, glucose homeostasis and detoxification are vital for 
maintaining homeostasis in animals. As a result, mutations associated with endoderm
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are usually lethal early on in development (Zaret, 1999). However, in the past few 
years many advances have been made towards elucidating the factors involved in 
endoderm development. In the following section, the molecular events known to 
determine competence and patterning of the developing endoderm will be discussed, 
with particular emphasis on the developmental relationship between liver and 
pancreas in the mouse.
1.A.1 Early endoderm development
1.A.1.1 Overview of endoderm development prior to gut tube 
formation
In the mouse, the fertilised egg moves from the oviduct to the uterus around 3 
days after fertilisation. During this stage, the fertilised egg becomes a fluid-filled 
“balloon-like” structure called the blastocyst. A day later, the primitive endoderm 
emerges from the inner cell mass (ICM). The cells of the ICM are the source of 
embryonic stem cells (Wells and Melton, 1999). The primitive endoderm contributes to 
the extraembryonic tissues rather than the formation of the definitive endoderm. Next, 
during the “egg-cylinder” stage, the blastocyst elongates along the 
embryonic-abembryonic axis to form a cup shaped structure consisting of two layers, 
the outer visceral endoderm and an adjacent group of undifferentiated cells, the 
epiblast. Bone morphogenetic protein (BMP) signalling, specific for BMP2 and BMP4, 
may regulate the structure of the epiblast and differentiation of visceral endoderm 
(Coucouvanis and Martin, 1999). This idea is supported by the detection of decreased 
expression of Hepatocyte nuclear factor 4 (HNF4), a visceral endoderm marker, when 
BMP signalling is blocked using a transgene encoding a dominant negative mutant
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form of BMP receptor Subsequently, gastrulation begins to form the ectoderm, 
mesoderm and endoderm from the epiblast.
The primitive streak (PS) is located at the posterior end of the epiblast and 
appears during gastrulation (around embryonic day 6.5 (E6.5)). The formation of the 
PS is essential to generate the anteroposterior axis of future embryo (Conlon et al., 
1994) and is mediated through the activity of Nodal factor (Varlet et al., 1997). 
Endodermal progenitor cells move out from the anterior PS and migrate towards the 
distal tip of the epiblast. Several investigations have been carried out to identify the 
signals that determine the fate of the endodermal cells in the anterior PS. One 
example of a signal is the requirement for fibroblast growth factors (Fgfs). Fgfs to 
pattern the mesoderm/endoderm cells based on the detection of ectopic neural 
structures in Fgf receptor-1 deficient mice (Ciruna et al., 1997). By the end of 
gastrulation (about E7.5 in mice), endodermal cells have acquired regional 
specification along the anterior-posterior (A-P) axis (Wells and Melton, 1999). There 
are three lines of evidence to support this statement. First, the genes Cerberus, Otx1, 
and Hesxl are expressed anteriorly (IFABP and Cdx2 are expressed caudally). 
Second, during cell migration, cells destined for the anterior move earlier than the 
cells destined for the posterior end. Third, the posterior endodermal cells divide at a 
higher rate than the anterior endodermal cells. Differences in patterning along the A-P 
axis might result from differential signals from the mesoderm (Wells and Melton, 
2000).
The next significant event at E8.5 is turning, a process that allows the three germ 
layers to be correctly positioned within the embryo. The endoderm becomes located 
inside the embryo while the ectoderm is positioned outside. In addition, the original 
visceral endoderm now assumes a protective role by surrounding the whole embryo. 
After turning (E9-E9.5), the gut opening closes and a drastic increase in the growth of
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mesenchymal cells around the endodermal gut tube is also observed. After this stage, 
the embryo proceeds through organogenesis to form individual differentiated internal 
organs (>E9.5).
1.A.1.2 Signalling factors associated with endoderm formation
Which molecules control endoderm formation? Over the past few decades, much 
data have been generated allowing these signals to be broadly divided into three 
categories.
1.A.1.2.1 Signalling factors
Nodal signalling is an extensively studied pathway involved in endoderm 
formation (Stainier, 2002; Whitman, 2001). Nodals are members of the Transforming 
Growth Factor-p (TGF-(S) family. One gene has been found in mouse {Nodal), two in 
zebrafish (eye and sqt) and five in Xenopus {Xnr1, Xnr2, Xnr4, Xnr5 and Xnr6). In 
Xenopus, Nodal related molecules induce isolated animal caps to express 
endodermal genes such as endodermin (Takahashi et al., 2000). Introduction of a 
dominant negative form of Nodal led to the decrease of expression of 
endoderm-specific genes including ceberus, Xhexl (a homeobox gene expressed in 
anterior endoderm) and Frzb (a secreted factor expressed in anterior endoderm) 
(Osada and Wright, 1999; Stainier, 2002). While in fish, the gut endoderm is absent in 
sqt;cyc double mutant embryos (Feldman et al., 1998). The importance of 
Nodal-related proteins for initiating and patterning embryonic endoderm was further 
confirmed using knockout mice. Knock-down of Nodal activity by Lowe et al 
suggested that Nodal signalling exhibits a gradient-effect on the formation of 
mesoderm and endoderm (low -  mesoderm; high -  endoderm) and this was 
confirmed in fish (Lowe et al., 2001; Warga and Nusslein-Volhard, 1999). These data
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all support the significance of Nodal in endoderm development.
Another essential signalling pathway involved in the generation of endoderm is 
the BMP signalling pathway. Incubation of the BMP antagonist Noggin with Xenopus 
animal caps enhances the expression of the pan-endodermal marker Endodermin 
(Sasai et al., 1996). Furthermore, in Bmp2 (-/-) and Bmp7 (-/-) mutant fish, 
endodermal precursors accumulate (Stainier, 2002).
1.A.1.2.2 Transcription factors
During early development, Sox, Gata and Forkhead genes are fundamental for 
initiating endoderm construction. It has been shown that Gata can induce the 
expression of the intestinal marker IFABP in nonendodermal cells both in vivo and in 
vitro (Gao et al., 1998). Homozygous inactivation of FoxA2 in mice results in the 
absence of the node, the structure that forms foregut and midgut (Ang and Rossant, 
1994). Sox17 plays a highly conserved role in the generation of the endoderm. It is 
normally expressed in visceral and definitive endoderm and mice deficient for Sox17 
exhibited the lack of axis rotation and deteriorating growth from E8.5 (Kanai-Azuma et 
al., 2002). Thereafter, disorganised growth and morphogenesis of the posterior trunk 
was detected, especially after E9.5.
Many transcription factors regulate organogenesis of the endodermal organs 
(Grapin-Botton and Melton, 2000; Wells and Melton, 1999). In budding organs, 
investigations using knockout mice have shown that Pax9 is found to be a master 
gene for parathyroid formation (Peters et al., 1998); Nkx2.1 is responsible for thyroid 
genesis (Kimura et al., 1996); G//2/G//3 (the downstream effectors in Sonic hedgehog 
(Shh) signalling pathway) are necessary for respiratory organ formation (Motoyama et 
al., 1998); and Pdx1 and Hlxb9 directs development and overgrowth of the pancreatic 
bud (Jonsson et al., 1994; Li et al., 1999).
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Another important event during organogenesis is the enhancement of 
proliferation in order to allow embryonic organs to reach mature tissue mass. 
Transcription factors evidenced to be important for this process, including Hlx for 
intestinal epithelial expansion (Lints et al., 1996), AP-1 and Hepatocyte Growth Factor 
(HGF) for liver growth (Zaret, 1998) and Cdx1 for proliferation in intestinal crypt cells 
(Subramanian etal., 1998).
1.A.1.2.3 Inducing factors
The relative position of endoderm to mesoderm during development suggests 
that interacting signals between these two layers might contribute to organogenesis 
(Cleaver and Krieg, 2001; Horb, 2000). Some recombination experiments have been 
carried out to confirm this hypothesis. For example, chick stomach epithelium adopted 
an intestinal epithelial fate when combined with intestinal mesoderm (Andrew and 
Rawdon, 1990). Similarly, the lung epithelium failed to branch when cultured with 
mesenchymal cells of the trachea (Cleaver and Krieg, 2001). More recently, Wells and 
Melton showed that in vitro endoderm explants (i.e. minus the mesoderm and 
ectoderm) isolated from E7.5 mouse embryos, failed to express Pdx1, Neuro D1 and 
Somatostatin. This observation directly demonstrates that mouse endoderm requires 
signalling from adjacent ectomesoderm for differentiation. Wells and Melton tested the 
potential of soluble factors secreted from the mesoderm to regulate endoderm 
development. The results showed that Fgf4 was able to induce endodermal gene 
expression in cultured explants (Horb, 2000; Wells and Melton, 2000).
Mesenchymally-derived Fgf signals are also important in specifying other 
endodermal tissues. For example, Pepicelli et al demonstrated that the initiation of 
branching in lung epithelium is regulated by Fgf 10 secreted from mesenchymal cells 
(Pepicelli et al., 1998). Conversely, lung development is abolished in Fgf 10 (-/-) mice
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(Min et al., 1998). Regarding the regionalisation of hindgut endoderm, Roberts et al 
showed that endodermal Shh signalling stimulates the expression of BMP4 and 
Hoxd13 in mesoderm and regressively control adjacent endodermal fates (Roberts et 
al., 1995; Roberts et al., 1998).
The notochord also takes part in patterning the endoderm. The notochord is the 
first rigid structure formed during early development and functions as a support for the 
entire embryo. It exists either as a transient structure in higher vertebrates or persists 
in lower veterbrate (Stemple, 2004). It has been shown that the notochord determines 
dorsal pancreatic fate through Shh signalling (see section 1.A.3). The importance of 
the timing of notochord signalling for normal gut development has been demonstrated 
by the detection of abnormal foregut development after prolonged reception of 
notochord signals. In addition, the growth deficiency of trachea and oesophagus 
under sustained contact with the notochord was also observed (Cleaver and Krieg,
2001).
1.A.2 Development of the liver
The parenchymal cells of the liver are derived from the endoderm. The adult liver 
carries out several essential functions including the secretion of serum proteins, the 
release of metabolising enzymes and the stabilisation of blood glucose concentration. 
Therefore, it is not surprising that many regulatory genes are essential for establishing 
and maintaining these functional properties in embryonic liver cells (Lemaigre and 
Zaret, 2004; Zaret, 1998; Zaret, 1999; Zaret, 2000; Zaret, 2001; Zhao and Duncan, 
2005).
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1.A.2.1 Competence stage
FoxA and Gata transcription factors play a highly evolutionarily conserved role in 
endoderm patterning, as demonstrated by deficient endoderm development in 
knockout animals, from mammals to worm (Gaudet and Mango, 2002). Recently, 
Zaret’s group proposed a model stating that FoxA2/Gata4 (potentiation factors), can 
“pre-pattern” the hepatic endoderm at around embryonic stage E6-E7. This model 
was demonstrated by sophisticated techniques, chromatin immunoprecipitation and in 
vivo footprinting, to determine the occupancy of sites in the albumin promoter by 
FoxA2 and Gata4 proteins at an early embryonic stage (Bossard and Zaret, 1998; 
Cirillo et al., 2002). The FoxA binding site is occupied before the albumin gene is 
expressed (before E8). The occupancy persisted from E8.5-E11.5 and additional 
recruitment of other transcription factors including CCAAT/enhancer-binding protein |3 
(C/EBP(3) and Nuclear Factor 1 (NF1) is needed for the active expression of the 
albumin gene. This early DNA-protein interaction suggested that FoxA and Gata4 
may determine the hepatic endodermal cell fate after gastrulation and enhances it in 
combination with more liver-specific transcription factors.
1.A.2.2 Specification and proliferation stage
Induction of the hepatic fate is thought to occur via repression of the default 
pancreatic programme by signals secreted from neighbouring mesenchymal cells 
(Deutsch et al., 2001). Between E7.5-E9, the cardiac mesoderm directly interacts with 
hepatic endoderm and hepatic differentiation begins. Some soluble factors, such as 
Fgfs, mediate regulation of liver development as evidenced by the induction of 
a 1-fetoprotein {AFP) and albumin mRNAs by treating the isolated foregut endoderm 
tissues with Fgfs (Jung et al., 1999). Additionally, another mesenchymal tissue 
surrounding the hepatic endoderm, the septum transversum, is essential for
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hepatocyte specification through secretion of BMPs, mainly BMP2 and BMP4 (Rossi 
et al., 2001). At about the same stage, Hex (Haematopoietically expressed homeobox) 
is also involved in normal liver development since Hex(-/-) mice exhibit impaired liver 
growth (Martinez Barbera et al., 2000). In addition to signalling from cardiac 
mesoderm, non-mesenchymal endothelial cells are also important for liver 
proliferation and migration. Matsumoto et al. showed this both in vivo (Vascular 
Endothelial Growth Factor Receptor 2 (VEGFR2) deficient mice) and in vitro 
(embryonic liver bud cultures treated with angiogenesis inhibitor NK4 to block vessel 
formation) models (Matsumoto et al., 2001). In VEGFR2 knockout mice, the early 
hepatocytes formed a multilayered epithelium but failed to form specified liver cells 
while in the NK4-treated embryonic liver bud cultures impaired liver buds growth was 
observed. These data confirmed the role of endothelial cells on early liver 
organogenesis (Nikolova and Lammert, 2003).
After the cell fate was determined, the hepatic endoderm is pulled to the midgut 
and early liver cells begin to proliferate within the endoderm at 9.5 days after 
fertilisation. At this stage, the liver mass is dramatically increased and haematopoietic 
cells migrate into the liver. The rod-like hepatoblasts secrete extracellular degrading 
enzymes to dissolve the basement membrane and migrate into the septum 
transversum (Michalopoulos and DeFrances, 1997). Several factors are essential for 
early liver development including Prox-1. Prox-1 (Prospero-related homeobox 1) is a 
homeobox gene originally cloned by homology to the Drosophila melanogaster gene 
prospero. It is expressed mainly in the adult central nervous system and in the 
developing eye lens, ventral pancreas, heart and liver (Oliver et al., 1993). 
Homologous knockout Prox-1 mice exhibit a defect in migration of liver cells at E10 
due to the presence of an abnormal basement membrane rich in E-cadherin, type 4 
collagen and laminin (Sosa-Pineda et al., 2000). This observation indicated that
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Prox-1 is crucial for hepatocyte delamination into the septum transversum. Gene 
disruption experiments also found that transcription factors associated with 
proliferation and apoptosis such as c-jun, RXR (Retinoid X receptor), jumonji, N-myc, 
K-ras and Rel A (NF-kB subunit) are also indispensable for differentiation and growth 
of the hepatocyte population (Zaret, 1998).
In addition to the soluble factors regulating the specification of early liver cells, 
the septum transversum also provides some signals to the developing liver to promote 
hepatocyte outgrowth and differentiation. Some evidence from gene-silencing studies 
showed that hepatocyte growth factor (HGF) signalling participated in this process. 
Hlx, a mesenchymal-specific transcription factor, activates the expression and 
secretion of HGF in the septum transversum. In turn, HGF activates the tyrosine 
kinase receptor c-met located on the hepatoblast cell surface (Jiang et al., 2005). 
Consequently, the phosphatidylinositol-3 kinase (PI3K), mitogen-stimulated STAT 
signalling or stress activated JNK kinase pathway is activated leading to the 
expression of the proliferation-related complex AP-1. In addition to the interacting 
receptors between cells and the extracellular matrix, integrin families also play a role 
in regulating the balance between proliferation and apoptosis during hepatocyte 
formation (Lora et al., 1998).
1.A.2.3 Hepatocyte or bile duct?
During liver outgrowth, hepatoblasts face a decision to become either 
hepatocytes or biliary cells (Suzuki et al., 2002). Recent evidence suggested that 
molecules including signalling factors and transcription factors are fundamental to 
distinguish hepatocyte and bile duct cell fates (Lemaigre and Zaret, 2004; Zhao and 
Duncan, 2005). TGF-p, Notch and Wnt are all possible candidates involved in the 
control of bile duct cell formation. For example, heterozygosity of the Notch ligand
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Jagged 1 leads to the clinical autosomal dominant disorder, Alagille syndrome, 
characterised by the loss of the intrahepatic bile ducts in humans (Lemaigre and Zaret,
2004). Coincidently, the Notch component Delta-like protein is expressed at the same 
time hepatoblast fate is determined (-E10.5) (Tanimizu et al., 2003). In Hes1 (-/-) mice, 
extrahepatic bile ducts are converted to both exocrine and endocrine pancreatic cell 
types. A role for Notch signalling in ductal cell determination is further supported by 
the observation that Hes1 is a negative regulator of the pro-endocrine gene 
Neurogenin 3 (Ngn3) as well as the downstream gene in the Notch signalling pathway 
(Sumazaki et al., 2004). In addition, the expression of various HNF networks plays a 
significant role in specifying the decision between hepatocyte and bile duct cell fate of 
hepatoblasts. HNF6 and HNFip are the two main transcription factors regulating bile 
duct formation. Biliary differentiation occurs prematurely in HNF6 knockout mice and 
the same defect is also detected in mice with liver-specific deficiency of HNF1(3 
(Clotman et al., 2002; Coffinier et al., 2002). In contrast, conditional loss of function of 
HNF4a indicated the requirement of HNF4a in hepatocyte maturation and 
epithelialisation (Parviz et al., 2003). Thus, the HNF networks actively regulate the 
latter stage of liver cell development (Odom et al., 2004).
1 .A.3 Development of the pancreas
In the recent years, considerable understanding of pancreas development has 
been gained. The pancreas is composed of three major functional units: the exocrine 
cells that secrete digestive enzymes for the digestion of macromolecules into smaller 
molecules; the duct cells that mediate transportation of digestive enzymes from the 
exocrine cells to the small intestine; and the endocrine cells that synthesise and 
secrete hormones. The exocrine and ductal cells represent more than 95% of total cell
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populations in the pancreas. About 2% is comprised of at least four different types of 
endocrine cells including a, p, 6, PP cells which produce glucagon, insulin, 
somatostatin and pancreatic polypeptide, respectively (Slack, 1995). More recently, 
another endocrine cell (called £-cells) was discovered in the pancreas. This cell type 
secretes the hormone ghrelin and is involved in the regulatory network of energy 
balance by increasing food intake and reducing fat utilization (Chanoine, 2005; Kojima 
et al., 1999; Wierup et al., 2002; Wierup et al., 2004). Organogenesis of the pancreas 
is discussed below with particular emphasis on the molecules that determine the 
endocrine cell fate.
1.A.3.1 Pancreatic organogenesis
1.A.3.1.1 Commitment to pancreatic fate
The commitment to a pancreatic fate occurs as early as E8.5 in mouse. Several 
signals released from adjacent structures including notochord, aorta and cardiac 
mesoderm are thought to be essential for the patterning of pancreatic endoderm 
(Wells and Melton, 2000). Inhibition of Shh signalling is required for patterning the 
dorsal pancreatic endoderm. This idea is supported by the detection of smooth 
muscle-like mesenchyme and interstitial cells of Cajal, characteristic of the intestine, 
rather than pancreatic mesenchyme in the pPdxl-Shh transgenic mice (Shh signals 
driven by Pdx1 promoter) (Apelqvist et al., 1997). A similar program of intestinal 
differentiation was also observed when the pancreatic explants were exposed to Shh 
(Apelqvist et al., 1997). Conversely, loss of Shh provokes a relative increase in 
endocrine cell number and pancreas size (Hebrok et al., 2000). It has been shown 
that activin-pB, a member of TGF-p family, and Fgf2 secreted from the notochord are 
able to repress the expression of Shh therefore activating the pancreatic programme
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in dorsal pancreatic endoderm (Hebrok et al., 1998; Kim et al., 1997). Interestingly, 
presence of Shh rather than absence of Shh, is required for pancreatic development 
in Zebrafish (Roy et al., 2001) indicating that in this regard the fish is very different 
from higher vertebrates.
The ventral pancreas is determined by the signals derived from the cardiac 
mesoderm, namely Fgfs and BMPs (Deutsch et al., 2001). The relative position of the 
endodermal epithelium and blood vessels also revealed a possible role of signals 
from vascular endothelium on pancreas development. At E9.5, the dorsal pancreatic 
bud is located adjacent to the aorta while the ventral pancreatic region is positioned 
close to the vitelline veins (Lammert et al., 2001). It was demonstrated that the signal 
from vessels, probably mediated through the activity of vascular endothelial growth 
factor (VEGF) plays a fundamental role on pancreatic differentiation (Lammert et al.,
2001). The development of the ventral and dorsal pancreatic buds is quite different. 
For example, the onset of mesenchymal condensation is different in the dorsal (E9.5) 
and ventral (E10.5) buds (Herrera et al., 2002). In addition, different phenotypes are 
induced in the dorsal and ventral pancreas in knock-out animals {Isl1(-/-), 
N-cadherin(-/-) and Hlxb9(-/-)) (see table 1.1) suggesting that the molecules 
determining dorsal and ventral pancreas are distinct.
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Table 1.1 Phenotype of dorsal and ventral pancreas in knockout mice of various 
pancreatic transcription factors. Reproduced from Herrera et al 2002
1.A.3.1.2 Timing o f appearance of different cell types and later events
Morphogenesis of the pancreas commences at about E9.5 and is first observed 
by the condensation of the dorsal mesenchyme. Both dorsal and ventral buds 
subsequently proliferate and undergo extensive branching. The endocrine cells 
appear at different times during development. Using immunofluorescent staining, 
glucagon-expressing cells are first detected at E9.5 in the dorsal pancreas (E10.5 in 
ventral pancreatic bud), followed by insulin and somatostatin expressing cells at 
E10.5-E11.5 and E13.5, respectively. The exocrine cells start differentiating from 
E14.5, while pancreatic polypeptide expressing cells are not detected until E18.5 
(Herrera et al., 1991; Slack, 1995). However, RT-PCR analysis performed on mouse 
tissue revealed the presence of glucagon and somatostatin mRNAs as early as 
E8.5-E9. At E10.5, the insulin I gene and PP mRNAs were found and at E11.5, insulin 
II was detected (Gittes and Rutter, 1992; Herrera et al., 1991). The early endocrine 
cells are located within the ductal epithelium and may contain more than one hormone 
in each cell (e.g. glucagon and PP- have been found co-localised in the same cells at
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E10.5) (Herrera et al., 1991). Later the cells interact with adhesion molecules, 
including collagen IV, to migrate into the surrounding connective tissues and form 
clusters (Herrera et al., 2002). At about E17, gut rotation allows the ventral pancreatic 
buds to fuse with the dorsal bud thus generating a single functional organ (Edlund, 
2001; Edlund, 2002; Grapin-Botton et al., 2001) and one day later the typical islet is 
found with the “one cell-one hormone” cell types (Herrera et al., 2002).
1.A.3.2 Cellular origins of pancreatic cell types
The question arises as to whether pancreatic cells are derived from one single 
origin (monoclonal) or numbers of progenitors (polyclonal)? To answer the question 
about cell origin, lineage tracing experiments were performed to label the progenitors 
and trace their descendants. Early methods used vital dyes, such as lipid-soluble 
carbocyanine dyes Dil or DiO to tag the cells. Due to their hydrophobic properties, the 
dyes become integrated into the cell membrane and hence label the cells. However, 
there are two problems associated with this technique. The first is that the dye labels 
groups of cells rather than individual cells so this makes it impossible to elucidate the 
fate of an individual cell. The second concerns the dilution of labelled cells during cell 
division (Herrera et al., 2002).
To overcome these disadvantages, genetic marking methods have been 
employed. One of the most convincing and commonly used methods is the Cre/loxP 
system (Rajewsky et al., 1996). This system is based on the idea that the progenitors 
can be labelled with a reporter gene after the excision of a LoxP-stop-LoxP genetic 
cassette by a cell- or tissue-specific Cre recombinase (Gu et al., 2003). Using this 
technique, the origin of pancreatic duct, exocrine and islet cells was addressed (Gu et 
al., 2003; Herrera et al., 2002). It was shown that: (a) all pancreatic cells are derived 
from endodermal epithelium and differentiated from Pdx1-expressing
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precursors(Herrera, 2000; Percival and Slack, 1999); (b) PTF1a-p48 is involved in 
determining both exocrine and endocrine pancreatic lineages (Kawaguchi et al.,
2002); (c) islet endocrine cells originate from Ngn3 positive progenitor cells (Gu et al.,
2002); (d) the insulin and glucagon cells develop independently (Herrera, 2000; 
Jensen et al., 2000a) and (e) exocrine, endocrine and ductal lineages are separated 
by E12.5(Grapin-Botton, 2005).
1.A.3.3 Hierarchy of transcription factors regulating different 
pancreatic cell fates
In contrast to the studies of the factors controlling the exocrine and ductal cells, 
the regulation of pancreatic endocrine cell formation has been much more extensively 
investigated. Greater interest in endocrine pancreas arises from the possible 
application to the treatment of diabetes (Weir, 2004; Weir and Bonner-Weir, 2004). 
The investigations based on gene-knockout showed that many factors, mainly the 
transcription factors located on the c/s-regulatory region of endocrine hormone (i.e. 
insulin), are involved in the regulation of the pancreatic endocrine cell development. 
Basically, these transcription factors belong to three different families: the 
homeodomain family, the basic helix-loop-helix (bHLH) family and the winged helix 
family of proteins (Schwitzgebel, 2001). The following paragraphs introduce these 
transcription factors including the onset of expression, function and the studies 
performed showing the roles of these factors in the developing pancreas (see Figure 
1.1) (Wilson et al., 2003).
17
W-C Li In vitro transdifferentiation of liver into functional pancreatic-like cells
PTFl-p48u. . W  tKocnne
Mist JT
HB9 ~  '
cells
Pdxl #     #
HNFs M l W  





Nkxs/lsll/Poxs/IAl !Pox4 ___- H  5




Figure 1.1 A simplified model for the role of islet transcription factors in endocrine 
differentiation in the developing pancreas.
1.A.3.3.1 Forkhead box (Fox) A family (Hepatocyte nuclear factors 3, 
HNF3)
Foxal (HNF-3a) and Foxa2 (HNF-3(3) belong to the winged helix family of 
transcription factors. These transcription factors contain a Fox DNA-binding domain 
along with four transactivation domains (Kaestner, 2000). As described in section 
1 .A.2, FoxA2 is expressed at about E6-E7 and is essential for formation of the foregut 
endoderm. Since homozygous deletion of the Foxa2 gene leads to the embryonic 
lethality at E11.5, due to a defect in foregut morphogenesis, a conditional knockout is 
needed to investigate the function of Foxa2 in pancreas development. Recently, a 
specific knockout of Foxa2 in pancreatic (3 cells was described. The animals showed 
hyperinsulinemic hypoglycemia revealing that Foxa2 is important for the maintenance 
of normal pancreatic histoarchitecture and the preservation of a normal physiological 
response to glucose. More recently, it was suggested that Foxa2 is also essential for 
the generation of glucagon-producing cells (Lee et al., 2005; Sund et al., 2001). 
Foxal is expressed in the endoderm at E7.5 (Monaghan et al., 1993) and knockout of 
Foxal does not affect development of the pancreas. Postnatally, targeted disruption of
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Foxal in the pancreas led to hypoglycaemia due to the reduced transcription of the 
glucagon gene (Kaestner et al., 1999).
1.A.3.3.2 Hlxb9
The Hlxb9 gene is a homeobox gene encoding HB9 protein. The earliest 
expression of Hlxb9 is detected at E8 in the notochord and gut endoderm and is later 
restricted to the adult islet p cells (Li et al., 1999). Deficiency of Hlxb9 in mouse 
pancreas causes failure of dorsal pancreas formation. The ventral pancreas forms at 
the expected time but with reduced (3 cell population (Li et al., 1999). It has been 
suggested that Hlxb9 is required for the generation of the dorsal pancreas as well as 
the terminal differentiation and maturation of pancreatic p cells. Conversely, 
experiments using the Pdx1 promoter to drive expression of Hlxb9 in the pancreas 
resulted in drastically perturbed pancreatic organisation and impaired differentiation. 
This notion is evidenced by the detection of more elongated, tube-shaped 
intestinal-like structure in the pancreatic area and decreased insulin-, amylase- and 
carboxypeptidase A-expressing cells (Li and Edlund, 2001). It further confirmed the 
necessity of tightly-controlled temporal expression of Hlxb9 during pancreas 
development.
1.A.3.3.3 Pancreatic duodenal homeobox 1 (Pdx1)
Pdx1 is a homeodomain containing protein and may be the most widely-studied 
transcription factor involved in pancreas development. Pdx1 is expressed in the 
pancreatic primordium, distal stomach epithelium and proximal duodenal region at 
around E8.5 (Guz et al., 1995) and has been shown important for the transactivation 
of several pancreatic genes including insulin, glucagon, somatostatin, islet amyloid 
polypeptide (JAPP) and glucose transporter GLUT-2 (Miller et al., 1994; Ohlsson et al.,
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1993; Waeber et al., 1996; Watada et al., 1996a). In mice carrying a null mutation for 
the Pdx1 alleles, the pancreas was absent, despite the initial formation of the 
pancreatic bud (Ahlgren et al., 1996; Johansson et al., 1999; Offield et al., 1996). 
Based on this result, the function of Pdx1 in later stages of pancreas development 
could not be examined. Recently, mice were generated with Pdx1 expression 
disrupted specifically in the pancreatic p cells. The mice lost p cells and developed 
diabetes. This demonstrated a second role for Pdx1 in the maintenance of pancreatic 
p cell identity and glucose-sensing machinery (Ahlgren et al., 1998). More recently, a 
mouse model was generated in which Pdx1 can be switched on or off at a specific 
stage of pancreas development. The results suggested that Pdx1 is essential for 
maintenance of p-cell functions, correct pancreatic structure, as well as exocrine 
development in the adult pancreas (Hale et al., 2005; Holland et al., 2005).
1.A.3.3.4 Islet 1 (Isl1)
Islet 1 belongs to the LIM-homeodomain family of proteins. In the pancreas, 
expression of Isl1 begins at E9 in the dorsal pancreatic epithelium and the 
mesenchymal region surrounding the dorsal bud but not in the ventral pancreatic 
primordia. Later, lsl1 is detected in the adult islets (Ahlgren et al., 1997). In Isl1 mutant 
mice, development is arrested soon after E9.5. The dorsal pancreatic mesenchyme is 
not formed, endocrine development is abolished and the exocrine component of the 
dorsal pancreas is largely decreased. However, the exocrine cell deficiency was not 
seen in the ventral region. The importance of Isl1 in islet cell differentiation was further 
confirmed by explant experiments. Exocrine, but not endocrine, cell differentiation in 
the dorsal pancreas can be rescued in vitro by co-culture with the mesenchyme 
derived from wild type embryos suggesting that Isl1 is essential for the generation of 
the dorsal pancreatic mesenchyme which in turn is important for exocrine
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differentiation. In addition, Isl1 has been shown to bind the promoters of several 
pancreatic genes including insulin, glucagon and somatostatin (Brink, 2003) and is 
therefore necessary for the functional identity of islet cells.
The aforementioned transcription factors mainly play a role in determining the 
region of the gut endoderm to become the pancreas (Pdx1 is also required for (3-cell 
function). Sequentially, the following factors are responsible for defining the formation 
of exocrine or endocrine progenitors (such as Ngn3, PTF1a-p48 and HNF6) and are 
required for the final differentiation of the various cell lineages.
1.A.3.3.5 Hepatocyte nuclear factors 6 (HNF6)
During pancreas development, HNF6 is detected at E9.5 in the epithelial cells 
and is later restricted to the exocrine and ductal cells (Rausa et al., 1997). In HNF6 (-/-) 
embryos, the exocrine pancreas develops normally however the endocrine phenotype 
is severely inhibited. At birth, fewer endocrine cells were found and the islets of 
Langerhans are absent in this animal. Interestingly, the islets reappeared with 
disrupted architecture at a later stage (Jacquemin et al., 2000). Therefore, the 
pancreatic epithelial cells can be committed in the absence of HNF6. However, they 
may fail to give rise to the expected precursor endocrine pool. This notion is 
supported by reduced Ngn 3, a potential marker of endocrine precursor cells, 
expression in HNF6 null mice (Jacquemin et al., 2000).
1.A.3.3.6 Ngn 3 and Hairy/Enhancer of Split-related protein 1 (Hes-1)
Ngn3, a bHLH transcription factor, is expressed in pancreas from E9.5, peaks at 
E15.5 and diminishes thereafter to undetectable levels in the neonatal mouse 
pancreas (Apelqvist et al., 1999). The Ngn3 knockout animal lacks endocrine cells at
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birth, while the persistent overexpression of Ngn3 drives the formation of additional 
endocrine cells (Apelqvist et al., 1999; Gradwohl et al., 2000). It is thought that Ngn3 
is responsible for the commitment of endocrine cells rather than all pancreatic cell 
lineages and mirrors its role in the later stages of pancreas development. It further 
confirmed that Ngn3 may require another ‘central regulator’ to change cell fate. More 
recently, Ngn3 was also shown to be crucial for differentiation of endocrine cell types 
in intestine and stomach (Jenny et al., 2002). For example, Ngn3 might be a mediator 
for converting intestinal epithelial cells to insulin-positive cells following treatment with 
glucagon-like peptide 1 in vitro and in vivo (Suzuki et al., 2003).
Hes1 also encodes a bHLH protein and is expressed at E9.5 in pancreas. The 
detection of pancreatic endocrine cell excess in the Hes1 (-/-) animals has suggested 
that Hes1 may have a role in repressing endocrine cell development through Notch 
signalling (Jensen et al., 2000b). The elevated expression of Ngn3 in the stomach, 
small and large intestine in Hes1 (-/-) mice confirmed that Hes1 and Ngn3 have 
opposite effects on the determination of endocrine cell fate (Sumazaki et al., 2004). 
Based on the pro-endocrine action of Ngn3, impaired expression of Hes1 would be 
predicted to increase differentiation of pancreatic endocrine cells. To further support 
this idea, conversion of the developing biliary system to pancreatic tissue in Hes1 
deficient mice has recently been described (Burke et al., 2004; Sumazaki et al., 2004). 
The experiments also claimed that the conversion from biliary system to 
pancreatic-like cells might be through the re-activation of Ngn3 that is initially 
restrained by Hes1.
The generation of scattered endocrine islets in the pancreas from an initial 
homogenous field of cells is executed by a process termed lateral inhibition mediated 
by the Notch signalling pathway. Along with the observations of Ngn3 and Hes1 
deficient animals, a model about how the exocrine-endocrine cell fate is determined
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was proposed (Docherty, 2001; Edlund, 2001). In this model, the high expression of 
Ngn3 activates Delta, the Notch ligand, in the endocrine cells and stimulates the 
adjacent cells to upregulate Hes1, in turn inhibiting Ngn3 expression to make the 






Figure 1.2 Role of Delta/Notch signalling in controlling endocrine versus exocrine cell 
differentiation. Reproduced from Docherty 2001
1.A.3.3.7 Pancreatic transcription factor 1 (PTF1-p48)
The bHLH transcription factor PTF1-p48 was first described as a DNA-binding 
subunit of the hetero oligomeric trancription factor PTF-1 The latter governs the 
expression of genes in the exocrine pancreas (Krapp et al., 1996). Recent results 
have revised the role of PTF1-p48, to also include an involvement in both exocrine 
cell lineage determination and accurate endocrine spatial organization in murine and
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zebrafish models (Kawaguchi et al., 2002; Krapp et al., 1998; Lin et al., 2004). 
1.A.3.3.8 Proxl
In addition to the importance for liver development, the homeobox gene Proxl 
has been shown to be expressed at E8.5 in the endodermal region that will give rise to 
liver and pancreas (Burke and Oliver, 2002). The fundamental role of Proxl for 
pancreas growth and appropriate morphogenesis (i.e. branching) has been confirmed 
recently using Proxl (-/-) mice (Wang et al., 2005). Proxl possesses a second role for 
further differentiation of endocrine cells based on the observation of substantial 
decrease in Ngn3, Pax4, NeuroDI and insulin producing cells at E13.5 in 
gene-disrupted mice (Wang et al., 2005). Conversely, the pancreatic exocrine cell 
numbers were shown to be increasing. Altogether, these observations suggest Proxl 
might not be involved in initiating pancreas development but it may be essential in 
stabilising endocrine cell identity.
1.A.3.3.9 NeuroDI I p cell E-box trans-activator 2(Beta2)
NeuroDI is a bHLH transcription factor expressed in the developing pancreatic 
epithelium at about E9.5 and in p cells throughout development (Naya et al., 1995). 
The essential role for NeuroDI in pancreatic endocrine development was shown by 
the detection of severely reduced endocrine phenotypes in homozygous mice at birth. 
NeuroDI (-/-) mice died within 5 days after birth due to the hyperglycaemia resulting 
from impaired islet formation. Moreover, p cells undergo massive cell death starting 
around E17.5 in NeuroD mutant mice (Chae et al., 2004; Naya et al., 1997).
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1.A.3.3.10 Paired-box homeobox gene Pax4/6
The paired-box homeobox genes encode key transcription factors involved in the 
organogenesis of many tissues including eye, brain and endoderm-derived organs 
such as the pancreas and thyroid gland (Mansouri et al., 1999). Among them, Pax4 
and Pax6 are associated with pancreatic endocrine differentiation. Pax4 and Pax6 are 
first expressed in the pancreas at E9.5 and E9, respectively (Sosa-Pineda et al., 1997; 
Turque et al., 1994). Targeted-disruption of Pax4 results in the absence of (3 and 6 
cells in the newborn mice whereas a cells are increased (Sosa-Pineda et al., 1997). 
The insulin and glucagon producing cells were detected in mutant mice at E10.5, 
however, insulin is no longer present by E13.5. Therefore, Pax4 plays a similar role to 
Proxl, that is to say, to maintain (3 cell differentiation and maturation rather than to 
initiate it. On the other hand, Pax6 seems to be more crucial for the a cells 
(glucagon-producing cells)(Sosa-Pineda, 2004; St-Onge et al., 1997). Double 
knockout of Pax4 and Pax6 have also been generated and show the complete loss of 
endocrine cell types (St-Onge et al., 1997). Hence, Pax4 and Pax6 act cooperatively 
to regulate islet cell identities.
1.A.3.3.11 NK class homeodomain protein Nkx2.2/Nkx6.1
NK class homeobox genes, Nkx2.2 and Nkx6.1, act at a relatively late stage of 
pancreas development. Nkx2.2 is expressed at E9.5 in the whole pancreatic 
endocrine epithelium then becomes restricted to a, (3 and PP cells (Sussel et al., 
1998). Reduced expression of Nkx2.2 decreases the number of (i) a and PP cells and 
(ii) the number of mature (3 cells (as indicated by the detection of IAPP and 
prohormone convertase 1/3 (PC1/3) in the absence of insulin). More recently, Prado 
et al. found that (3 cells were replaced by pancreatic £ cells (ghrelin-positive cells) in 
both Nkx2.2 (-/-) and Pax4 (-/-) mice (Prado et al., 2004).. The expression of Nkx6.1
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protein starts at E10.5 broadly in whole pancreatic epithelium and becomes confined 
to insulin producing cells in the adult pancreas (Oster et al., 1998). Nkx6.1 null 
animals display profoundly decreased (3 cell numbers after E12.5 stage (Sander et al.,
2000). Therefore, Nkx6.1 is required for expansion and final differentiation of p cell 
progenitors.
The phenotype of the Nkx2.2 (-/-) and double (Nkx2.2 and 6.1) knockout animals 
is very similar (Sander et al., 2000). Since Nkx2.2 is still present in Nkx6.1 (-/-) mice 
this indicates a possible common pathway with Nkx2.2 upstream of Nkx6.1.
1.A.3.3.12 Other transcription factors
In addition to the factors mentioned above, some additional transcription factors 
have been found to be important for pancreas development. For example, a 
POU-homeodomain protein Brn4 was found to be expressed in the developing 
pancreas and is responsible for the determination of progenitors to pancreatic a cell 
lineage (Heller et al., 2004; Hussain et al., 2002). In addition, the homeobox 
containing transcription factor Arx, which has restricted expression in the islet cells of 
the adult pancreas, is also required for a cell generation (Collombat et al., 2003). 
Recent data suggested that Arx might be cooperatively interacting with Pax4 thereby 
mediating proper endocrine fate allocation (Collombat et al., 2005).
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1.B Transdifferentiation 
1.B.1 Overview
It used to be generally accepted that the terminally differentiated state of a cell 
was fixed. However, we now know this is not the case and it has become clear that 
the differentiation status of some cell types can be reversed (Slack, 1985; Slack, 1986; 
Tosh and Slack, 2002). For example, the ectopic appearance of unexpected cell types 
during embryogenesis or regeneration does occur and is referred to as “homeotic 
transformation”, heterotopias or transdetermination (Slack, 1985). Most homeotic 
transformations are observed among the Arthropoda or Crustacea but it has also 
been documented in humans (Slack, 1985). Metaplasia is the term used to describe a 
change in tissue type which occurs in postnatal life (Slack, 1985) and can also be 
used to represent the alteration in cell fate of stem cell populations (Slack and Tosh,
2001). Transdifferentiation is one subset of metaplasias defined as an irreversible 
switch of one type of already differentiated cell to another, although such events are 
believed to be extremely rare in nature (Tosh and Slack, 2002). Normally 
dedifferentiation and cell division are essential intermediate processes for 
transdifferentiation although they may not be obligatory in all cases (Beresford, 1990). 
Transdifferentiation and metaplasia are associated with a discrete change in cellular 
morphology as well as a change in the programme of gene expression. At the 
molecular level, the cause of transdifferentiation is presumably a change in the 
expression of a master regulatory (master switch) gene whose normal function is to 
distinguish the two tissues in normal embryonic development (Slack and Tosh, 2001; 
Tosh and Slack, 2002).
It is important to study transdifferentiation for several reasons. First,
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understanding the molecular basis of cell-type switches will enhance our knowledge 
of normal developmental mechanisms. Second, from a pathological point view, some 
metaplasias predispose to malignant cancer and therefore may reveal useful cellular 
or molecular information for developing treatments for these diseases. Third, perhaps 
of most interest at present, uncovering the mechanisms controlling cell type 
conversions improve the ability to reprogramme cell fates for the development of 
therapeutic strategies for the treatment of degenerative and autoimmune disorders, 
such as Parkinson’s disease and diabetes mellitus (Burke and Tosh, 2005; Kume,
2005).
1.B.2 Criteria and Controversies of 
transdifferentiation
In order to clearly demonstrate that transdifferentiation has occurred, two criteria 
must be fulfilled (Eguchi and Kodama, 1993; Slack and Tosh, 2001; Tosh and Slack,
2002). The first prerequisite is that the differentiated state before and after 
transdifferentiation must be identifiable. Morphological differences between parental 
and transdifferentiated cells can be used to achieve this goal but further biochemical 
or molecular evidence should also be demonstrated. For example, functional assays 
specific for the converted cell type could be performed. The second requirement is to 
show the direct ancestor-descendant relationship between the cell types before and 
after the switch. One commonly used approach to address the ancestor-descendant 
relationship is to use the Cre-lox system. By this means, the progenies from the 
original cell type can be permanently labelled and therefore enable direct 
demonstration of the conversion event.
Recently, the term “transdifferentiation” has been applied to experiments of
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grafting of haematopoietic stem cells, or other stem cell types, into host animals. 
Some workers have claimed to find extensive colonisation by donor cells of 
differentiated tissues in the host and called this transdifferentiation. This claim has 
been highly controversial (Wells, 2002). One argument against this phenomenon is 
that, rather than direct conversion, cell-fusion may account for the mechanism behind 
the cell fate change. Alvarez-Dolado et al. found evidence of fusion of bone marrow 
derived cells (BMDC) with neurons, hepatocytes and cardiomyocytes in vivo
(Alvarez-Dolado et al., 2003). In addition, there is also the example of BMDC
incorporation into fully differentiated, non-proliferative Purkinje neurons in both
humans and mice (Weimann et al., 2003a; Weimann et al., 2003b). Cell fusion in 
non-dividing cells or damaged tissues, such as Purkinje neurons and cardiomyocytes, 
may still prove useful for developing cell therapies, however, these results did negate 
the transdifferentiation theory. Further evidence from transplantation studies
demonstrates that hematopoietic stem cells (HSCs) can rescue liver function in a 
mouse model of hereditary tyrosinaemia type I (Lagasse et al., 2000). These mice 
lack the enzyme fumaryl-acetoacetate hydrolase (FAH) and can only survive if treated 
with the drug 2-(2-nitro-4-trifluoro-methylbenzyol)- 1,3-cyclohexanedione (NBTC). 
HSCs derived from Fah (+/+) mice reconstituted the Fah (-/-) liver by fusing with the 
existing hepatocytes. The authors excluded the possibility that HSCs from Fah (+/+) 
mice converted to hepatocytes prior to fusion (Wang et al., 2003). It was also shown 
that granulocyte macrophage progenitors (GMP, the colony forming units of progenitor 
for granulocytes, macrophages and dendritic cells) or bone marrow-derived 
macrophages fuse with the host hepatocytes and rescued the mutant phenotype 
when transplanted into Fah (-/-) mice (Willenbring et al., 2004). In addition to these in 
vivo models, it has been also demonstrated that mouse bone marrow derived cells 
can spontaneously fuse with embryonic stem cells when cultured in the presence of
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the cytokine interleukin-3 (IL-3) (Terada et al., 2002). Ying et al. also found that neural 
stem cells co-cultured with embryonic stem cells could alter the phenotype through 
spontaneous generation of hybrid cells (Ying et al., 2002).
To date, BMDCs, consisting of HSCs and mesenchymal stem cells (MSCs), have 
been shown to fuse with liver, skeletal muscle, cardiac muscle and neurons to 
generate target tissues (Pomerantz and Blau, 2004). It is important to distinguish 
between the mechanisms of direct transdifferentiation versus cell fusion. One way to 
define these possibilities, in most cell types, is by the determination of the number of 
nuclei or chromosomes in transdifferentiated cells (Ambrosi and Rasmussen, 2005). 
There is evidence that fused cells become mononucleated again, either by nuclear 
fusion or by supernumerary nuclei elimination (Alvarez-Dolado et al., 2003; Wang et 
al., 2003). Whether the fusion products, the stable heterokaryons, can reactivate 
post-mitotic, terminally differentiated cell types to undergo cell division remains to be 
investigated. Furthermore, tissue damage is thought to be a primary factor for BMDC 
fusion with target cells, however, the precise signals regulating fusion and why only 
some cell types can fuse and others not is still unclear (Alvarez-Dolado et al., 2003; 
Wells, 2002).
Undoubtedly, more unambiguous carefully-designed experiments to confirm 
whether or not the transdifferentiation is a real biological event are required. In 
addition, how to amplify this event using molecular engineering or environmental 
selection might be another important issue for the application of transdifferentiated 
cells onto the therapeutic points (Wells, 2002).
1 .B.3 Identification of master switch gene(s)
During embryogenesis, different tissue types arise from a common cell sheet. By
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the orchestration of an on/off state of various regulatory factors in a specific temporal 
and spatial manner, individual tissues are formed (Soria, 2001). Since 
transdifferentiation appears to be the result of a single-step change, it is logical to 
assume that tissues between which such changes occur are neighbours in the sense 
that the combination of selector genes that defines them differ only in the state of one 
gene or a few genes (Slack and Tosh, 2001). The factors involving the stabilisation of 
the differentiation state might also be key regulators controlling cell fates or cell type 
switch (Eguchi and Kodama, 1993). For instance, the striated muscle tissues in 
jellyfish can be converted into neurons but transdifferentiation is inhibited in the 
absence of the extracellular matrix (ECM) (Schmid et al., 1993). This indicated that 
transdifferentiation is a cell-ECM interaction dependent event. In addition to the 
factors embedded in cell substrate, a number of genes, especially transcription 
factors, exemplify the definition of a master switch gene. For example, MyoD is a 
master switch gene for myogenesis while peroxisome proliferating activating 
receptor-gamma (PPARy), C/EBPa and phosphorylated C/EBPp are involved in 
adipogenesis (Park et al., 2004; Prusty et al., 2002; Rosen et al., 2002; Ross et al., 
2000; Tang et al., 2005). More recently, by overexpressing C/EBP(5 in pancreatic 
exocrine derived cells, the formation of hepatic-like cell types has been detected 
thereby suggesting the importance of C/EBPp during the conversion of pancreatice 
cells into liver cells. Furthermore, the potential capacity of pancreatic specific 
transcription factors including Pdx1 and Ngn3 for the conversion of hepatocytes into 
pancreatic-like cells has also been investigated (Shen et al., 2003).
1.B.3.1 Neurons derived from retinal pigmented epithelium 
(RPE)
One demonstration of transdifferentiation was the production of neural retina from
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RPE in the newt, chick, rat and human (Dutt et al., 1993; Eguchi and Kodama, 1993; 
Zhao et al., 1995). It has also been documented that neural retina cells can reversibly 
convert into RPE in chick embryo (Opas et al., 2001). The molecular basis underlying 
the transdifferentiation of RPE into neurons was investigated recently. Laminin was 
the first factor to be identified (Reh et al., 1987). Furthermore, ectopic expression of 
proto-oncogene H-ras (Dutt et al., 1993), mutation of bHLH transcription factor Mitf 
(Mochii et al., 1998) and overexpression of activated MAPK/ERK kinase MEK1 (Galy 
et al., 2002) each contribute to the transdifferentiation of RPE to neuron cells.
1.B.3.2 MyoD - a myogenic determining factor
The role of MyoD in transdifferentiation was found by a rather unusual 
experimental approach. It had been known that treatment of the mouse fibroblast cell 
line 3T3 and C3H/10T1/2CL8 with the hypomethylating agent 5-azacytidine is 
sufficient to produce three different mesenchymal lineages -  myocyte, chondrocyte or 
adipocyte clones (Taylor and Jones, 1979). All three phenotypes persist after 
withdrawal of 5-azacytidine, suggesting a stable switch has occurred. To identify 
which gene(s) was responsible for the switch from a fibroblasts to a muscle phenotype, 
subtracted cDNA probes were generated by isolating cDNA clones present in the 
5-azacytidine-treated 10T1/2 cells and the mouse myogenic cell line C2C12 but not in 
the undifferentiated 10T1/2 cells. One cDNA was identified which, when transfected 
into 10T1/2 cells, induced stable myoblast expression (Davis et al., 1987). The cDNA 
was called MyoD (Tapscott et al., 1988). It is now known that at least four myogenic 
regulatory transcription factors (MRFs) are important for skeletal muscle commitment 
and myotube formation - Myf5, MyoD, myogenin and MRF4 - and all are bHLH 
nuclear proteins (Parker et al., 2003). To determine whether MyoD was indeed the 
master switch gene for muscle, the transcription factor was introduced into primary
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fibroblasts, adipocytes, smooth muscle cells, baby hamster kidney cells, and 
hepatocytes. Upon MyoD expression, the cells started to adopt the muscle phenotype 
(myotube formation and fusion) and muscle cell markers such as myosin heavy chain 
(MHC) and myosin light chain (MLC2) were expressed (Weintraub et al., 1989). 
These results suggest that MyoD is indeed the master switch gene for muscle. MyoD 
can successfully inter-convert cells originating from different germ layers i.e. from 
hepatocyte (endoderm origin) into a myogenic phenotype (mesoderm origin), however, 
the muscle differentiation programme was not activated in all cells forced to express 
MyoD. Expression of MyoD in CV1 (an African green monkey kidney-derived cell) or 
HeLa (human cervical carcinoma) cells failed to activate differentiated muscle 
markers (Weintraub et al., 1989).
1.B.3.3 Transdifferentiation into adipocytes
Myoblasts and adipocytes arise from the same germ layer of the embryo, the 
mesoderm, and recent observations suggest it is possible to directly induce the 
conversion of myoblasts to adipocytes using G8 myoblast as a model (Hu et al., 1995). 
The transcription factors C/EBPa and PPARy, when expressed in G8 myoblasts, can 
suppress muscle-specific transcription factors (Myf5, MyoD, myogenin and MRF4) 
and, conversely, upregulate markers specific for adipocytes including aP-2, adipsin, 
lipoprotein lipase (LPL) and phosphoenolpyruvate carboxykinase (PEPCK). There are 
also cases where expression of C/EBPa in fibroblast cell lines (such as NIH3T3) will 
promote adipogenesis (Freytag et al., 1994). It has also been shown that the 
canonical Wnt signalling pathway is involved in inhibiting preadipocyte differentiation, 
probably through modulating expression of PPARy and C/EBPa (Ross et al., 2000). 
More recently, the transdifferentiation of mouse osteoblastic MC3T3-E1 cells into 
mature adipocytes by the ectopic expression of PPARy or PPARy+C/EBPa was
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performed (Kim et al., 2005) and it was shown that PPARy is a key regulator for the 
transdifferentiation to adipocytes in this model. Understanding the regulation of 
C/EBPs and PPARy is important not only for maintaining the adipocyte differentiation 
state but also in developing potential therapies for obesity.
1.B.4 Liver and pancreas transdifferentiation
One of the best-documented examples of transdifferentiation is the switch 
between liver and pancreas, a conversion that reflects the close developmental 
relationship between the two tissues (Wells and Melton, 1999). Since the liver and 
pancreas arise from adjacent regions of the embryo during development (mentioned 
in section 1 A), they may express a common transcription factor profile during the early 
stages of development. Transdifferentiation of pancreas and liver is observed 
following the exposure of animals to certain carcinogens, or in humans as 
preneoplastic alterations (Shen et al., 2003; Slack, 1985). The known molecular 
events underlying the switch between liver and pancreas and other 
endodermally-derived tissues are discussed below.
1.B.4.1 In vivo pancreas to liver transdifferentiation
Ectopic hepatic cells can be generated in the pancreas under a variety of 
conditions (Grompe, 2003; Shen et al., 2003). Rao et al observed the appearance of 
multiple foci of hepatocytes in the pancreas after the treatment of rats with a copper 
depletion-repletion scheme (Rao et al., 1986). The evidence for the presence of 
hepatocytes in the pancreas was based on the expression of albumin and catalase 
proteins although the molecular mechanisms mediating the switch in cell phenotype in 
this model remain elusive. Albumin and a-fetop^otein-positive cells have also been
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induced in the islets of Langerhans in transgenic mice expressing keratinocyte growth 
factor (KGF) under the control of the insulin promoter (Krakowski et al., 1999). By 
injection of certain carcinogens such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 
into hamsters, the pancreatic hepatocytes were induced and identified by the 
detection of Periodic Acid Schiff (PAS) staining. The ectopic hepatocytes in the 
hamster pancreas are morphologically identical to the normal liver (Rao et al., 1988). 
Additionally, two cases of hepatoid carcinoma arising from malignant islet tumor and 
pancreatic ductal carcinoma were reported in human patients (Paner et al., 2000).
1.B.4.2 In vitro transdifferentiation of pancreatic cells to 
hepatocytes
More recently an in vitro model exhibiting the formation of transdifferentiated 
hepatocytes in a subclone of the pancreatic-derived cell line AR42J (the subclone 
AR42J-B13 is referred as B13) has been described and may provide some clues to 
the mechanisms underlying the changes observed in vivo (Burke et al., 2006; Kurash 
et al., 2004; Shen et al., 2000; Tosh et al., 2002a; Tosh et al., 2002b). Dexamethasone 
induce hepatic phenotype and C/EBPp. It was demonstrated that C/EBPp is important 
for the transdifferentiation of pancreatic B13 cells to hepatocytes (Shen et al., 2000). 
Overexpression of C/EBPp induced the loss of the pancreatic phenotype and gain of 
the hepatic phenotype. The essential requirement for C/EBP(3 in the 
transdifferentiation was shown by a dominant negative approach. Introduction of liver 
inhibitory protein {UP), an alternative posttranscriptional product of C/EBPf5 mRNA, 
prior to the treatment of B13 cells with dexamethasone, inhibited the induction of 
transdifferentiation (Shen et al., 2000). Transdifferentiated hepatocytes display a wide 
range of liver properties including albumin secretion, insulin stimulated lipid deposition, 
ciprofibrate enhanced catalase expression and induction of acute phase proteins such
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as alpha2-macroglobulin (MG) and haptoglobin (Hp) (Burke et al., 2006; Kurash et al.,
2004).
1.B.4.3 Conversion of hepatic cells to pancreatic-like cells
Although experimentally less well-documented, recent progress in our 
understanding of the molecular biology of pancreatic development has taken us 
several steps closer to elucidating the mechanisms involved in the switch from hepatic 
to pancreatic cell types. Studies using mouse knockouts have demonstrated that 
certain transcription factors are essential for the steps in (3 cell formation: first the 
specification of a pancreatic rudiment in the endodermal epithelium, then the 
formation of endocrine precursor cells and finally the commitment to the |3 cell 
phenotype (Murtaugh and Melton, 2003; St-Onge et al., 1999; Wilson et al., 2003). In 
the mouse embryo, a single inductive signal, Fgf, distinguishes the region of 
endoderm that becomes the liver bud from that destined to become the ventral 
pancreatic bud (Deutsch et al., 2001), suggesting that only one or a few transcription 
factors need to have their activity switched on or off in order to interconvert the two 
tissues. Candidate transcription factors acting as master switch genes to determine a 
pancreatic fate include Pdx1, Ngn3 or Neuro D.
The notion that ectopic expression of Pdx1 may potentially induce pancreatic-like 
cells in liver was first demonstrated by Ferber et al using a first-generation adenoviral 
vector containing Pdx1 to infect streptozotocin (STZ)-induced diabetic mice (Ferber et 
al., 2000). The results showed that pancreatic genes were induced and the levels of 
blood glucose were returned to normal levels (Ber et al., 2003; Ferber et al., 2000). 
Koizumi et al. also demonstrated the induction of insulin-producing cells in 
STZ-treated mice after infection with Pdx1 in a replication-deficient recombinant 
adenoviral vector (Koizumi et al., 2004). Moreover, Miyatsuka et al revealed that
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pancreatic endocrine and exocrine products as well as some functional markers (e.g. 
islet-type glucokinase and the sulfonylurea receptor) were detected in the liver where 
Pdx1 was ectopically expressed in a transgenic mouse model (Miyatsuka et al., 2003). 
More recently, Cao et al. showed that high glucose culture conditions promotes the 
maturity of insulin-positive cells derived from liver cells overexpressing Pdx1Vp16 
(Cao et al., 2004). Imai et al. detected the insulin production in the murine liver but 
found that these insulin producing cells still possessed a hepatic phenotype as 
indicated by the presence of the liver proteins albumin and transferrin (Imai et al., 
2005). All these studies showed the activation of pancreatic genes (e.g. insulin) in 
liver cells, however, they did not show the formation of differentiated pancreatic cell 
types.
In previous experiments from our lab using transgenic Xenopus, we found that 
the unmodified Pdx1 or Xlhbox8 (Xenopus homologue of Pdx1) were not able to bring 
about transdifferentiation of liver to pancreas. However, inclusion of the Herpes 
simplex protein Vp16 domain in the construct was able to confer transdifferentiation 
potential with both the mouse and Xenopus genes(Horb et al., 2003). The conversion 
was observed by the presence of GFP in the transdifferentiated pancreas. The GFP 
was controlled by the pancreatic specific elastase promoter and was expressed in the 
liver region after ectopic expression of Xlhbox8Vp16 by the liver specific transthyretin 
(TTR) promoter. A working model is shown in Figure 1.3. The ectopic pancreas in 
Xenopus tadpoles was clearly differentiated, but there are questions about the degree 
of maturity of the liver at the time of transgene expression (Horb et al., 2003)
Ngn3 is expressed in all endocrine precursor cells and thought to be responsible 
for the commitment of endocrine cells rather than all pancreatic cell lineages (see 
section 1.A.3). The role in endoderm development supports Ngn3 as a potential 
candidate, probably being along with other pancreatic transcriptions factor(s), for the
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conversion of liver into pancreas. Only one investigation has shown the induction of 
the pancreatic gene insulin from liver cells by the expression of Ngn3, or Neuro D, in 
the presence of Pdx1Vp16 fusion protein (Kaneto et al., 2005). Furthermore, Ngn3 is 
able to drive pancreatic duct cells to a neuroendocrine phenotype with the formation 
of insulin-positive cells (Heremans et al., 2002). In addition, using helper-dependent 
adenovirus (HDAD) encoding Neuro D, in combination with betacellulin, the induction 
of islet neogenesis in the liver was observed and thereby rescue of a diabetic 
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Figure 1.3 Working model for the transdifferentiation of liver to pancreas in Xenopus 
tadpoles. (A) Green fluorescent protein (GFP) under the control of the 
pancreas-specific elastase promoter (Elas) is expressed in the pancreas of transgenic 
tadpoles. P: pancreas; L: liver. (B) Proposed scheme for transdifferentiation in 
transgenic Xenopus. Xlhbox8Vp16 is expressed in the liver of TTR-Xlhbox8Vp16; 
Elas-GFP transgenic tadpoles under the control of the hepatic-specific transthyretin 
(TTR) promoter. The ectopic pancreas (EP) in the liver is visualized by GFP. 
Persistent expression of GFP in older tadpoles indicates the stability of the 
transdifferentiated pancreas. Reproduced from Li et al, 2005
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1.B.5 Other metaplasias between internal organs
In addition to the derivation of pancreas from liver, several pieces of evidence 
have shown that pancreatic-like cells can be generated by the introduction of a single 
factor. For example, it has been demonstrated that Ngn3 might also be a mediator for 
converting intestinal epithelial cells to insulin-positive cells following treatment with 
glucagon-like peptide 1 in vitro and in vivo (Suzuki et al., 2003). Kawaguchi et al. 
demonstrated conversion of pancreatic progenitors into duodenal epithelium through 
the inactivation of PTF1-p48, thereby suggesting a close developmental relationship 
between intestine and pancreas (similar to that between liver and pancreas) 
(Kawaguchi et al., 2002). Also, it provides a possible route for creating new pancreatic 
cells following the overexpression of PTF1-p48 in other cell types such as intestine.
The generation of pancreas from different endodermal organs is not the only 
case of the transdifferentiation between two internal tissues (Slack, 1985). The 
appearance of intestinal cells in lung has been shown recently by the expression of 
hyperactive Wnt signalling (Okubo and Hogan, 2004). This observation was based on 
the drastically reduced number of Clara cells, a lack of fully differentiated alveolar type 
1 and 2 cells and abnormally high proliferation of the bronchial epithelium and the 
induction of multiple genes (trefoil factor 3, defensin related cryptidins 5, 6 and 15), 
characteristic of intestinal cell types such as Paneth and goblet cells, within the 
pulmonary epithelium of transgenic lungs. Furthermore, lungs from transgenic mice 
showed induction or upregulation in the expression of a number of transcription 
factors that are components or targets of the Notch signalling pathway. These factors 
include Atoh 1 (Mathl), not normally expressed in the lung but active in progenitor 
cells of the intestine (Yang et al., 2001). The other case is based on the likely function 
of the homeodomain transcription factor Cdx2 in controlling intestinal rather than
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foregut development. Normally Cdx2 is expressed in the caudal part of the endoderm. 
The induction of gastric intestinal metaplasia was found in transgenic mice in which 
expression of Cdx2 was controlled by cis-regulatory elements of the Foxa3 promoter 
(Silberg et al., 2002). Mutoh et al used the H+/K+ATPase [3-subunit gene promoter in a 
transgenic mouse to drive gastric Cdx2 expression and again demonstrated intestinal 
metaplasia (Mutoh et al., 2002). Evidence for the master switch function of Cdx2 is 
further supported by loss of function in the intestine leading to transformations to 
squamous epithelium resembling the oesophagus and forestomach 
(Chawengsaksophak et al., 1997).
1.B.6 Summary
Although transdifferentiation is rare as a natural phenomenon, this does not 
mean that it will be difficult or impossible to achieve by putting new genes or gene 
products into cells. With our present understanding of the transcription factors 
required for specification of various tissues, there should be many opportunities for 
successful transdifferentiation caused by gene over-expression using either in vitro or 
in vivo models.
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1.C Diabetes mellitus -  onset, classification, 
complications and treatments
In man, blood glucose is normally maintained at around 4-7 mM before diet and 
not exceed up to 10 mM after meals. The concentration of circulating blood glucose 
rises after food intake but is brought back to normal levels by the co-ordinated 
secretion of the hormones insulin (secreted from the (3 cells) and glucagon (secreted 
from the a cells) that reside in the pancreatic islets. After food intake insulin secretion 
is increased and glucagon secretion reduced. In order to maintain physiological blood 
glucose values, the pancreatic (3 cells respond through a series of reactions. These 
reactions include: (1) sensing the change in blood glucose levels (2) uptake of 
glucose into the (3 cells; (3) glucose being metabolised by the glycolytic pathway; (4) 
depolarisation and calcium entry; and (5) release of insulin granules and further 
insulin synthesis.
Diabetes mellitus (hereafter simply referred to as diabetes) is a complex 
metabolic disorder characterised by a relative or absolute lack of insulin. The reasons 
for this relative or absolute lack of insulin are due to either destruction of the (3 cells 
(e.g. by autoimmune antibodies to a glutamic acid decarboxylase GAD65) (Mackay 
and Rowley, 2004) ; or to a loss of ability of (3 cells to cope with demand (|3 cell 
dysfunction); or to the lack of response to insulin from peripheral organs (insulin 
resistance). The loss of (3 cells by autoimmune destruction is referred to as Type I or 
insulin-dependent diabetes mellitus and the others as Type 2 or non-insulin 
dependent diabetes. In fact many type 2 diabetic patients are treated with insulin so 
the term “non-insulin dependent” is something of a misnomer.
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1.C.1 Response of P cells to the change of blood 
glucose
1.C.1.1 Glucose sensing by pancreatic islets
After food intake, carbohydrates are broken down into mono- and disaccharides 
by the digestive enzymes secreted from the pancreas and intestine. The glucose is 
absorbed across the intestinal epithelium with the result that the blood glucose level 
rises. Insulin is released from the pancreatic (3 cells in response to this physiological 
challenge resulting in an increase of glucose uptake in peripheral tissues such as 
skeletal muscle and adipocytes. The insulin stimulated glucose uptake is mediated 
by GLUT4, a member of the GLUT family of glucose transporters (Foster and Klip, 
2000). Once inside the cell, glucose is converted into glycogen in muscle or converted 
to lipids in adipose tissues (lipogenesis) (Nonogaki, 2000).
Glucose sensing is the first step leading up to the release of insulin from the |3 
cells. In this step, both the high-Km glucose transporter GLUT2 and the high 
Km-glucose phosphorylating enzyme glucokinase (GCK) are important (Efrat et al.,
1994).
In order to respond to an elevated glucose concentration, glucose must enter into 
(3 cells. Glucose entry occurs by facilitated diffusion via GLUT2. GLUT2 was originally 
cloned from a rat liver cDNA library and is expressed specifically in liver and 
pancreatic islets (Unger, 1991). A parallel correlation has been shown between 
reduced GLUT2 levels and loss of glucose-induced insulin secretion in Zucker 
diabetic mice (Johnson et al., 1990). In addition, hyperglycaemia is observed in 
transgenic mice overexpressing GLUT2 antisense RNA. This reveals that GLUT2 
might be not only responsible for the transportation of glucose into cells but also
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essential for maintaining the glucose homeostasis. However, different observations 
were presented in other animal models. For example, In RIP-Hras transgenic mice 
(Hras protein is specifically expressed in insulin-producing cells), there is a reduction 
of GLUT2 but this change did not affect glucose homeostasis (Tal et al., 1992). 
Furthermore, in man, another member of the glucose transporter family, GLUT1, is 
more abundantly expressed than GLUT2 in pancreatic (3 cells (De Vos et al., 1995). 
These results suggested that the function of GLUT2 may be primarily for the transport 
of glucose into cells (Schuit, 1997).
GCK is a member of the hexokinase family of enzymes and expressed in 
pancreatic p cells and hepatocytes. GCK catalyses the ATP-dependent 
phosphorylation of glucose after glucose entry into pancreatic (3 cells (Weir et al., 
1997) generating glucose-6-phosphate (G-6-P) (Tirone and Brunicardi, 2001). It 
functions as a glucose sensor in (3 cells by controlling the rate of entry of glucose into 
glycolysis and the tricarboxylic acid (TCA) cycle (Matschinsky et al., 1998). A 
decrease in p-cell glucokinase activity is observed in several situations associated 
with decreased insulin release. For example, the rat insulinoma RIN-m5F cells secrets 
little or no insulin in response to glucose and is correspondingly deficient in 
glucokinase (Meglasson and Matschinsky, 1986). It was also reported that the 
impaired GCK activity is related to one type of an autosomal dominant mode of 
inheritance mature-onset diabetes of the young, MODY 2 (Froguel et al., 1993). This 
further confirms the importance of GCK for insulin secretion and glucose 
homeostasis.
1.C.1.2 Insulin secretion
Metabolism of glucose through the glycolytic pathway yields two molecules of 
ATP (MacDonald et al., 2005). As a result of the increase in ATP production, the
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intracellular ATP/ADP ratio is increased. This change leads to closure of K Atp  
channels which then results in depolarisation of the cell membrane. Ca2+ accumulates 
in the membrane-depolarised cells via activation of the VGCC or release of Ca2+ from 
the ER. In addition to the KATp-dependent pathway, PKA and protein kinase C (PKC) 
pathways are activated by sensing the glucose metabolic signalling in a 
KATp-independent manner although the molecular basis is not yet known 
(Bratanova-Tochkova et al., 2002).
Biphasic insulin secretion is observed in the pancreas following rapid and 
sustained stimulation of (3 cells with glucose (Henquin et al., 2002). The immediate 
reaction, so-called first phase insulin release, is mediated by rapid release of the 
insulin granule pools in a Ca2+- dependent manner (Straub and Sharp, 2004). The 
insulin granule populations are complex, consisting of three pools including a reserve 
pool, a docked pool and a readily releasable pool. The increase of the intracellular 
Ca2+ concentration is accelerated not only by the closure of KATP channel but also by 
several KATp-independent mechanisms (Straub et al., 2002). The orchestration of 
KATp-dependent and KATP-independent signals positively augments the pre-existing 
insulin granules to release insulin. Under prolonged exposure to a high glucose 
environment, the demand for insulin to maintain normal physiological glucose 
homeostasis drives the next round of insulin production, namely insulin biosynthesis.
1.C.1.3 Insulin biosynthesis
Insulin is synthesised in response to prolonged elevated blood glucose. Briefly, 
the sequence of events is as follows: (1) production of preproinsulin transcripts in the 
cell nucleus; (2) packaging of preproinsulin into proinsulin in the rough endoplasmic 
reticulum (RER); (3) synthesis of mature insulin from proinsulin in the Golgi apparatus 
and lastly (4) precipitation of insulin protein in the secretory granules (Figure 1.4).
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Figure 1.4 Illustration of insulin secretory pathway. Details are discussed in chapter
1.C. 1.2 and 1.C.1.3. Reproduced from Tischler 2004
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The preproinsulin is the original single polypeptide used to form mature insulin. It 
consists of four regions, from N-terminal to C-terminal, a hydrophobic signal sequence 
(SS), B-chain polypeptide, connecting peptide (C-peptide) and A-chain polypeptide 
(Figure 1.5). Figure 1.6 showed the processing of preproinsulin to folded proinslin. 
Briefly, the transcribed preproinsulin mRNA moves to a ribosome and sequentially 
binds to the signal recognition particle (SRP) initiating protein translation. The 
translated SS peptide (called the nascent chain) tags onto the SRP and migrates to a 
high-affinity receptor for SRP named the SRP docking protein (SRPdp) that is located 
at the external surface of RER (Gilmore et al., 1982). Subsequently, the ribosome 
dissociates from the SRP and SRPdp and is restrained by the ribosome receptor (RR) 
on the ER membrane. The natural hydrophobic property of SS (22 of 24 amino acids 
in SS are hydrophobic) facilitates and enhances the binding affinity between 
ribosome-mRNA complex and the phospholipid bilayer of the ER membrane (Do et al.,
1996). In addition to SRPdp, other membrane proteins such as translocating-chain 
associated membrane (TRAM) and Sec61 proteins are essential for directing the 
ribosome-mRNA complex to the ER membrane (High et al., 1993; Knight and High, 
1998; Voigt et al., 1996). Through the joint interaction of membrane proteins, the 
complex is placed at the site on the ER membrane termed a translocon (McCormick 
et al., 2003) where the SS peptide guides the extension of the preproinsulin 
polypeptide chain into the ER lumen. The SS peptide is excised by signal peptidase 
positioned on inner ER membrane and proinsulin is formed. The native proinsulin is 
then folded by a molecular chaperone (e.g. protein-disulfide isomerase, PDI) by the 
formation of the disulfide bonds (Winter et al., 2002).
The vesicles filled with proinsulin then bud out from the RER towards the Golgi 
apparatus where the zinc / calcium rich environment around the Golgi favours the 
formation of the zinc-containing proinsulin hexamer (Dodson and Steiner, 1998).
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Proinsulin passes through c/'s, medial, and trans Golgi cisternae and is converted to 
insulin at the stage of vesicle formation. This transformation is driven by 
membrane-associated prohormone convertase enzymes (PCs). The catalytic sites 
targeted by PCs are called the dibasic sites (Goodge and Hutton, 2000). 
Subsequently, the granules are packed with mature insulin, coupled with the 
precipitation of removed C-peptide and are maintained in the cytoplasm as an “insulin 
secreting vesicle pool”. Once the (3 cells sense certain physiological challenges such 
as high glucose, the insulin is secreted through the release of these primary granules 
in order to maintain normoglycaemia.
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Figure 1.5 The amino acid sequence of human preproinsulin. The four domains of 
preproinsulin are shown. See chapter 1.C.1.3 for details. Reproduced from p.65 of 
Insulin: Molecular Biology to Pathology, 2nd edition, Edited by F.M. Aschroft and S.J.H. 
Aschroft, 1992
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Figure 1.6 Mechanism for uptake of preproinsulin into the lumen of the ER and 
subsequent processing to proinsulin. Details are described in chapter 1.C.1.3. 
Reproduced from Tischler 2004
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1.C.2 Classification of Diabetes mellitus
A relative or absolute lack of insulin means that glucose cannot enter 
insulin-responsive cells (i.e. muscle and adipocytes). Under these circumstances, 
diabetes results. Diabetes is the name given to the clinical description of patients with 
a number of symptoms arising from raised glucose levels. A number of pathological 
complications arise in diabetic patients if the blood glucose levels are poorly 
controlled. Examples of complications include angiogenic disorders (cardiovascular 
disease, hypertension, retinopathy), neuropathy and kidney dysfunction. One of the 
possible molecular mechanisms responsible for these complications is via the 
increased oxidative stress induced by chronic hyperglycaemia (King and Loeken,
2004). In brief, persistent hyperglycaemia will drive insulin-independent tissues to 
take up glucose. The increased glucose will enter glycolysis, Krebs cycle and 
oxidative phosphorylation pathways (King and Loeken, 2004). This increased flux 
generates excess reactive oxygen species (ROS) (see Figure 1.7) and the 
accumulated ROS elicits the increased oxidative stress and may interfere with normal 
function of tissues. For example, the ROS increase: blood flow in the retina (Kowluru 
and Kennedy, 2001) (retinopathy) and contractility of vascular smooth muscle cells 
(Sharpe et al., 1998) (vascular disorders). ROS decreases neural conductivity in 
peripheral nerves (Hounsom et al., 2001) (neuropathy). Another major factor in the 
development of the diabetic complications may be the increased glycosylation of 
proteins. This can be lead to the accumulation of advanced glycosylation 
end-products and lipoxidation end-products (AGEs/ALEs) (Wada and Yagihashi,
2005). AGEs/ALEs can induce cross-linking of proteins or induce specific cellular 
responses including the release of profibrogenic and proinflammatory cytokines thus 
causing diabetic retinopathy and nephropathies such as glomerulosclerosis,
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interstitial fibrosis, and tubular atrophy (Bohlender et al., 2005). In addition to ROS 
and AGEs/ALEs, VEGF in diabetic retinopathy (Aiello, 2005) and microalbuminuria for 
cardiovascular and renal disorders in T2DM (Lane, 2004) has also been shown.
s \ m \  NADr
A — —  sorbitol
lildote reduct asc
nonetuymatic p.lipaxeC*"^ DAG -►  J PKC
glycatioo J  I----------- , DA{. K 7 "
glucose****!1—
, ( G6PD >
1  NADPH
v  NADP‘ \
fructose-6-P — — — ► g|ucosainine-6*P
i  
I












+ 0 , — ► 11.0. ------- ► 11,0 + 0,
SOD catalase
Figure 1.7 Schematic diagram of pathways that contribute to oxidative stress in 
response to increase glucose flux. Reproduced from King and Loeken 2004.
1.C.2.1 Type 1 diabetes m ellitus (T1DM)
As previously mentioned, there are two types of diabetes T1DM and T2DM. 
T1DM is much less common than type II diabetes and the patients are
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insulin-dependent. Type I diabetes usually appears suddenly in non-obese children or 
young adults. This is why it has been referred to as juvenile-onset diabetes. T1DM is 
an autoimmune disease characterised by the destruction of the p-cells. This occurs as 
a result of direct attack by aberrant p-specific autoimmune antibodies (Narendran et 
al., 2005). T1DM is characterised by the presence of antibodies and T-cells response 
to islet proteins. Histological analysis of islets shows lymphocyte attack which is not 
present in a type 2 or a healthy individual (Foulis et al., 1987). Further evidence to 
suggest an autoimmune disease comes from experiments performed using 
immunosuppressor to modulate T1DM. Immunosuppressive drugs such as 
cyclosporin and azathioprine can slow the progression of p cell destruction and have 
been used in prevention trials for T1DM (Narendran et al., 2005). Candidates for the 
islet auto-antigens include islet cell antigen (Narendran et al., 2005), insulin or 
proinsulin (Palmer et al., 1983), glutamic acid decarboxylase (GAD) (Baekkeskov et 
al., 1990) and protein tyrosine phosphatase (IA-2) (Narendran et al., 2005). 
Interestingly, the diabetic phenotype (i.e. glucose intolerance) is not detected until the 
late stage of the disease in spite of the presence of autoimmune antibodies for several 
years (Knip et al., 1994). This observation suggested that the preclinical period of 
T1 DM is long and might allow the provision of appropriate treatment so as to save any 
residual p cell mass or even prevent T1 DM (Narendran et al., 2005).
1.C.2.2 Type 2 diabetes mellitus (T2DM)
T2DM is a complex illness with both genetic and environmental pathogenic 
elements. T2DM patients are usually obese, have disturbed insulin secretion and 
peripheral insulin insensitivity (Beck-Nielsen and Groop, 1994). The onset of T2DM is 
due to the prolonged exposure of pancreatic p cells to glucose. This eventually leads 
to p-cell exhaustion and glucose toxicity. The effect of p-cell exhaustion is the early
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form of the disease and is likely to be reversible whereas the glucose toxicity (or 
called (3-cell failure) occurs later in the disease and is less reversible (Rossetti et al., 
1990). More recently, a harmful effect of elevated levels of free fatty acids on p-cell 
function have also been studied and suggested that diabetes is not only the 
carbohydrate disease but is also associated with disordered lipid metabolism (Unger, 
1995). In addition, the deposits of islet amyloid present in T2DM diabetic pancreas 
may lower the functional p-cell mass (Kahn et al., 1999; Marzban et al., 2003). 
Several lines of evidence indicated that hyperglycaemia induces p-cell apoptosis by 
inducing apoptotic molecules including glucose-induced NF-kB, apoptotic-associated 
protein caspase 3 and ROS. Once the apoptosis-related factors have accumulated, 
p-cell mass is reduced, insulin secretion is impaired and eventually diabetes occurs 
(Mandrup-Poulsen, 2003). Insulin resistance and p-cell dysfunction (exhaustion of p 
cells) are the two major clinical characteristics found in T2DM diabetic subjects.
As described in detail in section 1.C.1, insulin acts to maintain euglycaemia and 
this process involves several steps. A significant disruption of any of these actions 
regardless of the presence of normal or even high circulating levels of insulin 
indicates the presence of “insulin resistant” phenotype (Reaven, 1988). Insulin 
resistance is the first defect to be detected in T2DM and must be accompanied by p 
cell deficiency for full development of the disease (Martin et al., 1992). The early 
insulin resistance in insulin-targeted organs including liver, muscle and adipose 
tissues starts to be detected during pre-diabetic stage and therefore elevated insulin 
is subsequently produced from p cells to compensate the require of insulin to maintain 
glucose homeostasis. Over a period of time, however, overexpression of insulin does 
not match the requirement of insulin to uphold euglycaemia and the next pathological 
condition, p-cell failure, occurs. Furthermore, the expansion of p-cell mass, namely 
islet hyperplasia, is another notable and consistent feature associated with insulin
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resistance in T2DM animals (Tokuyama et al., 1995).
The working model for the (3-cell dysfunction in T2DM can be discussed using a 
T2DM animal model, 90% pancreatectomy (Px) rats. It was found that insulin 
secretion is enhanced (hypersensitivity) during the period when the blood glucose is 
as stable as the level in control animals (within 2 weeks post surgery) in Px rat 
(Bonner-Weir et al., 1983). This can be explained by the idea that, in order to 
compensate for the demands of insulin, |3 cells overwork to produce sufficient insulin 
to reach normoglycaemia. Another effect that accompanies the hypersecretion of 
insulin from (3 cells in Px rats is the increase of glucokinase activity. This increased 
activity is thought to increase glucose sensitivity (discussed in section 1.C.1.1). 
Additionally, an increase in the low-Km hexokinase activity is also observed in 90% of 
diabetic rats in comparison with the non-diabetic control animals (Hosokawa et al., 
1995). Higher activity of hexokinase results in increased sensitivity of (3 cells even 
when the blood glucose concentration is low. Thus, established hyperglycaemia and 
enhanced p-cell hexokinase activity lead to very high level of insulin output (Cockburn 
et al., 1997). Since the insulin-targeted tissues are insulin-resistant, the 
hyperglycaemia is more serious in spite of constitutive insulin secretion. Finally, 
overworked p cells become fatigued and insulin granules are depleted.
The occurrence of dysfunctional insulin receptor (IR) and downstream kinase 
provided another mechanism to explain why insulin resistance occurs. In the 
peripheral organ (e,g, muscle and liver) of insulin resistant subjects, a defect of IR and 
the insulin receptor kinase was observed (Farese et al., 2005; Kellerer and Haring,
1995). Defects in IR function were originally determined by the detection of IR-specific 
autoimmune antibody, the mutation on IR and the decreased IR numbers (Kahn et al., 
1996; Taylor et al., 1990). However, this defect is unlikely to be significantly 
contributing to the pathology of diabetes while the antibody titre is generally low and
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large changes of insulin-IR binding have never been seen (Kahn et al., 1996). More 
attempts therefore were turned to investigate the effect of deficient IR kinase for the 
onset of insulin resistance. Insulin-IR binding activates insulin receptor substrate-1 
(IRS-1 )-dependent phosphatidylinositol 3 - kinase (PI3K) which activates atypical 
protein kinase C (aPKC, namely PKCA and Q and protein kinase B (PKB/Akt) 
pathways and thereby regulates glucose transport (see Figure 1.8) (Schinner et al., 
2005). The results exhibiting the reduced Akt kinase activity in the skeletal muscle 
tissue of T2DM patients (Krook et al., 1998) and defective activation of aPKC in 
muscles and adipocytes of rats with T2DM (Kanoh et al., 2001) suggested that 
IR-related kinase plays a major role for the development of insulin resistance.
1.C.2.3 Maturity-onset diabetes of the young (MODY)
MODY is a specialised type of T2DM since it is characteristic of an onset before 
the age of 25 years and usually in childhood and adolescence (Fajans et al., 2001). 
MODY can result from the mutation in any one of at least six genes. One of them, 
MODY2, encodes the glycolytic enzyme glucokinase (Froguel et al., 1993) whereas 
the other five types of MODY are associated with pancreatic transcription factors: 
HNF4a (related to MODY1) (Yamagata et al., 1996a), HNF1a (associated with 
MODY3) (Yamagata et al., 1996b), Pdx1 (associated with MODY4) (Stoffers et al.,
1997), HNF-1p (associated with MODY5) (Horikawa et al., 1997) and NeuroDI 
(associated with MODY6) (Malecki et al., 1999). These genes are all expressed in 
pancreatic p cells and the disruption of each gene leads to p-cell dysfunction, and 
eventually diabetes. In comparison to late-onset T2DM, the onset of MODY is more 
likely to be a genetic issue. This statement is supported by the fact that the screening 
of family pedigrees of MODY diabetic patients showing a history of diabetes in three 
or four generations(Busch and Hegele, 2001; Fajans et al., 2001).
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Figure 1.8 Schematic representation of insulin signaling. Binding of insulin to the IR 
activates PI3-K through IRS. Downstream of PI3-K, the phosphoinositide-dependent 
kinase (PDK) mediates activation of PKB. Activated PKB can regulate transcription of 
target genes via glycogen-synthase kinase-3 (GSK-3) or Foxola. Also, PKB regulates 
glucose uptake by recruiting GLUT-4 to the plasma membrane. Downstream of the IR 
the signalling cascade branches with PKCA and £ as additional downstream effectors 
of insulin. Modulation of PKC 0 activity by fatty acids may impair signalling through 
IRS/ PI3 kinase and GLUT4-dependent glucose transport. Abbreviations are shown in 
text. Reproduced from Schinner et al 2005
1.C.2.4 Anim al m odels o f diabetes m ellitus
In order to mimic the diabetic phenotype, several rodent models have been 
established based on the features of various types of DM (Rees and Alcolado, 2005). 
For T1 DM, toxic agents specific for (3 cells are usually used. One of the best known is 
streptozotocin (STZ). STZ is a powerful alkylating agent and activated through the 
binding of GLUT2. The administration of STZ induces multiple DNA strand breakage
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and hence specifically destroys p cells (Szkudelski, 2001). In addition, inbred 
non-obese diabetic (NOD) mice exhibiting insulitis was also generated as a model for 
T1DM study (Rees and Alcolado, 2005). T2DM represents a heterogeneous group of 
disorders, therefore animal models of T2DM are more complex. Obese animals, such 
as the ob/ob mice, db/db mice and Zucker (fa/fa) rats are used. These animals are all 
deficient for leptin or leptin receptor and develop insulin resistance thereby quickly 
developing hyperglycaemia (Chagnon and Bouchard, 1996; Lee et al., 1996).
1.C.3 Treatments for diabetes mellitus
A major aim of glucose-lowering therapy in people with diabetes is to delay or 
prevent the complications of diabetes that threaten the quality and duration of life. The 
current treatment for DM can be divided into several categories. One of the basic 
therapies is insulin administration in DM patients. The primary goal of insulin therapy 
is to replace endogenous insulin secretion in patients with T1 DM or T2DM between 
meals and overnight as well as postprandially. However, this treatment fails to provide 
tight blood glucose control, interferes with patients’ life quality and possibly can in 
some cases cause hypoglycaemia(Devries et al., 2004). Recent advances in insulin 
therapy include the insulin pump technology to make continuous subcutaneous insulin 
infusion (CSII) (Stephens and Riddle, 2003) and the improvement (i.e. requirement for 
smaller blood samples and the possibility of continuous measurement) of glucose 
monitoring systems (Goldstein et al., 2003).
Drugs that increase insulin secretion (insulin secretagogues), or decrease the 
insulin resistance, have also been used as routine treatments for diabetic patients. 
Insulin secretagogues may be divided two groups, the initiators and the potentiators. 
The former are substances that are capable of stimulating insulin release on their own
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whereas the insulin potentiators comprise a number of hormones and are able to 
induce insulin secretion in the presence of glucose only (Rustenbeck et al., 2004). 
The most commonly used insulin secretagogues are the sulphonylurea drugs. The 
principal target for sulphonylurea is the ATP-sensitive potassium channel (K Atp )  that 
controls cell membrane potential in pancreatic (3 cells (Proks et al., 2002). Once the 
sulphonylurea binds the K Atp , the level of cytosolic Ca2+ increases and insulin is 
released (Proks et al., 2002). In order to reduce insulin resistance, metformin, 
thiazolidinediones and other hypoglycaemia agents are used (Seufert et al., 2004). 
Taking metformin as an example, it helps to lower the blood glucose by (i) 
suppression of hepatic glucose production and (ii) increasing insulin-mediated muscle 
glucose uptake. Metformin also reduces fatty acid oxidation (Bailey and Turner, 1996). 
Moreover, metformin also possesses several nonglycaemic effects such as stabilising 
body weight by preventing weight gain (Bailey, 2005). In addition to the 
aforementioned medical therapy, regular exercise to control body weight is beneficial 
for all diabetic patients (Hopkins, 2004). Physical training results in lower fasting and 
postprandial insulin concentration and increase insulin sensitivity (LaMonte et al., 
2005). In patients with T1 DM, reduced insulin resistance leads to less requirements of 
insulin administration and, forT2DM patients, increased insulin sensitivity might result 
in improved glycaemic control.
The best treatment for DM is whole pancreas or islet transplantation. 
Transplantation has received much attention since an improved protocol for 
immunosuppression has been introduced by a group in Edmonton (Shapiro et al., 
2000). However, the main limitation for islet transplantation is the shortage of isolated 
islets from cadavers (Ohgawara et al., 2004). This problem could be overcome by: (1) 
generating xenotransplantable islets (xenotransplantation: the transplantation of 
organs/tissues of other species origins); (2) bioengineering of functional islets, or
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insulin-producing (3 cells, from various cell sources including stem cells, tissue specific 
progenitors and even differentiated cells (transdifferentiation) (Bonner-Weir and Weir,
2005). For example, under certain chemical or genetic manipulations, the generation 
of pancreatic islet-like cells from embryonic stem cells, pancreatic ductal and acinar 
cells and liver cells have been proposed from many groups (Katdare et al., 2004; Kim 
et al., 2003; Lumelsky et al., 2001; Ogata et al., 2004; Sapir et al., 2005; Zulewski et 
al., 2001). In addition, it has also been demonstrated that human peripheral blood 
monocytes can be reprogrammed into pancreatic-like (3 cells by incubating in 
pancreatic islet-specific differentiation media after the treatment of macrophage 
colony-stimulating factor and interleukin 3 (Ruhnke et al., 2005).
A different approach to induce (3-like cells has been to take intestinal K cells and 
engineer them by providing the human insulin gene linked to the 5’-regulatory region 
of the gene encoding glucose-dependent insulinotropic polypeptide (GIP). In mice 
expressing this transgene, human insulin is specifically produced in gut K cells. To 
investigate if the expression of insulin in K cells can protect the mice from developing 
diabetes, STZ was introduced into either GIP transgenic mice or aged control animals 
to induce diabetic phenotype and the blood glucose level was determined. The results 
showed that neither glycosurea not fasting hyperglycaemia was observed in GIP 
transgenic mice whereas STZ resulted in the hyperglycaemia and the presence of 
glucose in urine in control animals (Cheung et al., 2000). Adult stem cells residing in 
the ductal region of pancreas are also able to generate functional (3 cells in vitro 
(Bonner-Weir et al., 2000; Ramiya et al., 2000). Using a cell lineage tracing strategy, a 
recent study suggested that insulin-secreting cells can be generated from adult 
pancreatic acinar cells (Minami et al., 2005). Interestingly, an in-vitro culture study 
proposed that p cells can de-differentiate into fibroblast-like cells and then 
re-differentiate to p cell phenotype (Gershengorn et al., 2004; Lechner et al., 2005).
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This study shows the possibility to transform mesenchymal cells into pancreatic p 
cells. This idea is also supported by an observation that the conversion of the 
nestin-positive cells (i.e. mesenchymal cells) into insulin-producing cells can be 
promoted by expressing a pancreatic-specific transcription factor Pax4 (Blyszczuk et 
al., 2003).
ES cells, in contrast to all the other sources of p cells, are more advantageous for 
the generation of p cells since they (i) can be derived from patients by somatic cell 
nuclear transfer (SCNT) technique (Fulka et al., 1998), (ii) have virtually unlimited 
capacity and (iii) can give rise to all cell types in the body including the differentiated p 
cells when they are in the right environment (Colman and Kind, 2000; Nir and Dor,
2005). However, spontaneous differentiation of ES cells only produced extremely low 
number of cells that express p cell markers. The molecular basis to direct from the ES 
cells into functional pancreatic p cells is also still poorly understood (Nir and Dor, 2005; 
Rajagopal et al., 2003). Recently, Soria and colleagues successfully induced 
differentiation of mouse ES cells into pancreatic p cells by a 3-step in vitro 
differentiation method consisting of directed differentiation, cell-lineage selection, and 
maturation (Soria, 2001). By using these purified p cells, the blood glucose 
concentration of the streptozotocin-induced diabetic mice was normalised following 
transplantation of the ES cell-derived p cells. This result therefore opens new 
possibilities for tissue transplantation in the treatment of diabetes even though the 
identification of the molecular basis associated with this conversion process is 
remained to be determined (Leon-Quinto et al., 2004; Vaca et al., 2005).
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1.D Aims
The present project had the following aims:
1. True transdifferentiation of liver to pancreas has never convincingly been 
demonstrated (Ber et al., 2003; Ferber et al., 2000; Imai et al., 2005; Kojima et al., 
2003; Miyatsuka et al., 2003; Sapir et al., 2005). Although results of some 
investigations appear to show the conversion of liver cells into pancreatic-like cells, 
almost all of the investigations show only the detection of a “mixed-cell” phenotype, 
namely the liver cells expressing pancreatic markers rather than becoming bone fida 
pancreatic cells. As described in section 1.B.4.3, in an earlier observation from our 
laboratory, it has been described the appearance of ectopic pancreas in transgenic 
tadpoles of Xenopus levies. It was also shown the expression of amylase and insulin 
proteins in cultured human hepatoma HepG2 cells (Horb et al, 2003). Therefore, in 
order to unambiguously determine whether it was possible to induce the true 
transdifferentiation of hepatic cells to pancreatic cells, changes at both cellular and 
molecular levels were examined. The human hepatoma cell line HepG2 was used in 
this study. Briefly, the main aims of this project was to determine: the alteration of 
pancreatic and hepatic phenotype in transdifferentiated cells; the 
ancestor-descendant relationship between parental and transdifferentiated cells and 
finally to characterise the functional nature of the transdifferentiated cells.
2. Due to the limitations of HepG2 cells, it was then decided to investigate the 
potential of other liver cell models to undergo transdifferentiation to pancreatic cells. 
The first was based on culture of embryonic liver and the second involves isolation 
and culture of adult rat hepatocytes. The embryonic liver tissues were cultured 
following the same technique that has been established in the lab and established a 
good delivery system for introducing genes to induce transdifferentiation. To isolate
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hepatocytes, standard 2-steps perfusion procedure was used. The isolated 
hepatocytes were then cultured in the chemically-defined medium to maintain the 
differentiation properties and further to induce the conversion into pancreatic-like cells 
after the introduction of one or several pancreatic-specific transcription factors.
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ChaPter 2‘ .e
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2.A Materials
All chemicals were dissolved in distilled water unless otherwise stated.
2.A.1 General chemicals and buffers
Glucagon-like peptide 1 (GLP-1, fragment 7-37), human recombinant betacellulin, 
EDTA (stock=0.5M), 3-aminopropyltriethoxysilane (APTS),
4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid (HEPES), phenobarbital, 
dexamethasone, Oil red O, trypan blue, urease buffered solution, phenol nitroprusside, 
alkaline hypochlorite, L-arginine, Isonitropropiophenone (ISNP) and MnCI2were all 
purchased from Sigma, UK. Tris base, chloroform, 2-propanol, ethanol and acetone 
were from Fisher Scientifics, UK. PBS powder was obtained from BIOCHROM AG, 
Berlin, Germany.
2.A.2 Cell culture reagents
The rat pancreatic-exocrine cell line, AR42J-B13 (provided by Dr. Itaru Kojima, 
Tokyo, Japan) was cultured in Dulbecco’s Modified Eagle’s Medium containing 100 
units/ml penicillin, 100 pg/ml streptomycin, 2 mM L-glutamine, and 10% Foetal Bovine 
Serum. The human hepatoma cell line HepG2 was obtained from the European 
Collection of Cell Cultures (ECACC, UK) and maintained in Dulbecco’s Modified 
Eagle’s Medium (with 5.5mM glucose or25mM glucose in, Sigma, UK) containing 100 
units/ml penicillin, 100 pg/ml streptomycin, 2 mM L-glutamine, 1 X MEM 
Non-Essential Amino Acids (all were from Sigma, UK) and 10% Foetal Bovine Serum 
(Gibco™/lnvitrogen Life Technologies). The RIN-5F insulinoma cell line was 
purchased from ECACC and kept in RPMI1640 medium (Sigma, UK) containing 100 
units/ml penicillin, 100 pg/ml streptomycin, 2 mM L-glutamine, and 10% Foetal Bovine
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Serum. Human pancreatic ductal cell line PANC-1 (ECACC), was cultured in 
Dulbecco’s Modified Eagle’s Medium containing 100 units/ml penicillin, 100 pg/ml 
streptomycin, 2 mM L-glutamine, and 10% Foetal Bovine Serum. Serum free medium 
for the culture of isolated rat hepatocytes were Williams’ Medium E (Sigma) or KSFM 
(Gibco™/lnvitrogen Life Technologies) containing 100 units/ml penicillin, 100 pg/ml 
streptomycin, 2 mM L-glutamine, 50 pg/ml gentamycin, 100 ng/ml Fungizone (both 
from Gibco™/lnvitrogen Life Technologies) with indicated supplements (see below).
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Table 2.A.1 DNA preparation reagents
Kit Components Supplier
QIAEX II gel extraction kit
Buffer QX1 
QIAEX II suspension Buffer PE
Qiagen, UK
Wizard Plus SV Minipreps 
DNA purification system
Ceil resuspension solution 
Cell lysis solution 
Alkaline protease solution 
Neutralisation solution 




Wizard Plus SV 
Maxipreps DNA 
purification system
Cell resuspension solution 
Cell lysis solution 
Alkaline protease solution 
Neutralisation solution 
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Amylase Rabbit 1/300 Sigma, UK
Albumin Rabbit 1/300 Sigma, UK
a1-antitrypsin Rabbit 1/100 Sigma, UK
Apolipoprotein B (ApoB) Mouse 1/100 Chemicon International
Carbamoyl phosphate synthetase I 
(CPS I)
Rabbit 1/300
a gift from Dr. Wouter H. 









human C-peptide Rabbit 1/100 Acris Antibodies
Connexin 32 Mouse 1/100 Zymed Laboratories Inc.
Cyp2E1 Rabbit 1/600
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p-galactosidase Rabbit 1/100 MP Biomedicals UK
Glucagon Mouse 1/100 Sigma, UK
Glutamine synthetase(GS) Mouse 1/300
BD Transduction 
Laboratories, USA
Green fluorescence protein(GFP) Mouse 1/300 Sigma, UK




Insulin Guinea pig 1/300 Sigma, UK
IPF1(Pdx1) Rabbit 1/100 JMW Slack




Somatostatin Rabbit 1/100 DakoCytomation
Transferrin Rabbit 1/100 DakoCytomation
UDP-glucuronosyltransferase
(UGT)
Sheep 1/1000 Cypex Ltd., Dundee, UK
Vimentin Mouse 1/100 Sigma, UK
Vp16 Mouse 1/100 Sigma, UK







acetate (AMCA) conjugated IgG
Horse 1/200 Vector Laboratories
70
W-C Li In vitro  transd iffe ren tia t ion  of l iver into functional pancreat ic - l ike  cells
Anti-mouse fluorescein 
isothiocyanate (FITC) conjugated 
igG
Florse 1/200 Vector Laboratories
Anti-guinea pig FITC-conjugated 
IgG
Goat 1/200 Vector Laboratories
Anti-rabbit FITC-conjugated IgG Goat 1/200 Vector Laboratories
Anti-sheep FITC-conjugated IgG Rabbit 1/200 Vector Laboratories
Anti-sheep texas-red conjugated 
IgG
Rabbit 1/200 Vector Laboratories
Anti-mouse texas red-conjugated 
IgG
Horse 1/200 Vector Laboratories
Anti-rabbit tetramethylrhodamine 
isothiocyanate (TRITC) conjugated 
IgG
Swine 1/200 DakoCytomation
All the antibodies were diluted in 2% blocking buffer 
(Boehringer Mannheim, UK)





Albumin Rabbit 1/2000 Sigma, UK
Cyp2E1 Rabbit 1/10000
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Sweden
Haptoglobin Rabbit 1/1000 Sigma, UK
HNF1a Goat 1/1000 Santa Cruz Biotechnology
HNF4a Goat 1/1500 Santa Cruz Biotechnology
Transferrin Rabbit 1/1000 DakoCytomation
a-tubulin Mouse 1/10000 Sigma, UK





Peroxidase-labelled anti-rabbit IgG Goat 1/1000 Vector Laboratories
Peroxidase-labelled anti-rabbit IgG Goat 1/2000 Vector Laboratories
Peroxidase-labelled anti-rabbit IgG Goat 1/1000 Vector Laboratories
HRP-conjugated anti-goat IgG Rabbit 1/1000 Abeam
HRP-conjugated anti-goat IgG Rabbit 1/1000 Abeam
Peroxidase-labelled anti-rabbit IgG Goat 1/1000 Vector Laboratories
Peroxidase-labelled anti-mouse IgG Horse 1/2000 Vector Laboratories
HRP-conjugated anti-sheep IgG Rabbit 1/3000 Abeam
Table 2.A.4 Primers for PCR
Species Gene Forward primer Reverse primer





Human Albumin CTCAAGT GT GCCAGT CT CCA TGGGAI I I I ICCAACAGAGG 272 NM_000477
Human Amylase CAT CTGTTT GAAT GGCGAT G TT CCCACCAAGGT CT GAAAG 138 NM_0020978
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Human /3-actin AGAAAAT CT GGCACCACACC GGG GTGTT G AAGGT CT C AAA 142 NMJ501101
Human EGFR GGT GCAGGAGAGGAG AACT G GGT GGC ACCAAAGCT GTATT 270 AY098023
Human GLP1R GTT CCCCT GCT GTTT GTT GT CTT GGCAAGT CT GCATTT GA 228 NM_002062
Human Glucagon CATTCACAGGGCACATTCAC CGGCCAAGTT CTT CAACAAT 275 NM_002054




ACCT GCGT GGCTCT GTT ACT C AGCGT GT CCT CTTT GTGT C 180 NM_002722




TT GGCT GAAAGAGAACGG GATACATCT
ACTT CTTT GGT GATT GCTTT GG 
CGGTG
457 NM_033508
Human Somatostatin AGCT GCTGTCT G AACCCAAC CCATAGCCGGGTTT GAGTTA 126 NM_001048
Human Transferrin AGAAGGGAGAT GT GGCCTTT CGACCGGAACAAACAAAAGT 296 NM_001063
Mouse Neurogenin 3 CGAAGCAGAAGTG GGTGACT GCAGGGT CT CGACCTTT GT A 236 NM_009719
Mouse Nkx2.2 T CTACGACAGCAGCGACAAC GCTTT GG AG AAGAGCACT CG 220 NM_010919
Mouse Nkx6.1 ACCTTT GGGCT C ACATAACC GCGCTGGGGCTAAAGTAGAG 360 NM_144955
Rat P-actin TCCGTAAAGACCT CTAT GCC AAAGCCAT GCC AAAT GT CT C 477 V01217





CGT CCAAG ATT CCTT GGT GT AT GG AAGAGAGGCT G GG ATT 158 NM_017072
Rat Chromogranin A ACTAAGGT GAT GAAGT GT GT T CT CTACAGT GT CCTT GGAG 353 NM_021855
Rat Cyp reductase GGCAAGGAGCT GTACCT GAG AT GAT G AC AGGT GT GGTGG A 356 M10068
Rat CYP2B12 CGCAT GGAGAAGGAGAAGT C CCT CAGTGTT CTT GGGAAGC 352 X63545
Rat CYP7A1 CCT CCT GGCCTT CCT AAAT C GT C AAAGGT GGAGAGCGT GT 351 NM_012942
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T CT CTT CT GCAACCGAACCT CT GGT GCAGTGCAAGTGTCT 351 S75952
Rat IAPP GGCT GTAGTT CCT GAAGCTT AAGGTT GTT GCT GGAGCG AA 260 NM_012586
Rat Insulin 1/2 T GCCCAGGCTTTT GT CAAACAGC ACCTT CT CCAGT GCCAAGGT CT GAA 187 NM_019129
Rat Kir6.2 ACCACGCT GGT GGACCT C M G GCACCACCTGCATATGAATGG 481 RNU44897

















ACACCGGAACTAG ACCAT CG TGGAACCCCATTGCATATTC 152 NM_012683
Mouse Neurogenin 3 CGAAGCAGAAGTGGGTGACT GCAGGGTCTCGACCTTTGTA 236 NM_009719
Mouse Nkx2.2 TCTACGACAGCAGCGACAAC GCTTTGGAGAAGAGCACTCG 220 NM_010919
Mouse Nkx6.1 ACCTTTGGGCTCACATAACC GCGCTGGGGCTAAAGTAGAG 360 NM_144955
Xenopus Xlhbox8 TGCCAACTT CAT CCCAGCCC GGCAGATGAAGAGGGCTC 198 X16849
All the primers were purchased from Gibco™/lnvitrogen Life Technologies
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Table 2.A.5 Adenoviral reagents
Original adenovirus reagents are gifts from Dr. Harry Heimberg in Diabetes Research 
Center, Vrije Universiteit Brussel, Belgium.
Reagent Stock No. Titre (PFU/ml)
Ad CMV-HA-moNgn3-eGFP 121 3*1010
Ad CMV-HA-Nkx6.1 -eGFP 83 4.6*1010





All the adenovirus reagents were kindly provided by Dr.Mark A Hornsey and Dr.Daniel
Eberhard
Table 2.A.6 Other experimental reagent or 
equipment
Supplier
Live-Dead assay Molecular Probes
LSM 510 confocal microscope Zeiss, Hertfordshire, UK
DMRB microscope Leica, Milton Keynes, UK
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2.B Methods 
2.B.1 Cell culture
2.B.1.1 Cell passaging and maintenance
All cell lines were passaged by the same method. Prior to splitting cells, the 
reagents were pre-warmed to 37°C. For a 75cm2 flask at approximately 80% 
confluence, the culture medium was aspirated and the cells were washed with 10 ml 
of sterile PBS. The PBS was then removed and 5ml of trypsin-EDTA solution 
(Gibco™/lnvitrogen Life Technologies) was added and incubated at 37°C for 3-5 
minutes to detach the cells from the flask. The same volume of supplemented medium 
was added to neutralise the activity of trypsin and cells were gently resuspended by 
gently pipetting up and down. The cells were next centrifuged at 1000 rpm in a bench 
top MSE mistral 1000 centrifuge (ISTCP) for 4 minutes at room temperature. The 
supernatant was then removed and the cell pellet was resuspended with 1 ml fresh 
medium and 250 pi of total suspension was plated out into a new 75cm2 flask 
containing 15ml fresh complete medium (indicated in section 2.B.2). The cells were 
incubated at 37°C, in an atmosphere of 5% (v/v) C02.
2.B.1.2 Cell storage
All cells were washed and detached as previously described (see section
2.B.1.1). After the centrifugation step, the cell pellet was resuspended in 1ml freezing 
medium, FBS mixed with 10% (v/v) DMSO (VWR International, UK), and transferred 
into cryovials and kept in -20°C for about 20 minutes, followed by storage in -80°C 
overnight and finally transferred to liquid nitrogen for long-term storage.
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2.B.1.3 Cell revival
Cells were revived by removing the cryovial from the liquid nitrogen and rapidly 
thawing at 37°C. The cells were then transferred into a centrifuge tube with 1ml of 
fresh warm medium and centrifuged at 1000 rpm for 4 minutes. The cells were then 
seeded in a 75cm2 flask and cultured at 37°C with an atmosphere of 5% (v/v) C02. 
The medium was replaced with fresh medium the following day and changed every 
two days thereafter.
2.B.2 Primary cell culture
2.B.2.1 Isolation of the embryonic pancreas
The technique for isolation of embryonic pancreas is shown diagrammatically in 
Figure 2.1. Embryonic day 11.5 dorsal pancreatic tissue was obtained from female 
CD1 albino mice bred at the University of Bath. Adult mice were killed by cervical 
dislocation and the decidua removed and placed into ice-cold PBS. The embryos 
were dissected out and placed in Minimal Essential Medium (MEM) containing Hank’s 
salts (Sigma, UK). The embryos were opened laterally and the stomach located. The 
dorsal pancreas was identified at the posterior end of the stomach and the tissue was 
removed with fine forceps and needles. Isolated pancreatic buds were placed cut 
surface down into stainless steel cloning rings on subbed and fibronectin-coated 
coverslips. These were in 35mm culture dishes containing 2 ml of Basal Essential 
Medium (BME, from Sigma, UK) with Earle’s salts containing 2 mM L-glutamine, 50 
pg/ml gentamycin and 20% FBS. After 24 hours of culture, the cloning ring was 
removed and medium was replaced with fresh medium. The medium was then 
changed every 2 days. Subbed coverslips (22mmX22mm; Scientific Laboratory
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Supplies Ltd., UK) were prepared by rinsing with 2% (v/v) APTS in acetone overnight, 
followed by washing twice in acetone and sterile water. The coverslips were then 
dried at 37° C and heat sterilized at 180° C for at least 3 hours. The coverslips were 
then coated with fibronectin (Fisher Scientifics, UK) by applying 40 pi of 50 pg/ml 
bovine fibronectin to the centre of each coverslip and allowed to dry.
2.B.2.2 Embryonic liver cutures
The liver tissue in E11.5 embryos is easy to distinguish from other organs as the 
liver is the main site of hematopoiesis and is engorged with blood. The embryo was 
opened and the embryonic liver lobes isolated and dissected into several small pieces 
(one liver lobe could be split into an average of 4-6 fragments) using sharp forceps 
and needles. The small pieces of embryonic liver were then placed on subbed 
coverslips and cultured in Basal Essential Medium (BME) with Earle’s salts containing 
2 mM L-glutamine, 50 pg/ml gentamycin and 20% FBS for the time periods indicated 
in the text at 37°C in an atmosphere of 5% (v/v) C02. To remove the mesenchymal 
cells from hepatic epithelium, KSFM containing 10units/ml penicillin, 100pg/ml 
streptomycin, 2mM L-glutamine, 5ng/ml rhEGF, 50pg/ml BPE and FBS (with various 
concentration) was used.
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Figure 2.1 Dissection procedure for embryonic liver and pancreas from E11.5 mouse 
embryos. (A) The embryos were isolated from the deciduas and then placed in a dish 
ready for dissection; (B) The embryos were decapitated just below the lower jaw and 
the lower limbs were removed using fine forceps. (C) The forceps were then used to 
cut through the cavity after removal of the lower limbs and cut along the side of the 
embryo; (D) The internal organs (liver, stomach etc) were exposed; (E, F) The internal 
organs were removed by separating them from the back of the embryo to which they 
are attached; (G) Using a sharp tungsten needle, the liver was separated from the 
stomach. (H) The dorsal pancreatic tissue (indicated by the arrow) is located at the 
posterior end of the stomach and removed (indicated by the arrow).
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2.B.2.3 Rat hepatocyte isolation
The technique for isolation of adult rat hepatocytes is shown diagrammatically in 
Figure 2.2. Male Wistar rats, weighing 270-330g, were obtained from the Animal 
House of the University of Bath. Hepatocytes were isolated by the two-step 
collagenase perfusion technique with modifications as described previously (Tosh and 
Coilings, 1986). Briefly, the rat was anaesthetised with 4.5% isofluorane (Baxter 
Healthcare Ltd.) mixed with 1500 ml/minute oxygen. The rats were tested for deep 
anaesthesia (absence of the pedal reflex). When the rat is fully anaesthetised, the 
isofluorane was reduced to 3% and the animal placed dorsal side down on a tray 
(Fisher Scientifics). The anaesthesia was maintained via a face mask. A small amount 
of 70% ethanol was sprayed on the abdominal fur to reduce the risk of infection. A “U” 
shaped incision was then made through the skin of the lower abdomen to the lateral 
aspect of the rib cage and the skin was folded back over the chest. The intestines 
were moved aside to reveal the portal vein and the vena cava. A pair of hooked 
forceps were gently pushed under the portal vein and used as a guide to place a 
matchstick under the portal vein. Any excess adipose tissue was removed with the 
blunt side of the forceps and a non-absorbable suture (4-0; Ethicon™ Mersilk™) was 
loosely tied around the portal vein prior to inserting the cannula (18GA; Becton and 
Dickinson). After inserting the cannula into the portal vein the suture was tightly tied to 
secure its position. The inner needle of the cannula was removed and the abdominal 
blood vessels cut before attaching the cannula to the pump to allow perfusion medium 
I [0.05% (w/v) KCI (Fisher Scientific) in 10mM HEPES buffer, 5mM D-glucose (Sigma, 
UK), 200pM EDTAand 0.001% (v/v) phenol red (Sigma, UK) all in sterile saline pH7.4] 
to perfuse through the liver. The perfusion pump was set to 30-35 ml/minute. The 
chest cavity was then opened and the thoracic portion of the inferior vena cava was 
cut. The abdominal blood vessels were then clamped to ensure blood flows through
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the liver. The medium was collected in the chest cavity using a syringe and discarded. 
After about 10 minutes perfusion at a flow rate of 30-35 ml/minute, perfusion medium I 
was replaced with a perfusion medium II [20mM HEPES buffer, 5mM D-glucose, 1mM 
CaCI2 (Fisher Scientific), 0.001% (v/v) phenol red (Sigma) all in sterile saline at pH 
7.4], Approximately 150mls of collagenase-containing perfusion medium II was 
delivered to the liver for 10-15 minutes (with recirculation) at a flow rate of 30-35 
ml/minute. For mouse hepatocyte isolation, the procedure was similar except that the 
perfusion flow rate is 5-10 ml/minute and the cannula is inserted into the abdominal 
vena cava and the portal vein is cut to allow perfusate to escape.
Following collagenase perfusion, the liver was removed and hepatocytes were 
dissociated using two pairs of fine forceps. The cells were filtered through a 70pm 
filter (Gore-Tex, USA). Dead and dying cells were removed by differential 
centrifugation. Cells were washed three times (50 x g for 2 minutes) in perfusion 
media II or Williams’ Medium E. Using 0.4% trypan blue (w/v), the cell viability was 
determined to be approximately 85%. The isolated hepatocytes were initially placed in 
35mm culture dishes in hepatocyte attachment medium (Williams’ Medium E 
containing 10units/ml penicillin, 100 pg/ml streptomycin, 2mM L-glutamine, and 10% 
FBS). For immunohistochemistry, the cells were cultured on glass coverslips. After 6-8 
hours, the attachment medium was removed and replaced with the indicated medium. 
The composition was as follows: Williams’ Medium E (W), Williams’ Medium E plus 
dexamethasone (WD), Williams’ Medium E plus supplement (5ng/ml rhEGF and 
50pg/ml BPE, from Gibco™/lnvitrogen Life Technologies) (WS) and Williams’ 
Medium E plus supplement plus 1pM dexamethasone (WDS), KSFM (K), KSFM plus 
1pM dexamethasone (KD), KSFM plus 5ng/ml rhEGF (KE), KSFM plus 50pg/ml BPE 
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Figure 2.2 Procedure for hepatocyte isolation (using Wistar rat as an example here). 
(A) Equipment for hepatocyte isolation. See details described in chapter 2.B.2.3.; (B) 
Flow chart for isolating hepatocytes. Checking the mouse is fully anaesthetised by 
using the pedal reflex and U-shapely opened the abdomen of the mice (B.1-B.5); 
removing the excess fat tissues to expose the portal vein and loosely tying a suture 
around the vena cava prior to inserting the cannula (B.6, B.7); inserting the cannula 
into the vena cava, removing the inner needle of the cannula and securing with the 
suture (B.8-B.10); introducing perfusion medium I to perfuse through liver (B.11); 
meanwhile, opening the chest cavity and clamping vena cava (B.12-B.14); after 10 
minutes perfusion, changing from perfusion medium I to perfusion medium II for 
another 10 minutes and removing the liver when it was adequately digested (B.15,
B.16); (C) Procedure for the preparation of dissociated liver cells. Dissociating liver 
lobes using two pairs of forceps and filtrating the homogenised liver cells through a 
gauze mesh filter.
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2.B.3 Plasmid construction
The reagents for molecular cloning, plasmid maps and construction strategies 
are all shown in appendix 1. In general, the indicated restriction enzymes were 
incubated with 1-2 pg plasmid DNAat 37°C (unless otherwise stated) for 1.5-2 hours. 
The digested products were then separated by electrophoresis on a 1-1.5% agarose 
gel and the DNA extracted from the gel using a DNA extraction kit (section 2.A.3) 
according to the manufacturer’s instructions. To produce blunt ended plasmid DNAs, 
the DNA was incubated with Klenow fragment (1 unit per mg DNA) at 30'C for 20 
minutes. The reaction was stopped by the incubation of samples at 70’C for 15 
minutes. The vector was treated with CIP to catalyse the removal of 5' phosphate 
groups from DNA. Since CIP-treated fragments lack the 5'-phosphoryl termini 
required by ligases, they cannot self-ligate. Afterwards, 1:3-1:5 (vector/insert ratio) of 
DNA was mixed with 1X buffer and 0.5 units T4 DNA ligase at 20°C for overnight for 
ligation reaction. The ligation products were then incubated with several different 




Transfection of plasmids into cells was tested with various transfection reagents 
including GeneJuice (Novagene, USA), Lipofactamine 2000 (Gibco™/lnvitrogen Life 
Technologies), Exgene 500 (Fermentas) and Fugene 6 (Roche, UK) according to the 
manufacturer’s instructions. Among them, GeneJuice transfection reagent exhibited 
the optimal condition for transfection of plasmid DNA into cells (Figure 2.3). Briefly, for
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each reaction, 3pl GeneJuice reagent was mixed with 1 0 0 |j I serum free medium and 
allowed to stand at room temperature for 5 minutes. The same amount of plasmid 
DNAs (usually 1-2 pg) were then added into the GeneJuice-medium mixture and 
incubated for 20-30 minutes. Lastly, for HepG2 and Panc-1 cells, the GeneJuice-DNA 
mixture was evenly distributed over the cells. For transfection of liver buds, GeneJuice 
was added directly onto the tissue whilst in a cloning rings.
2.B.4.2 Adenoviral infection
HepG2 cells were seeded onto 35mm dishes at a density of 1X106. Rat 
hepatoctyes were plated onto culture dishes at a density of about 5X105 (for 35mm 
dishes) or 1X106 (for 60mm dishes). To test the adenoviral infection efficiency in 
HepG2 cells, the stock Ad CMV-GFP virus (an adenovirus containing the GFP gene 
under the control of the CMV promoter) was diluted at 1:100, 2:100 and 3:100 in 
sterile PBS. Cells were infected with the infection concentration of 100, 200 and 300 
MOI (multiplicity of infection, the number of viral particles taken up by each individual 
cell). The infected cells were incubated at 37° C for 1 hour and the medium was then 
changed to fresh medium. The cells were maintained for 2 days before fixation for 
immunostaining.
Infection of embryonic liver cells was carried out by the same procedure as for 
infection of HepG2 cells. However, the total virus load (with various dilutions) was 
deposited in the cloning ring. For viral infection of rat hepatoctyes, the infection was 
carried out after the cells had been in culture for 72 hours. For rat hepatocytes, the 
titres tested were 200, 20, and 2 MOI. In the combination experiments, the total viral 
titre was about 20 MOI, that is to say, infecting 1X107 or 2X107 total viral particles onto 
35mm and 60mm dishes, respectively.
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Figure 2.3 Comparison of transfection efficiency of HepG2 cells with different 
transfection reagents. HepG2 cells were transfected with 1pg CMV-nGFP plasmid 
DNA according to the manufacturer’s instructions. After 24 hrs, transmitted light 
images (A-D) and fluorescent images (GFP expression) (E-H) were collected. Merged 
images are also shown (l-L). Scale bar = 20 pm
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2.B.5 Qualitative and quantitative RT-PCR
2.B.5.1 RNA extraction
Total RNA was extracted from cells using the TRI reagent (Sigma, UK) following 
the manufacturer’s instructions. Digestion with RQ1 RNase-free DNase (Promega) 
was performed to eliminate any contaminating genomic DNA. The concentration of 
extracted RNA was measured on a Beckman Spectrophotometer. The ratio of 260nm 
to 280nm of each sample ranged from 1.8 to 2.0.
2.B.5.2 Reverse trancription
Messenger RNA was isolated from total RNA by using Superscript™ First-Strand 
Synthesis System for RT-PCR. Briefly, the messenger RNA (mRNA) was first isolated 
by incubation of Oligo(dT)12.i8 oligonucleotides from 5-10 pg extracted total RNA. 
Complementary DNA (cDNA) was prepared
by Superscript™!I reverse transcriptase treatment. cDNA samples were incubated 
with 2 units RNase H at 37° C for 20 minutes to remove the RNA-cDNA hybridised 
residues. All the reagents were from Gibco™/lnvitrogen Life Technologies.
2.B.5.3 PCR reaction
Polymerase chain reactions containing the mixture of the same concentration of 
cDNA, 1X PCR buffer, 1.5mM MgCI2, 0.2mM dNTP, 50 ng sense/antisense primers 
and 1.25 U Platinum Taq polymerase were processed in a DNA thermal cycler using 
the following conditions: denatured at 94° C for 1 minute, amplification at 58° C for 1 
minute and elongation at 72° C for 1 minute for 30-40 cycles. The samples were 
analysed in 1.2-1.5% agarose electrophoresis with 1 kb ladder marker.
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To obtain more quantitative results for the different samples, we also performed 
real-time PCR using the Lightcycler system (Roche). The same amount of cDNAfrom 
calibrator and experimental cell extracts was mixed with 1XSYBR@ Green Taq 
ReadyMix™ (Sigma, UK), 50 ng sense and antisense primers and transferred into 
Lightcycler capillaries. The following conditions were used for the amplification of 
PCR products: denaturation at 95°C for 30 seconds; amplification at 58°C for 5 
seconds followed by 72°C for 20 seconds for 50 cycles; cooling at 40°C for 2 minutes. 
The fluorescence signal was detected at the same time point of each cycle. Data were
presented as the normalised ratio, W hich iS (Cone, [target gene (experimental)] /  Cone, [reference 
gene (experim ental)])*(ConC. [target gene (control)] /  C o n e ,  [reference gene (control)]) b y  L ig h tc y c lO T  R e l a t i v e
Quantification software.
2.B.6 Immunofluorescence staining
For immunofluorescence staining, the cells were rinsed with PBS to remove 
any excess medium and then fixed with 4% (w/v) paraformaldehyde (PFA, VWR 
International) in PBS for 20-30 minutes, the cells were then permeabilised with 0.1% 
(v/v) Triton X-100 (Sigma, UK) in PBS for 30 min. For the preparation of 100ml 4% 
PFA, 4 gm PFA was added into 85 ml lukewarm PBS. The pH was then adjusted to 
7.4 by adding 10M NaOH and concentrated HCI. The volume was then topped up with 
PBS. In contrast to cells, primary cultures of embryonic tissues were fixed in MEMFA 
for 20-30 minutes. MEMFA was prepared by mixing the following reagents: 10% v/v 
formaldehyde (Sigma stock concentration = -38% so final concn is about 4% w/v), 0.1 
M MOPS (pH 7.4) (Sigma), 2mM ethylene-glycotetraacetic acid (EGTA, Sigma) and 
1mM MgS04 (Sigma). Tissue was permeabilised with 1% Triton X-100 in PBS for 30 
minutes. For the antigens including connexin 32, E-cadherin and smooth muscle actin,
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the cells or tissues were fixed with acetone-methanol (1:1; v/v) fixatives at -20°C for
5-8 minutes, permeablised with 1% Triton X-100 in PBS for 30 minute and then 
incubated in 1X citrate buffer (Lab Vision Corporation, CA) at 37° C for 30 minutes 
before blocking. Afterwards, cells or tissue were incubated in 2% blocking buffer for at 
least 1 hour. The coverslips were then incubated with primary antibody overnight at 4°
C. On the following day, the coverslips were washed with PBS. The 
fluorescently-conjugated secondary antibodies were added to the coverslips for 3 
hours and then washed with PBS. The slides were mounted with Gel/Mount mounting 
medium (Biomeda, Foster City, CA). If there was more than one antigen to be 
detected, the primary and secondary antibodies were added sequentially using the 
same protocol described above. For cell counting experiments, cells were incubated 
with antibodies followed by incubation with 500ng/ml 4,6-Diamidino-2-phenylindole 
(DAPI; Sigma, UK) for 20 minutes before mounting.
2.B.7 Insulin ELISA
2.B.7.1 Sample collection
Cells were cultured for 5 days and transfected with TTR-VP16 or 
TTR-Xlhbox8Vp16 and treated with medium containing either normal glucose (5.5mM) 
or high glucose (25mM) for 12 hours. The media was concentrated by using Centricon 
YM-3 Centrifugal Filter Devices (Millipore Corporation, nominal molecular weight limit 
3 KiloDalton). 15-20 ml medium were applied into the sample reservoir and 
centrifuged at 6500xg until all the medium had been filtered. The concentrated 
samples were collected into retentate vials by inverting the unit and centrifuging at 
1OOOxg for 5 minutes.
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2.B.7.2 Protein concentration analysis
The concentration of total protein was assayed by the Bio-Rad protein reagent 
(Bio-Rad Laboratories). Briefly, a 1:1000 dilution of the sample and standard (0-25 
pg/pl bovine serum albumin; Pierce Biotechnologies Inc.) proteins were mixed with 
1/5 volume of assay reagent and incubated at room temperature for 5 minutes. The 
optical density was then measured at 595nm. The values were blank corrected and a 
standard curve was plotted of absorbance against protein concentration. The protein 
sample concentration was determined from the standard curve.
The insulin concentration in the medium was analysed using a rat Insulin ELISA 
kit (Mercodia AB) following the manufacturer’s instruction. The samples and 
standards (recombinant human insulin; Sigma, UK), which were different 
concentrations of recombinant human insulin solution diluted in distilled H20, were 
performed in triplicate for each set of assays.
2.B.8 Histochemistry
2.B.8.1 Oil red O staining
To detect lipid storage in cultured rat hepatocytes, oil red O staining was 
performed. The rat hepatocytes were cultured for various time periods and fixed with 
MEMFA for 20-30 min. The fixed cells were pre-treated with 60% (v/v) 2-propanol for 2 
minutes and then incubated in oil red O staining solution (prepared by dissolving 1% 
(w/v) oil red O in 60% 2-propanol solution) for 10 minutes. The staining solution was 
incubated at 100°C, cooled down to room temperature and filtered through 0.22pm 
syringe filter prior to use. The cells were then post-treated with 60% (v/v) 2-propanol 
for another 30 seconds and washed with running tap water for 10-20 seconds.
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Counter staining of cell nuclei was carried out by incubating the cells in Ehrich’s 
haematoxylin solution (Raymond A LAMB limited) for 1 minute. The cells were 
mounted in DePeX mounting medium. The images were visualized using the 40X 
objective lens of a Leica DMRB microscope and photographed with a digital spot 
camera.
2.B.8.2 Periodic acid - Schiff (PAS) staining
The PAS assay was performed to detect glycogen storage (Lazaro et al., 2003). 
The reaction is based upon the fact that periodic acid oxidise 1,2-glycol groups to 
produce aldehydes which form a coloured reaction product with Schiff’s reagent 
(Derenzini et al., 1986). Briefly, the cells were seeded on the coverslips and culture for 
1 / 2 / 3  and 4 weeks in KDS medium and then incubated with KDS plus 25mM 
glucose for the following 24 hours. The cells were fixed with 4% PFA and then 
permeabilised with 1% Triton X-100 at room temperature for 20-25 minutes. The cells 
were washed with tap water for 1-2 minutes and transferred to 1% periodic acid 
solution for 30 minutes. Next, the cells were washed with running tap water for 3 
minutes and then incubated in the Schiff’s reagent at room temperature for 30 minutes 
to develop the red colour showing the expression of glycogen. After washing in 
running tap water for 10 minutes, the slides were mounted with Gel/Mount aqueous 
mounting medium.
2.B.9 Western blotting
2.B.9.1 Preparation of the cell lysate
Cells were harvested by washing 3 times in cold PBS and detached by applying
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trypsin-EDTAfor approximately 3 minutes. The cells were centrifuged at 1000 rpm for 
4 minutes and the cell pellet was then suspended with 100pl lysis buffer [150mM NaCI, 
1mM EDTA, 2mM dithiothreitol (DTT; Sigma, UK), 20mM HEPES (pH 7.6) and 1 %(v/v) 
Triton X-100] containing 1/100 dilution of protease inhibitor cocktail (Sigma, UK). The 
lysate was kept on ice for 10 minutes then centrifuged at 13000 rpm in a bench top 
MSE Micro Centaur centrifuge (ISTCP) at 4°C. The supernatant was transferred into a 
new tube and stored in -80°C until use. To extract the protein from the whole tissues, 
the tissue was homogenised using a plastic homogeniser (Fisher Scientifics) in lysis 
buffer containing 1/100 dilution of protein inhibitor cocktails and following the same 
procedure described above.
2.B.9.2 Protein quantification assay
The proteins were measured using Bio-Rad protein assay (see section 2.B.7.2).
2.B.9.3 SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
and Western blot
10-15pg total protein was mixed with the same volume of 2X sample loading 
buffer [125mM Tris-HCI (pH 6.8), 4%(v/v) SDS, 20% (v/v) glycerol (Sigma, UK), 
0.2mM DTT and 0.02% (v/v) bromophenol blue (Sigma, UK)] and denatured by 
heating to 100°C for 5 minutes. The proteins with molecular weight standards 
(Bio-Rad Laboratories) were then separated in 10% or 15% Criterion™ pre-cast 
Tris-HCI polyacrylamide gel (Bio-Rad Laboratories) at constant voltage of 80-100. 
Prior to the Western blot transfer, the gel, nitrocellulose (Pall Corporation, Pensacola 
FL), filter paper (Amersham Bioscience) and support pads were soaked for 15 
minutes in transfer buffer [pH8.3, prepared by mixing 25mM Tris, 192mM Glycine 
(Sigma, UK) and 20% methanol (Fisher Scientifics)]. The Western blot cassette was
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assembled according to manufacturer’s protocol. Air bubbles were removed by rolling 
a tube on top of the sandwich. The whole cassette was placed in the blotting chamber 
and enough transfer buffer was added to submerge it. The blotter was then connected 
to a power supply and the transfer was run at 200mA for 2 hours.
2.B.9.4 Immunoprobing and signal detection
The nitrocellulose paper was stained with diluted Ponceau S [prepared by mixing 
1% (w/v) Ponceau S (Sigma, UK) and 5% (v/v) CH3COOH (Fisher Scientifics) and 
diluted with distilled water in a ratio of 5:9] for about 1 minute and destained with 
distilled H20  to visualise the protein. The Ponceau S was totally removed by washing 
in 0.1% (v/v) PBS-Tween20 (PBST; Tween-20 is from Sigma, UK). To reduce 
non-specific background, the membrane was blocked with 5% (v/v) non-fat milk in 
0.1% (v/v) PBST at 4’C overnight. For the following stages, the blot was incubated at 
room temperature with gentle constant agitation on a rocker (Jencons Scientific Ltd., 
UK). All antibodies were diluted in 3% (v/v) non-fat milk in 0.1% (v/v) PBST. The 
membrane was probed with primary antibodies, at the dilutions shown in the text, for 2 
hours. The blots were then washed with PBST 3 times for 15 minutes and incubated 
with diluted secondary antibodies for 1 hour. After the last 15-minute wash with 
PBST, the signals on the membrane were detected with the ECL™ Western blotting 
analysis system (Amersham Bioscience) by incubating the membrane with 1:1 mixed 
ECL reagents and developed on Hyperfilm™ (Amersham Bioscience) by X-ray 
processing.
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2.B.10 Urea cycle assays
Two colourimetric assays, designed to detect secretion of urea and activity of 
arginase, were carried out on the cultured rat hepatocytes.
2.B.10.1 Urea assay
The urea assay was performed based on a previously published protocol (Meng 
et al., 2004) with minor modifications. Briefly, 100pl of urea standards (0-50pg/ml; 
Gibco™/lnvitrogen Life Technologies) and 24-hour culture medium were prepared and 
incubated with 300pl urease buffered solution at room temperature for 20 minutes. 
600pl of phenol nitroprusside, 600pl of alkaline hypochlorite and 3ml distilled H20  
were then added, gently mixed and incubated at room temperature for 30 minutes. 
The absorbance of standards and samples were then measured at an OD of 630nm.
2.B.10.2 Arginase assay
The arginase assay was based on a method by Corraliza et al (Corraliza et al.,
1994) with minor changes. The urea production was detected at OD 540nm. Urea 
production from the hydrolysis of arginine by arginase was taken as proportional 
representation of endogenous arginase activity. In short, the cultured rat hepatocytes 
were lysed in 0.1% (v/v) Triton X-100 containing a 1/100 dilution of protease inhibitor 
cocktail and shaken for 30 minutes. The lysate was then mixed with same volume of 
25mM Tris-HCI (pH 7) containing 5mM MnCI2 and the enzyme was activated by 
incubation at 56°C for 10 minutes. 25pl of activated lysate was then incubated with 
25pl of 0.5M L-arginine at 37°C for 1 hour. The samples and the urea standards 
(0-500pg/ml) were then incubated with 400pl of an acid solution comprised of H2S04 
(98%; VWR International), H3P04 (88%; Fisons scientific apparatus) and H20  at a
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ratio of 1:3:7 and 25pl 9% (w/v; dissolved in 100% ethanol) ISNP at 100°C for 45 
minutes.
2.B.11 Live-dead assay
The live-dead assay was performed using LIVE/DEAD® Viability/Cytotoxicity 
Assay. It provides a two-colour fluorescence cell viability assay that is based on the 
simultaneous determination of live and dead cells with two probes that measure 
recognized parameters of cell viability -  intracellular esterase activity and plasma 
membrane integrity. The live cells are determined by the generation of green 
fluorescence by the breakage of a nonfluorescent cell-permeant calcein AM dye into 
fluorescent calcein. This reaction is only active in cells with intracellular esterase, 
namely live cells. The ethidium homodimer dye can enter into cells while the cell 
membrane is damaged, i.e. apoptotic cells or necrotic cells (Lucas et al., 1998; 
Pulliam et al., 1998; Reader et al., 2003), and undergo enhancement of fluorescence 
upon binding to nucleic acids (Rye et al., 1991), thereby producing a bright red 
fluorescence in the dead cells.
Briefly, the cells were treated with 320nM calcein AM and 1.6 pM ethidium 
homodimer reagents and incubated at 37°C for 20-40 minutes. The cells were then 
washed with sterile PBS for 3 times and checked under the fluorescence microscope.
2.B.12 Image processing
Fluorescent specimens were examined and images collected under a Zeiss LSM 
510 confocal microscope. Images were processed with Adobe Photoshop 7.0. For cell 
counting experiments, numbers of random fields were selected using the 40X 
objective lens of a Leica DMRB microscope. The cell numbers were visualised by
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4J6-diamidino-2-phenylindole (DAPI staining). DAPI was dissolved in PBS at 500 
jug/ml, and used at a dilution of 1:1000. Coverslips were incubated with DAPI (500 
ng/ml) for 30 min at room temperature before being mounted on to slides in Gel/Mount 
mounting medium.
2.B.13 Statistics
The data were expressed as mean ± standard deviation. Comparison of 
individual treatments was conducted using Student’s t-test.
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Chapter 3.
In vitro conversion of human 
hepatoma HepG2 cells into 
pancreatic-like cells
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Overview
It has been previously demonstrated the conversion of liver cells to pancreatic 
cells in two model systems: Xenopus laevis and human HepG2 cells. In both models 
conversion of liver to pancreas was brought about by overexpression of a modified 
form of Pdx1 (Horb et al., 2003). While these results were informative, we wished to 
investigate in more detail the transdifferentiation event. The aim of the research 
outlined in this chapter is two-fold. First we are determining the phenotype of the liver 
cells and pancreatic cells. Second, we wanted to determine the cell lineage to find 
whether transdifferentiation was really occurring. It has been applied to the conversion 
of HepG2 cells to pancreatic cells the criteria of Eguchi and Kodama for 
transdifferentiation (see discussion in section 1.B). The first criterion is to demonstrate 
the phenotype of the parent cell and the daughter cell either by protein expression 
(e.g immunohistochemistry) or RNA expression (by RT-PCR). The second criterion is 
to show the ancestor-descendant relationship between the two cell types. We also 
asked whether (i) the presence of the Vp16 domain affects the transdifferentiation and 
(ii) the transdifferentiated pancreatic cells induced from HepG2 cells can divide?
3.A Differentiated properties of HepG2 cells
The HepG2 cell line was derived from a liver biopsy of a male Caucasian (aged 
15 years)(Aden et al., 1979). It is a well-differentiated hepatocellular carcinoma and 
has been shown to secrete a range of liver serum proteins (Aden et al., 1979; Dashti 
and Wolfbauer, 1987). To examine the differentiated properties we determine the 
expression of liver-specific proteins by immunostaining. The results showed that 
HepG2 expressed liver-specific proteins (albumin, a 1-antitrypsin, ceruloplasmin, 
haptoglobin and UDP-glucuronoyltransferase) and liver-enriched transcription factors
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(C/EBPp, HNF4a and RXRa) similar to normal hepatocytes (Figure 3.1). The results 
suggested that HepG2 cells are differentiated cells and therefore may be used to 
investigate transdifferentiation
3.B Molecular examinations for 
transdifferentiation
3.B.1 TTR-Xlhbox8Vp16; EI-GFP transfection in 
HepG2 cells
We wished to extend our previous observations on the conversion of liver to 
pancreas in HepG2 cells to examine the transdifferentiation event in more detail in 
molecular and cellular aspects (Horb et al., 2003). We transfected the 
pCS2-TTR-Xlhbox8Vp16; EI-GFP plasmid into HepG2 cells. In principle, it would be 
expected that the TTR promoter is active in HepG2 cells because transthyretin is 
expressed (Figure 3.2) (Costa et al., 1986). This would drive expression of 
Xlhbox8Vp16.
However, once a cell starts to express Xlhbox8, it will acquire a pancreatic identity. 
When the HepG2 cells convert to a pancreatic cell, the TTR promoter will shut down 
and the pancreas-specific elastase promoter will be activated. Since the region of the 
elastase promoter used in the present studies is active in both exocrine and endocrine 
cells activation of the promoter will only indicate conversion to a pancreatic phenotype 
and not specifically exocrine differentiation (Kruse et al., 1993). We determined the 
expression of Vp16 (which is controlled by TTR promoter) and GFP (which is 
controlled by the elastase promoter) by immunofluorescence staining.
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Acyl sulphotransferase Ceruplasmin
a1-fetoprotein Haptoglobin
Albumin Multiple drug resistant protein
a1 -antitrypsin UDP-glucuronosyltransferase
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Figure 3.1 Characterisation of the liver phenotype in HepG2 cells. Indirect 
immunofluorescence staining was performed on HepG2 cells. The hepatic proteins (A) 
aryl sulphotransferase; (B) a1-fetoprotein; (C) albumin; (D) a 1-antitrypsin; (E) 
ceruloplasmin; (F) haptoglobin; (G) multiple durg resistant protein; (H) 
UDP-glucuronosyltransferase and liver enriched transcription factors (I) C/EBPa; (J) 
C/EBPfr (K) HNF4a and (L) RXRa were detected in HepG2 cells. Scale bar: (A-H) 10 
pm; (l-L) 20 pm.
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CMV-nGFP --> HepG2 TTR-nGFP --> HepG2
Figure 3.2 Transfection of (i) pcDNA3-CMV-nGFP and (ii) pcDNA3-TTR-nGFP 
plasmids into HepG2 cells. The result showed similar transfection efficiency of these 
constructs in HepG2 cells indicating the ubiquitous expression of TTR promoter 
activity in HepG2 cells. (A,D) transmitted images; (B,E) GFP expression; (C,F) 
merged images. Scale bar = 20 pm.
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Results showed that GFP expression was activated from day 1 post transfection 
(Figure 3.3). Co-staining for Vp16 and GFP expression in the converted cells 
demonstrated time-dependent changes. The results show that Vp16 expression 
gradually decreased while GFP expression increased from the 1st to the 5th day after 
transfection (Figure 3.4). The cells displaying expression of only one of the two 
products show a crossover in frequency between two and three days after 
transfection although the majority of the cells express both Vp16 and GFP proteins.
This result is consistent with the proposed mechanism, but a surprisingly high 
percentage of pCS2-TTR-Xlhbox8Vp16; EI-GFP transfected cells co-localised 
Vp16/GFP on 1st day after transfection. Further investigation revealed that the 
elastase GFP reporter system is to some extent active in the control HepG2 cells so 
there is a significant background of GFP positive cells. Figure 3.5A, 3.5B shows 
control experiments done with pCS2-TTR-Vp16; EI-GFP and plT2-EI-GFP. This 
problem was further exemplified by qualitative data on the co-staining for insulin and 
GFP or amylase and GFP, which showed an extremely low percentage of cells 
expressing both pancreatic markers and GFP (Figure 3.6). In addition, control 
experiments including the detection of GFP protein in (transgene null control) 
transfected cells or the unlabelled GFP in insulin/amylase producing cells (Figure 
3.7C, 3.7D) were demonstrated. An interesting observation was found that GFP was 
not detected in HepG2 cells while the Elastase-GFP reporter cassette is put in a 
pcDNA3 backbone (Figure 3.5C). These data confirmed that the pCS2-EI-GFP 
reporter system is not sufficiently reliable for following the expression of the 
pancreatic phenotype in HepG2 system. Based on these results, it was decided to 
remove EI-GFP from pCS2-TTR-Xlhbox8Vp16; EI-GFP plasmid to make a new 
construct: pCS2-TTR-Xlhbox8Vp16 for the remaining experiments (see Appendix 1). 
In parallel, a negative control construct was generated: TTR-Vp16 which lacked the
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functional Xlhbox8 sequence.
Figure 3.3 GFP expression in pCS2-TTR-Xlhbox8Vp16; EI-GFP transfected HepG2 
cells after 24 hours. The expression of GFP protein reflects the activation of TTR 
promoter. Scale bar = 20 pm.
180 r 
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— A —  GFP(-)A/p16(+) — GFP(+)/Vp16(-) - m -  GFP(+)A/p16(+)
Figure 3.4 Time-dependent expression of pancreatic (elastase) and hepatic (TTR) 
promoters in the HepG2 cells transfected with pCS2-TTR-Xllhbox8Vp16; 
elastase-GFP. The gradual increase of GFP(+) / VP16(-) and decrease of GFP(-) / 
VP16(+) cells indicates that there is a dynamic process occurring in the conversion of 
hepatic cells to pancreatic cells.
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TTR-Vp16;EI-GFP ~> HepG2 (2days) plT2-Elastase-GFP •> HepG2 (2days) pcDNA3-Elastase-GFP -> HepG2 (2days)
Figure 3.5 The detection of GFP expression in (A) pCS2-TTR-Vp16; EI-GFP, (B) 
pCS2-Elastase-GFP or (C) pcDNA3-Elastase-nGFP transfected HepG2 cells. The 













Figure 3.6 The percentage of the amylase or insulin producing cells among GFP 
positive cells after 5 days of pCS2-TTR-Xlhbox8Vp16; EI-GFP transfection in HepG2 
cells. The results are presented as mean+S.D. (n>6)
1.312 0.898
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Amylase I GFP Insulin I GFP
Figure 3.7 Dual staining of GFP and amylase or insulin on the HepG2 cells 
transfected with pCS2-TTR-Xlhbox8Vp16; EI-GFP plasmid for 5 days. The amylase or 
insulin positive cells were either co-stained with GFP protein (A,C) or solely 
expressed (B,D). Scale bar =10 pm.
3.B.2 Do HepG2 cells express multiple 
pancreatic phenotypes following ectopic 
expression of pCS2-TTR-XlhboxVp16?
3.B.2.1 Expression of pancreatic exocrine and endocrine 
markers
The pancreas is composed of multiple cell types, including exocrine and
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endocrine cells (Percival and Slack, 1999). We used pancreatic tissue from E11.5 
mouse embryos cultured for 7 days as control tissue for immunostaining of amylase, 
insulin, glucagon, somatostatin and pancreatic polypeptide (Figure 3.8). The question 
arises whether ectopic expression of the pCS2-TTR- Xlhbox8Vp16 plasmid simply 
induces pancreatic gene expression or whether it is possible to induce the formation 
of specific pancreatic cell types. Following transfection of HepG2 ceils with the 
pCS2-TTR-Xlhbox8Vp16 plasmid, some cells expressed pancreatic exocrine amylase 
(Figure 3.9F) and endocrine hormones insulin (Figure 3.9G), glucagon (Figure 3.9H), 
and somatostatin were expressed (Figure 3.9I) in HepG2 cells by the fifth day, 
although the efficiency of conversion to pancreatic phenotype was extremely low. The 
only principal pancreatic hormone not observed was pancreatic polypeptide (PP, 
Figure 3.9J). This observation may be explained because of the small proportion of 
PP cells in the normal pancreatic islets (~ less than 1 % of total endocrine cells (Slack,
1995)). In contrast, the HepG2 cells that were transfected with the control construct 
pCS2-TTR- Vp16 showed no pancreatic protein expression at all (Figure 3.9A-3.9E). 
As well as protein detection by immunohistochemistry, we studied the expression of 
pancreatic genes by RT-PCR. This approach is complementary to immunodetection 
because it can show low levels of mRNA and, using the Light Cycler system, can 
provide quantitative results. The results showed that there is low-level expression of 
some, but not all, pancreatic genes, in the parental HepG2 cells under the same PCR 
conditions (28 cycles). The pancreatic genes include amylase and somatostatin, and 
an appreciable level of pancreatic polypeptide (Figure 3.10A). The real-time 
quantitative RT-PCR of cells transfected with pCS2-TTR-Xlhbox8Vp16 plasmid 
showed a sharp increase in mRNA expression for amylase, insulin, glucagon and 
somatostatin. The rise in mRNA expression occurred between 3 and 5 days after 
transfection, consistent with the timing of appearance of the pancreatic proteins
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(Figure 3.1 OB-3.10E). It is noteworthy that pancreatic polypeptide mRNA was also 
upregulated on the 5th day after transfection (Figure 3.1 OF). The difference between 
RT-PCR and immunostaining results may be due to the limited sensitivity of protein 
detection by immunostaining (e.g. the protein may be folded so that the epitope is not 
apparent to the antibody). Altogether, these results demonstrate that the Xlhbox8Vp16 
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A
Figure 3.8 Pancreatic proteins expressed in cultured dorsal pancreatic buds.
Amylase (A), somatostatin (B) and pancreatic polypeptide (C) are shown in green and 
insulin and glucagon are shown in red and blue respectively. Scale bar: 100 pm.
Figure 3.9 Pancreatic proteins are induced in HepG2 cells after transfection with 
pCS2-TTR-Xlhbox8Vp16 plasmid. Amylase (F), insulin (G), glucagon (H), 
somatostatin (I) but not pancreatic polypeptide (J) was detected at 5th day after 
transfection of pCS2-TTR-Xlhbox8Vp16. In contrast, no pancreatic protein expressing 
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Figure 3.10 Pancreatic mRNA expression is induced or upregulated in 
transdifferentiated cells. (A) Qualitative detection of pancreatic mRNAs in human 
pancreatic cells and in untransfected HepG2 cells. HPC: human pancreatic cells, -ve: 
no template control. (B-F) The relative mRNA expression was determined via 
real-time RT-PCR for amylase (B), insulin (C), glucagon(D), somatostatin (E) and 
pancreatic polypeptide (F) on 1st (purple bar) 3rd (yellow bar) and 5th day (light green 
bar) after transfection with pCS2-TTR-Xlhbox8Vp16. HPC=human pancreatic cells; 
-ve=no template control.
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3.B.2.2 Colocalisation of pancreatic proteins in converted cells
An important issue in the conversion of HepG2 cells to pancreatic cells is the 
fidelity of the pancreatic cell types. In postnatal endocrine cells only one hormone is 
expressed in a cell. To investigate if transdifferentiated pancreatic cells also possess 
this characteristic, we co-stained HepG2 cells transfected pCS2-TTR-Xlhbox8Vp16 
plasmid for pairs of different pancreatic markers. The results showed that none of the 
pancreatic proteins, including amylase, insulin or glucagon, were co-expressed in the 
same transdifferentiated cell (Figure 3.11). This means the converted cells are more 
likely to be normal differentiated pancreatic cell types rather than liver cells that are 
ectopically expressing pancreatic genes.












Figure 3.11 The histogram shows the number of pCS2-TTR-Xlhbox8Vp16 
transfected cells stained for two pancreatic proteins. The results showed that no 
co-expressing cells were detected. Numbers of counted cells = 153, 88, 126 for 
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3.B.3 Downregulation of hepatic proteins in 
converted HepG2 cells
3.B.3.1 Loss of hepatic proteins in transdifferentiated cells
It is possible that cells expressing pancreatic proteins continue to express liver 
genes. To examine the fate of the hepatic proteins in the cells expressing pancreatic 
proteins, dual-immunostaining for several hepatic proteins (e.g. albumin, a1 
anti-trypsin, haptoglobin, transferrin and transthyretin), was performed along with the 
(3-cell hormone insulin. This was performed in control (pCS2-TTR-Vp16) and in 
Xlhbox8Vp16 transfected HepG2 cells. The results indicated that the hepatic proteins 
in transformed cells were lost in some insulin-positive cells (Figure 3.12F, 3.12G and 
3.12N) but were present in others (Figure 3.12H-3.12M, 3.120). By contrast, the cells 
transfected with the control pCS2-TTR-Vp16 construct showed no insulin expression 
or loss of hepatic protein expression (Figure 3.12A-3.12E). The proportion of 
converted cells with or without hepatic markers was determined. Between one-sixth 
and a quarter of the insulin positive cells had completely lost hepatic proteins 
including albumin (25%), a1 anti-trypsin (24%) or transferrin (16%) and so are 
presumably transdifferentiated pancreatic (3-like cells (Figure 3.13). We also 
examined the time-course of albumin expression in transfected cells. To quantify the 
number of albumin-expressing transfected cells we identified immunostained albumin 
and Vp16. A progressive loss of albumin over the 5-day period in Vp16 expressing 
cells was found (Figure 3.14). So although the majority of cells do still contain liver 
proteins at 5 days it is likely that albumin expression has been turned off and the 
protein is gradually decaying. Based on above data, the two main criteria for 
transdifferentiation characterisation of phenotype of the converted cells and
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demonstration of the relationship between the original and converted cells were 
fulfilled to some extent. Therefore, it might be acceptable to use the term 
transdifferentiated cells for these pancreatic-like cells.
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Figure 3.12 Hepatic proteins were repressed in some transdifferentiated cells. HepG2 
cells were transfected with control pCS2-TTR-VP16 (A-E) or pCS2-TTR-Xlhbox8Vp16 
plasmids (F-O) and stained for the hepatic markers albumin (A.F.K), ai-antitrypsin 
(B.G.L), haptoglobin (C.H.M), transferrin (D.I.N) and transthyretin (E.J.O) (red) and 
insulin (green). Insulin was not expressed in the pCS2-TTR-VP16 cells. The 
co-expression of insulin with a liver protein (H-M and O) is observed in some cases 
while some cells express insulin without the liver protein (F,G and N, white arrows). 
Scale bar: 10pm in C, D, E, H, I, J, K, L and M, 20pm in A, B, F, G, N and O.
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Insulin I Albumin Insulin I Transferrin insulin I a  1-antitrypsin 
(N=187) (N=155) (N=167)
□ % of colocalised ceHs □ % of non-colocalised cells
Figure 3.13 The percentage of cells co-expressing insulin and hepatic markers at day 
5 after transfection of pCS2-TTR-Xlhbox8Vp16.
20.79%
1st day 2nd day 3rd day 4th day 5th day 
□ Vp16(+)/Albumin(-) □  Vp16(+)/Albumin(+)
Figure 3.14 Progressive loss of albumin in pCS2-TTR-Xlhbox8Vp16 transfected 
HepG2 cells. These data were shown from the determination of 6 random fields of two 
independent experiments based on the immunofluorescent detection of Vp16 and 
albumin proteins.
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3.B.3.2 Suppression of hepatic promoter activity in 
Xlhbox8Vp16 transfected cells
In order to further confirm the repression of the hepatic phenotype in 
transdifferentiated cells, another set of experiment was designed. We compared the 
promoter activity in cells transfected with the pCS2-TTR-Xlhbox8Vp16 construct and 
those transfected with either: (1) CMV- Xlhbox8Vp16 or (2) TTR-nGFP. In the first 
experiment, the CMV promoter is expected to be continuously active regardless of the 
state of differentiation of the cell. The proportion of Vp16 positive cells in the total cell 
population was measured on each day and then converted to a relative ratio for the 
TTR versus the CMV construct (Figure 3.15A). Although the percentage of Vp16 
positive cells decreased in cells transfected with either construct, there was more 
repressive activity of TTR promoter in contrast to CMV promoter. A similar 
experimental procedure was carried out in TTR-Xlhbox8Vp16 versus TTR-nGFP 
transfected cells. The TTR-nGFP construct was used as a negative control for the 
effect of the transgene on the TTR promoter. The same measurement was performed 
and the result was presented as a proportion of Vp16 positive to nGFP positive cells. 
By contrast, the number of Vp16 expressing cells was significantly less than GFP 
positive cells at the same time point (Figure 3.15B). These experiments implied that 
TTR promoter activity is downregulated in TTR-Xlhbox8Vp16 transfected cells, in 
other words, the hepatic phenotype is switched off during transdifferentiation. These 
figures do not match Figure 3.4 quantitatively, but the precision of the results is limited 
by the fact that there is a certain loss of transfected cells during the culture period, and 
means that the results should be treated as qualitative rather than quantitative.
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Figure 3.15 Repression of hepatic promoter activity in transdifferentiated cells. (A) 
Vp16 positive cells as a percentage of total cells in pCS2-TTR-Xlhbox8Vp16 or 
pCS2-CMV-Xlhbox8Vp16 transfected HepG2 cells. The different time points after 
transfection are shown. (B) Vp16/GFP positive cells as a percentage of total cells in 
pCS2-TTR-Xlhbox8Vp16 or pcDNA3-TTR-nGFP transfected HepG2 cells. The results 
on different days after transfection are shown.
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3.B.4 The transgene is only transiently required 
to induce transdifferentiation
As mentioned previously, one possible clinical application for this study is to 
provide an alternative treatment for type 1 diabetes meliitus. Currently, insulin 
injection is the usual treatment for type 1 diabetic patients. However, regardless of the 
use of either traditional injection injections or the insulin pump to achieve the 
normoglycaemia in diabetic patients, the necessity of repeated injections or invasive 
therapy has seriously affected patients’ quality of life. If gene therapy is ever to be of 
use, to avoid unexpected effects the shorter the time the transgene is expressed in 
the cells, the better. We followed the Xlhbox8 expression using both qualitative and 
quantitative real-time RT-PCR. The results showed a remarkable decrease of Xlhbox8 
at the 5th day following the transfection of pCS2-TTR-Xlhbox8Vp16 in contrast with 
levels after 1 day of transfection (Figure 3.16) and compared to the levels of insulin 
and amylase by day 5 (Fig. 3.10). This examination correlates with the TTR promoter 
experiments and suggested that the transgene for transdifferentiation of HepG2 cells 
to pancreatic cells is only transiently required, and that once the pancreatic fate is 
acquired it remains stable.
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Xlhbox8
Beta-actin
V1 X1 V3 X3 V1 X5 -ve
B
1st day 3rd day 5th day 
P-value *:0.000395<0.005
Figure 3.16 RT-PCR analysis for Xlhbox8 trasngene expression in transdifferentiated 
cells. (A) Qualitative RT-PCR showing decline of Xlhbox8 transcripts over the 5-day 
post-transfection period. V=pCS2-TTR-Vp16 control; X=pCS2-TTR-Xlhbox8Vp16 
transfected cells. (B) Real-time quantitative RT-PCR showing downregulation of 
Xlhbox8 transcripts
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3.C Origin of transdifferentiated cells
For the conversion of one cell type to another to be termed transdifferentiation, 
the relationship between the parental and transdifferentiated cells should be 
demonstrated. Although it has been demonstrated that a proportion of 
transdifferentiated cells expressed hepatic markers along with pancreatic protein 
insulin (Figure 3.12), it would be advantageous to develop a cell-tracing model to find 
out the origin of the transdifferentiated cells. Several experimental designs have used 
to determine the ancestor-descendant relationship. For example, it is possible to 
cross two animals containing a Cre recombinase regulated by tissue specific promoter 
(i.e. promoter X) and a certain reporter protein controlled by ubiquitous promoter (i.e. 
CMV promoter) to generate a offspring displaying the labelled X progenitors (Ghosh 
and Van Duyne, 2002; Sauer, 1998; Utomo et al., 1999). To examine the histological 
phenotype of in vitro cultures made from two individual strains of animals which have 
different distinguishable genotypes (such as Rosa 26 crosses with CD1 mice) was 
also demonstrated (Percival and Slack, 1999; Seymour et al., 2004). More recently, 
grafting of labelled, e.g. GFP-labelled, tissue to the same region of distinct animals 
was used to trail down the destiny of the specific cell types (Gargioli and Slack, 2004). 
Therefore, it was decided to generate a reliable reporter system in combination with 
immunostaining to address the question of the cell origin of the transdifferentiated 
cells.
3.C.1 Construction and expression property of 
CMV-Xlhbox8Vp16; CMV-DsRed plasmid
In order to trace the cell lineage using a transient transfection method, it is 
essential to have: (i) constitutively active promoter to drive transgene and reporter
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gene and (ii) a reporter protein of low cytotoxicity.
Based on the steady-state levels of viral mRNA and the abundance of the protein 
product in CMV infected cells, the CMV promoter is one of the strongest promoters 
used in mammalian vectors (Thomsen et al., 1984). DsRed is derived from an 
Indo-Pacific sea anemone-relative, Discosoma species and can be highly expressed 
in mammalian cells (Jakobs et al., 2000; Matz et al., 1999). The total number of 
DsRed positive cells did not show any decay at least until 4 days after transfection of 
CMV-DsRed into HepG2 cells (Figure 3.17). Hence, DsRed is suitable for tracing the 
cell lineage of the transfected cells.
By combining CMV-Xlhbox8Vp16 and CMV-DsRed, a new construct was 
generated (Figure 3.18A). To understand the properties of this new construct, we 
determine the time-course of transgene and reporter expression by dual-staining for 
Vp16 and DsRed respectively. The results indicate that almost 80% of transfected 
cells co-expressed the transgene and DsRed even 5 days after transfection (Figure 
3.18 B and C). This result suggested that both the Xlhbox8Vp16 and the DsRed were 
permanently expressed in all transfected cells regardless of phenotype. Although 
there are a few cells on day 1 that are negative for DsRed, this is probably due to the 
fact that the expression had not built up so that it was visible under fluorescence. In 
addition, there are a few more cells at each time point that are negative for Vp16. This 
may reflect a certain level of excision of the Xlhbox8Vp16 caused by recombination 
between the two CMV promoters.
3.C.2 Pancreatic phenotype is expressed in 
Xlhbox8Vp16 transfected cells
Five days after the introduction of the CMV-Xlhbox8Vp16; CMV-DsRed construct
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into the HepG2 cells, transfected cells were compared with control CMV-DsRed 
transfected cells (Figure 3.19A). Insulin-positive cells were detected in 
CMV-Xlhbox8Vp16; CMV-DsRed transfected cells in a similar fashion to the results 
obtained from the TTR-Xlhbox8Vp16 transfected HepG2 cells (Figure 3.19B). 
Moreover, about half of the insulin producing cells came from transfected cells based 
on the detection of insulin/DsRed co-expression at the 5th day after transfection of the 
plasmid. This result confirmed the source of transdifferentiated cells (Figure 3.19C). It 
is true that some insulin producing cells do not express dsRed. This does raise the 
possibility that cells might transdifferentiate without containing the Xlhbox8Vp16 
themselves, through some sort of cell interaction. But we cannot conclude much from 
this fraction as the cells might lose either of the genes by recombination between the 
CMV sequences. The double positives are therefore more significant than the single 
positives.
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Figure 3.17 DsRed expression in HepG2cells transfected with pcDNA3-DsRed 
plasmid. 1pg pcDNA3-CMV-DsRed DNA was introduced into HepG2 cells and 
detected by cell counting from the 1st to the 5th day after transfection (A). Confocal 
microscope images (B) were taken on the 2nd day after transfection). It was shown 
that DsRed persists for at least 4 days and there is loss of expression after 5 days of 
transfection. Scale bar in B and C is 20 pm.
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Figure 3.18 Testing of CMV-Xlhbox8Vp16; CMV-DsRed construct in HepG2 cells. (A) 
Schematic representation of CMV-Xlhbox8Vp16; CMV-DsRed construct; (B) The 
expression of Vp16 (green) and DsRed (red) for the 2-day CMV-Xlhbox8Vp16; 
CMV-DsRed transfected HepG2 cells. (C) Analysis of Vp16 and DsRed expression in 
HepG2 cells transfected with CMV-Xlhbox8Vp16; CMV-DsRed on the 1s', 3rd and 5,h 
day after transfection. The graph was shown based on the data from the 
determination of 6 random fields from two independent experiments.
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CMV-DsRed CMV-X8vp16;CMv-DsRed
-> HepG2 (5 days) -> HepG2 (5 days)
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Figure 3.19 Cell origins of transdifferentiated cells. The origin of transdifferentiated 
cell was investigated in CMV-DsRed (A) and CMV-Xlhbox8Vp16; CMV-DsRed (B) 
transfected HepG2cells. Insulin (in green) positive cells were detected with (yellow 
arrow) or without (white arrow) co-expression with DsRed. (C) ratio of the 
DsRed(+)/lnsulin(+) or DsRed(-)/lnsulin(+) cells to total insulin (+) cells 5-days after 
transfection with CMV-Xlhbox8Vp16; CMV-DsRed plasmid. The figure was shown 
based on the data from the determination of 5 random fields of two independent 
experiments.
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3.D Mechanisms to induce 
transdifferentiation
3.D.1 Vp16 does not work by promoting nuclear 
localisation
Previous work has shown that the Vp16 domain is essential to achieve 
transdifferentiation in the Xenopus system (Grapin-Botton et al., 2001; Heller et al., 
1998; Horb et al., 2003). The Vp16 activation domain is a herpes virus protein and 
was shown to be a potent activator of transcription that is bound to the promoter 
region as a consequence of its association of several DNA-binding proteins, for 
example transcription factor TFIIH (Jiang et al., 1994; Xiao et al., 1994). Several 
mechanisms have been proposed to account for the activity of the Vp16 domain. For 
example, it could be through the neutralisation of the repressive effect of histones on 
transcription or grouping of the factors involved in the initiation or activation of 
transcription regulatory factors. These factors include TATA-binding protein (TBP), 
TBP-associated components including transcription factor IID (TFIID) and 
transcription factor MB (TFIIB) and histone acetyltransferase(Croston et al., 1992; 
Horikoshi et al., 1988; Ikeda et al., 2002; Lin and Green, 1991). Therefore, it is 
possible that part of the activity of Vp16 domain may depend on increasing nuclear 
localisation of the Xlhbox8 protein. To investigate this hypothesis, two more plasmids 
were generated: CMV promoter driving either mouse Pdx1 or mouse Pdx1Vp16 
fusion protein. These experiments were done with the mouse sequence rather than 
the Xenopus one because of the limited availability of a suitable antibody to detect the 
Xenopus protein. These two constructs were then transfected into HepG2 or Panc-1
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cells to investigate the intracellular localisation of Pdx1. Panc-1 is a human pancreatic 
ductal cell line derived from 56-year-old Caucasian male and does not express Pdx1. 
Panc-1 provides a control comparison to understand whether the transcriptional 
activation effect of the Vp16 sequence is only exerted in liver; and, more specifically, 
whether or not the localisation of Pdx1, before and after tagging with Vp16 domain, is 
only altered in “pancreatic-like” cells.
The rat insulinoma cell line, RIN-m5F, was used as a control for the Pdx1 
antibody activity since endogenous Pdx1 is highly expressed in this cell line (Figure 
3.20A, 3.20B). Pdx1 is expressed either in the nucleus or the cytoplasm in both 
HepG2 and Panc-1 cells (Figure 3.20C-3.20F). There was no significant difference in 
nuclear localisation between Pdx1 and Pdx1Vp16 in either cell line by quantitative cell 
counting at 5th day after transfection. The proportion of nuclear Pdx1 or Pdx1Vp16 in 
both cell lines was estimated at 65%~75% of total transfected cells (Figure 3.21). In 
conclusion, Vp16 does not exert its effect by increasing nuclear localisation.
HepG2 cells were transfected with either CMV-Pdx1, CMV-Pdx1Vp16 or 
TTR-Xlhbox8Vp16 to determine whether there were any difference in the nuclear 
localisation. Depending on the construct, the nuclear localisation of the transgene was 
examined by detection of Vp16 or Pdx1. A significant increase in nuclear localisation 
of transcription factors was observed in TTR- Xlhbox8vp16 transfected cells (Figure 
3.22). This may result from a sequence difference between the mouse and Xenopus 
genes. Therefore, by using the Clustal X  alignment software and the domain tool on 
the PubMed website, the amino acid sequences of mouse Pdx1 and Xenopus 
homologue Xlhbox8 were compared. Although 100% identity of input sequences 
(human, mouse and Xenopus Pdx1 homologue) from E151 to R216 (the homeobox 
region of Pdx1 gene) was displayed, the homology of total amino acid sequences in 
mouse and Xenopus was far different, about 58% identity (165 out of 283 amino acids)
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(Figure 3.23). Based on this observation, we assumed that the difference of 
percentage of nuclear Xlhbox8 and mouse Pdx1 in transfected HepG2 cells might be 
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Figure 3.20 Nuclear localisation of Pdx1 or Pdx1Vp16 in different cells. Rat 
insulinoma (RIN-5F) cells (A,B), HepG2 cells (C,D) and human pancreatic ductal 
Panc-1 cells (E,F) immunostained for Pdx-1 (red in A,B; green in C,E) or Vp16 (green 
in D,F) and DAPI (blue) to determine transgene localisation. HepG2 and Panc-1 cells 
were transfected with pcDNA3-mpdx1 (C,E) or pcDNA3-mpdx1Vp16 (D,F) plasmid. 
Scale bar: 50 pm.
HepG2
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□  CMV-PDX1 QCMV-PDX1Vp16
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Figure 3.21 Pdx-1 nuclear localisation is not altered by the presence of the Vp16 
activation domain. Cell counts were performed for nuclear Pdx1 expression on cells 
transfected with either Pdx1 or Pdx1Vp16 in HepG2 or Panc-1 cells. There was no 
significant difference between the absence and presence of Vp16.
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Figure 3.22 Variation of nuclear localisation of Pdx1, Pdx1Vp16 and Xlhbox8Vp16 in 
HepG2 cells. The graph represents the mean±S.D. for at least 5 random fields of 3 
different slides.
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Figure 3.23 The alignment of human, mouse and Xenopus Pdx1 homologues using 
Clastal X software.
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3.D.2 Higher glucose concentration does not 
increase nuclear Pdx1 in HepG2 & Panc-1 cells 
but increases insulin production in 
transdifferentiated cells
It has recently been shown that a high glucose environment stimulates nuclear 
translocation of Pdx1 from cytoplasm into nucleus (Macfarlane et al., 1999; Rafiq et 
al., 2000; Rafiq et al., 1998). This effect may mediate the increasing phosphorylation 
of Pdx1 by activation of phosphatidylinositol 3-kinase, SAPK2/p38 signalling 
pathways or directly by interacting with the nuclear import receptor family member, 
importin (31 (Elrick and Docherty, 2001; Guillemain et al., 2004). Using the idea that 
high glucose can promote insulin expression, it might also be possible to promote 
either the efficiency of transdifferentiation or maturation of transdifferentiated [3-cells. 
To test this idea, the ratio of nuclear Pdx1 in CMV-Pdx1 transfected HepG2 and 
Panc-1 cells were compared in physiological (5.5mM) and high (25mM) glucose. The 
percentage of cells displaying nuclear Pdx1 showed no significant difference between 
these two culture conditions in either cell lines (Figure 3.24).
The in vivo data from Cao et al. suggested that high glucose treatment with mice 
injected with Pdx1Vp16 adenoviral construct improved the maturation of 
transdifferentiated cells (Cao et al., 2004). To further test if a higher concentration of 
glucose also enhanced the maturation of transdifferentiated cells in the HepG2 
system, the cells were transfected with TTR-Xlhbox8Vp16 and incubated in high 
glucose (25mM) culture medium for either (1) an additional 2-8 hours after 5 days of 
transfection or (2) for the entire time (1-5 days) after transfection. The insulin and 
glucagon mRNAs were detected using real-time RT-PCR. The short-term incubation
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showed the insulin mRNA was largely increased by about 104 folds after 6-hours 
treatment of high concentration glucose in comparison with the insulin expression at 
zero time point (Figure 3.25). Long-term exposure to high concentration glucose in 
HepG2 cells transfected with TTR-Xlhbox8Vp16 indicated that insulin and glucagon 
mRNA were significantly enhanced after prolonged high glucose treatment after 5 
days (Figure 3.26). In summary, it can be concluded that high glucose promotes 
complete transdifferentiation in HepG2 cells but it may not be due to increased 
nuclear translocation of Pdx1. This work was done late in the thesis period so the 
result could not easily be exploited. However it suggests that many of the other 
results would have been much clearer had the experiments been performed in high 
glucose.
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Figure 3.24 High glucose does not alter the nuclear localisation of Pdx1 in HepG2 
and Panc-1 cells. Cell counting results showed no significant difference of nuclear 
Pdx1 expression between the cells incubated in medium with either 5.5mM or 25mM 
glucose for HepG2 and Panc-1 cells.
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Figure 3.25 Short-term effect of high glucose on insulin mRNA in transdifferentiated 
cells. The cells were transfected with control (pCS2-TTR-Vp16) or 
pCS2-TTR-Xlhbox8vp16 plasmids and then were cultured in medium containing 5.5 
mM glucose for 5 days and changed to the medium contained 25mM glucose for up to 
8 hours. The real-time RT-PCR to detect insulin mRNA was then performed. The 
sharpest increase of the insulin occurred between 4 and 6 hours after incubation of 
transdifferentiated cells in high glucose. The result was presented as mean+S.D. for 3 
different experiments.
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Figure 3.26 Long-term effect of high glucose on insulin mRNA in transdifferentiated 
cells. The cells were treated with normal or high glucose from the day after 
transfection of pCS2-TTR-Xlhbox8Vp16. The (A) insulin and (B) glucagon mRNA was 
then detected using real-time RT-PCR. The results are presented as mean+S.D..
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3.E Endogenous pancreatic programme 
activation and division of 
transdifferentiated cells
Regarding the future possible clinical application of transdifferentiated cells for 
the treatment of diabetes, two interesting questions remained. First, is the endogeous 
pancreatic developmental programme induced in the course of transdifferentiation? 
Second, can the transdifferentiated cells proliferate? Previous work has shown that 
endogenous pancreatic transcription factors can be induced after exogenous genetic 
stimulation. Ber et al. infected mouse liver with the first generation adenoviral vector 
encoding rat Pdx1. Although the rat Pdx1 was infected, the mouse Pdx1 gene was 
induced suggesting a self-feedback regulation (Ber et al., 2003). In the present study, 
the Xenopus Pdx1 homologue Xlhbox8 was used as the experimental material in a 
human cell line, it is therefore possible to design specific primers to detect human 
Pdx1 expression. Because of the low transdifferentiation efficiency, the culture period 
after transfection was extended up to 7 days and the PCR program was increased to 
40 cycles to enrich the signals (Figure 3.27). This shows a low but reproducibly 
detectable signal from the endogenous human Pdx1 gene in the transfected cells. 
This result suggests that Xlhbox8Vp16 transfected HepG2 cells do induce their 
endogenous Pdx1 gene.
The restricted availability of transplant pancreas has been an impediment for the 
treatment for type I diabetic patients. If cell transplantation is to be of use, it will be of 
benefit if the transdifferentiated cells can be expanded in vitro. To examine this issue, 
the detection of a mitotic marker, phosphohistone H3 (Ajiro et al., 1996), in 
transdifferentiated cells was performed. Some insulin producing cells were also 
positive for phospho H3 (Figure 3.28) suggesting that the transdifferentiated cells are 
capable of dividing.
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Figure 3.27 Endogenous Pdx1 expression in transdifferentiated cells. X=transfected 
with pCS2-TTR-Xlhbox8Vp16; V=controls transfected with pCS2-TTR-VP16, 
HPC=human pancreatic cells; -ve=no template.
Figure 3.28 Cell division in transdifferentiated cells. The 5-day 
pCS2-TTR-Xlhbox8vp16 transfected HepG2 cells were stained with insulin (green) 
and phosphohistone H3 (red, nuclear staining). The result shown that the insulin 
positive cells co-expressed with (yellow arrow in A) or without (white arrow in B) 
phosphohistone H3. Scale bar= 20 pm.
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3.F Discussion
In the present chapter, the results show that transfection of Xlhbox8Vp16 into 
HepG2 cells is able to induce pancreatic cell phenotypes. The phenotypes include 
amylase-expressing exocrine cells and a range of endocrine cells, at least a 
(glucagon-expressing), p (insulin-expressing) and 6 (somatostatin-expressing) types 
(Figure 3.9 and 3.10). It is noteworthy that a similar pancreatic cell distribution of the 
transdifferentiated cells to normal pancreatic cells was present. In normal pancreas, 
p-cells constitute the major endocrine cell type, followed by a-cells, ghrelin-cells, 
5-cells and finally PP-cells make the smallest number (Slack, 1995). Among the 
transdifferentiated cells insulin-expressing cells are about four times more prevalent 
than glucagon-producing cells under the same culture conditions (Figure 3.11). One 
interesting result displayed from this work is the existence of the “dynamic” 
transdifferentiation process. This statement is based on the observation of both insulin 
/ hepatic co-expressing cells and insulin-producing cells lacking hepatic protein after 
transdifferentiation (Figure 3.12). This is the first time such a process has been 
proposed in transdifferentiation studies. As a result of these observations, it is 
believed that a gap, the demonstration of relationship between the original cell type 
and the converted cell type, has been filled. This confirmed a genuine 
transdifferentiation of liver cells to pancreatic cells by introduction of a single 
“master-switch gene”. It is true that the proportion of transfected cells that become 
differentiated pancreatic cells is very small. This observation suggests that the HepG2 
cells may not be homogeneous and therefore have some intrinsic variability of 
competence, the basis of which is not currently understood.
Results from the current study also demonstrated that transgene expression (as 
determined by the detection of Vp16 or Xlhbox8) is only transiently required for
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transdifferentiation of hepatocytes to pancreatic cells. By the end of the culture period 
a proportion of pancreatic cells have lost transgene expression and expressed a 
pancreatic phenotype. A similar effect was also found in the in vivo study of Ber et al 
(Ber et al., 2003). From a clinical point of view, a transient action of the transgene 
would be beneficial because it would remove the need for transgene integration which 
might create problems of insertional mutagenesis.
It is not known why the Vp16 domain changes the biological activity of Pdx-1 so 
profoundly. In this work it is shown that there is no significant effect on the degree of 
nuclear localisation e.g. by comparison of the proportion of nuclear mPdxl and 
mPdx1Vp16 while transfection into HepG2 cells. One factor is probably the fact that 
Vp16 is a very active transcriptional activation domain so that the change of capacity 
for transdifferentiation is occurred on the transcriptional level instead of on the activity 
of nuclear entry of the proteins. Another is that it may be able to act in the absence of 
the various partner proteins that are used, by Pdx-1 in the context of the normal 
pancreatic cell types (Andersen et al., 1999; Glick et al., 2000; Goudet et al., 1999; Liu 
et al., 2001).
In the cell-lineage tracing experiment, it was shown that about 50% of 
insulin-expressing cells are transgene positive, based on the detection of the 
expression of the DsRed reporter protein (Figure 3.19C). A question that arises is: 
why don’t all of the insulin-producing cells express DsRed? We considered the 
following reasons might provide an explanation. First, it is possible that 
insulin-positive cells lose DsRed by the 5th day after transfection. This possibility is 
based on the observation of a small reduction of DsRed expression in CMV-DsRed 
transfected cells, as shown in Figure 3.17A. Second, an accumulation of a high level 
of DsRed proteins in the transfected cells may be inhibitory for transdifferentiation. It is 
possible for the cells to reduce the amount of DsRed protein either via a mechanism
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that involved removal of the protein or active homologous recombination between the 
two CMV promoters to remove the CMV-DsRed portion from the plasmid. Thirdly, 
certain “transdifferentiation promoting factors” might be transmitted between the cells 
and play a role to induce adjacent cells to become pancreatic-like cells. An unknown 
soluble factor could be secreted from insulin-positive cells (DsRed positive) into 
medium and consequently taken-up by the other cells (DsRed negative) to induce the 
endogenous pancreatic programme, for example, expressing insulin protein. Five-day 
inoculation of the parental HepG2 cells in the culture medium collected from 
TTR-Xlhbox8Vp16 transfected HepG2 cells was carried out to test this hypothesis. 
However, no insulin-producing cells, were detected. Lastly, a recent investigation 
suggested that insulin uptake from the culture medium might be the reason 
contributing to the detection of insulin-expressing cells derived from other cell types, 
e.g. embryonic stem cells(Rajagopal et al., 2003). This is unlikely in our case because 
of the insulin mRNA increase (Fig.3.10) and the demonstration of C-peptide in the 
cells (chapter 4).
Although the results in the present study are encouraging, the transdifferentiation 
efficiency in the HepG2 cell model needs to be improved. First, use of the high 
glucose medium might be helpful. Second, establishing a cell line which stably 
expresses Pdx1Vp16 gene or using a more efficient gene delivery method such as 
adenovirus infection might serve to ameliorate the low efficiency of transient 
transfection. Third, the introduction of several pancreatic transcription factors in 
combination, at appropriate times and dosage manner, to mimic normal pancreas 
development might increase the percentage of transdifferentiated cells (Soria, 2001; 
Wang et al., 2001). Fourth, epigenetic manipulation may promote loss of the 
chromatin structure and thereby enhance the potency of transcription factor for cell 
reprogramming (Pomerantz and Blau, 2004). For example, the treatment with the
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DNA methylation inhibitors 5-aza-cytidine and 5-aza-deoxycytidine might lead to 
de-condensation of chromatin structure and therefore perhaps more favourable 
conditions for genetic modification (Goffin and Eisenhauer, 2002; Haaf, 1995).
In summary, the current study shows that in HepG2 cells can be converted into 
pancreatic-like cells, and we have observed a dynamic process of transdifferentiation 
by the detection of the changes of hepatic and pancreatic proteins during 
transdifferentiation.
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Chapter 4. 
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Overview
The experiments described in Chapter 3 demonstrated that the hepatoma cell 
line HepG2 can be reprogrammed to pancreatic cells by introduction of a master 
regulatory gene, Xlhbox8Vp16. Although the transdifferentiated cells displayed some 
of the characteristics of pancreatic cells (e.g. expression of [3-cell markers), the 
question still remains to what extent the transdifferentiated show the functional 
properties of (3-cells? In order to answer this question, a number of assays were 
performed.
4.A Induction of insulin processing 
machinery
4.A.1 Molecules involving insulin biosynthesis
All four pancreatic hormones (insulin, glucagon, somatostatin and pancreatic 
polypeptide) are initially synthesised as larger prohormones and can be catalytically 
converted by prohormone convertases (PCs) into smaller, biologically active 
hormones(Tomita, 2002). For example, proinsulin and proglucagon are the precursors 
of insulin and glucagon proteins and are post-translationally cleaved into insulin and 
glucagon by PC1/3 and PC2 (Blache et al., 1994; Tomita, 2002). Proinsulin is 
preferentially cleaved by PC1/3 at the C-terminal side bond between the C-peptide 
and B-chain junction whereas PC2 exclusively digests those between the C-peptide 
and A-chain junction(Smeekens et al., 1992). A reduced activity of PCs is positively 
correlated to the tumourogenic phenotype of pancreatic endocrine derived tumour 
cells including insulinomas, glucagonomas and pancreatic polypeptideomas (Tomita,
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2001). Mutations in the PC1/3 gene leads to reduced insulin production resulting in 
disrupted glucose homeostasis in obese females (Jackson et al., 1997). These results 
indicate that PCs are functionally important for pancreatic endocrine cell types. In 
particular, PC1/3 is required for the conversion of insulin precursor into functional 
insulin protein in the insulin producing (3-cells.
During the conversion of proinsulin to insulin, an intermediate product, C-peptide, 
is produced (see section 1.C.1.3). The C-peptide is stored in secretory granules and 
is released with insulin into circulation system. The physiological role of C-peptide 
was originally considered as a linker between the A- and B-chain of the insulin protein. 
In addition, the gene sequence of C-peptide exhibits considerable variation between 
species in contrast with the highly-conserved mature insulin peptides (Wahren, 2004). 
From an evolutionary point of view, it might support the idea that C-peptide is not 
required for normal biological functions. However, recent investigations suggested a 
role for C-peptide in maintaining glucose homeostasis(Marques et al., 2004). For 
instance, C-peptide can activate the insulin receptor tyrosine kinase 
pathway(Grunberger et al., 2001), stimulate glycogen synthesis in hepatocytes and 
cause insulin-induced cell growth as well as prevent high-glucose stimulated cell 
apoptosis in human neuroblastoma SH-SY5Y cells (Li et al., 2003b). These studies 
provide a basis for administration of C-peptide as a potentially effective therapy for 
diabetes.
4.A.2 Analysis of insulin-processing proteins in 
transdifferentiated cells
In order to determine whether the insulin biosynthetic machinery is present in the 
transdifferentiated cells, the expression of prohormone convertase PC1/3, the
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predominant active form of PCs in panceatic (3-cells, was detected by real-time 
RT-PCR in transdifferentiated cells. The parental HepG2 cells exhibited no PC1/3 
activity while the expression of PC1/3 was induced on the 3rd day following 
transfection of Xlhbox8Vp16 and increased until the 5th day (Figure 4.1). The 
detection of PC1/3 coincides with the appearance of pancreatic endocrine genes in 
the transdifferentiated cells (Figure 3.10).
C-peptide should be produced in transdifferentiated cells assuming the 
insulin-processing machinery is intact. The co-expression of C-peptide and insulin 
was examined in control (TTR-Vp16) and Xlhbox8Vp16-transfected HepG2 cells 
(Dodson and Steiner, 1998). The antibody used for C-peptide detection (see Chapter 
2.B.8) reacts with human and mouse C-peptide (Figure 4.2). In the cells transfected 
with TTR-Vp16 control plasmid, neither human insulin nor C-peptide were expressed 
whereas the transdifferentiated (3 cells (characterised by the expression of insulin 
protein 5 days after TTR-Xlhbox8Vp16 transfection) co-expressed C-peptide protein 
along with insulin (Figure 4.3). This result confirmed the presence of the insulin 
processing machinery in transdifferentiated cells.
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Figure 4.1 Prohormone convertase 1/3 (PC1/3) is detected in HepG2 cells following 
Xlhbox8Vp16 transfection. Real-time RT-PCR analysis was performed on RNA 
isolated from transfected cells at the time points indicated. The calibrator used is the 
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Figure 4.2 Immunofluorescence detection of C-peptide and insulin in the pancreatic 
tissues derived from different species. C-peptide is detected using the anti-human 
C-peptide antibody on (A) human pancreatic human tissues; (B) 7-day cultured E11.5 
dorsal pancreatic buds but not on (C) rat insulinoma cell line, RIN-m5F.
Figure 4.3 C-peptide and insulin colocalisation in transdifferentiated cells. The 
immunofluorescence staining showed that human C-peptide and insulin are 
co-expressed in transdifferentiated cells after 5 days of Xlhbox8Vp16 (B) but neither is 
seen in the control (TTR-Vp16) transfected cells (A).
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4.B Responsiveness for physiological 
stimuli of transdifferentiated cells
A number of physiological stimuli regulate maturation of function of the pancreatic 
(3 cells. These stimuli include high glucose, glucagon-like peptide 1 (GLP-1) and 
betacellulin (Li et al., 2004; Meier and Nauck, 2005). The effects of each of these 
factors were tested on the Xlhbox8Vp16 transfected cells to further characterise the 
functional properties of the transdifferentiated (3-cells.
4.B.1 Effect of GLP-1
4.B.1.1 Physiological effect of GLP-1 on pancreatic £ cells
GLP-1 is encoded within the proglucagon gene and is synthesised in the 
enteroendocrine intestinal L-cells of the distal ileum and colon by tissue-specific 
posttranslational processing (Figure 4.4) (Baggio and Drucker, 2004; Drucker, 2001). 
In response to nutrient intake, GLP-1 secretion is rapidly increased via the neuronal 
stimulation of the vagus nerve (Baggio and Drucker, 2004). Native GLP-1 is a 
polypeptide composed of 37 amino acids and the half-life of circulating biologically 
active GLP-1 is less than 2 minutes because of the rapid degradation by a 
ubiquitously-distributed membrane-associated peptidase, dipepidyl peptidase IV 
(DPP-IV) (Kieffer et al., 1995). The physiological effect of GLP-1 is of immense 
interest due to its effect on glucose homeostasis, i.e. decreasing insulin resistance in 
peripheral tissues such as muscle and increasing the insulin secretion from (3 cells 
(D'Alessio et al., 2005; Meier et al., 2002). GLP-1 exerts a wide range of 
extrapancreatic effects. For example, GLP-1 delays gastric empting, slows small 
intestine motility (Giralt and Vergara, 1999) and also increases glycogen synthesis in
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the liver, adipose tissues and skeletal muscles (Valverde et al., 1994). In addition, 
GLP-1 exhibits a profound influence in controlling appetite and weight by neuronal 
regulation, a notion based on the expression of GLP-1 receptor within the anterior 
hypothalamic nuclei involved in appetite regulation in brain (Alvarez et al., 1996; Holst, 
2000). Acute administration of GLP-1 leads to satiety and decreases food intake 
whereas the introduction of a truncated form of GLP-1, the antagonist exendin 9-39, 
neutralises the effect of the GLP-1 and promotes weight gain (Flint et al., 1998; 
Meeran et al., 1999). Reduced food intake and appetite has also been observed in 
human type 2 diabetic patients after short-term treatment with GLP-1 or its long-term 
agonist, exendin 4 (Toft-Nielsen et al., 1999).
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Figure 4.4 Diagrammatic representation of mammalian proglucagon structure. The 
tissue-specific post-translational processing of the proglucagon-derived peptides. 
GRPP, glicentin-related polypeptide; IP-1, intervening peptide-1; IP-2: intervening 
peptide-2; MPGF, major proglucagon fragment; GLP-1 and GLP-2, glucagon-like 
peptide-1 and -2 is also shown. Reproduced from Baggio & Drucker, 2004.
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The actions of GLP-1 in the pancreas to govern glucose homeostasis have 
generated much interest and the mechanisms underlying blood glucose regulation by 
GLP-1 are now much understood. The effect of GLP-1 is mediated via the activation 
of the G-protein coupled receptor that is highly expressed in pancreatic p cells 
(Thorens, 1992). A sequence of intracellular signalling events is activated following 
GLP-1 receptor binding, resulting in the increase of insulin biosynthesis, the 
enhancement of proliferation and differentiation as well as the inhibition of apoptosis 
of pancreatic (3 cells (Gromada et al., 2004; List and Habener, 2004). Adenylate 
cyclase is activated when GLP-1 binds the receptor thereby inducing cyclic 
5-adenosine monophosphate (cAMP) production. In turn, the accumulation of cAMP 
activates the protein kinase A (PKA) signalling pathway and sequentially closes K Atp  
channels. This blockage of efflux of potassium ions depolarises the cell membrane 
and directs a shift of intracellular Ca2+ concentration through the opening of 
voltage-gated calcium channel (VGCC). The resulting prolonged action potential of 
the membrane positively regulates the intracellular ATP/ADP ratio. At the same time, 
the voltage-gated K+-channels (Kv) are also inhibited by GLP-1 hence strengthening 
the action potential. The active PKA signalling also induces Ca2+ release from the ER 
mediated by inositol-1,4,5-triphosphate (IP3), a by-product of the breakdown of 
phosphatidylinositol-4,5-biphosphate (PIP2) in the cell membrane. The pumping of 
Ca2+ ions into cells triggers insulin granule mobilisation and subsequent insulin 
exocytosis. Furthermore, it has been suggested that GLP-1 inhibits cell apoptosis via 
a PKA- and phosphatidylinositol 3-kinase (PI3K)- pathway in mouse insulinoma MIN6 
cells(Hui et al., 2003). Additionally, GLP-1 can also improve insulin resistance in 
diabetic subjects(Sandhu et al., 1999).
GLP-1 is capable of converting other cell types into pancreatic endocrine cells, 
particularly (3 cells. In other words, GLP-1 also has the ability to promote the
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differentiation of endocrine cells. The expression of insulin and Pdx-1 as well as 
glucagon or pancreatic polypeptide were induced or up-regulated after the treatment 
of GLP-1 or related agonist exendin 4 in some cell lines including the rat pancreatic 
tumour derived AR42J cells, the rat ductal cell line ARIP and the human pancreatic 
adenocarcinoma Capan-1 cells (Hui et al., 2001; Zhou et al., 2002; Zhou et al., 1999). 
It is also noteworthy that Pdx-1 negative cells, such as human pancreatic ductal cells 
Panc-1, are able to become insulin-producing cells after the treatment with GLP-1 in 
combination with the introduction of Pdx-1 (Hui et al., 2001). These results suggested 
that the effect of GLP-1 on transforming non-endocrine cells into endocrine cells is 
mediated via a Pdx-1 dependent mechanism (Li et al., 2005). This hypothesis was 
further confirmed by a recent publication describing the conversion of intestinal cells 
(Pdx-1 positive) into insulin-producing cells by the administration of GLP-1 (Suzuki et 
al., 2003).
4.B.1.2 GLP-1 receptor is induced in transdifferentiated cells
From the description above, it is clear that normal pancreatic cells are responsive 
to GLP-1. Assays to determine the sensitivity of transdifferentiated cells to GLP-1 
were carried out. Since the action of GLP-1 is mediated through binding with the 
GLP-1 receptor, transdifferentiated cells were first examined for GLP-1 receptor 
expression using real-time RT-PCR. Low-level expression of GLP-1 receptor was 
detected in parental HepG2 cells (Figure 4.5). Five days after transfection with 
Xlhbox8Vp16 the GLP-1 receptor mRNA was upregulated by -5.5 fold in comparison 
with the calibrator (Figure 4.6).
The expression of insulin mRNA in transdifferentiated cells was then tested using 
the following protocol. The HepG2 cells were transfected with either TTR-Vp16 or 
TTR-Xlhbox8Vp16 DNAand maintained for 5 days. The transdifferentiated cells were
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then treated with 10nM GLP-1 for 12, 36 and 60 hours. This concentration of GLP-1 
was previously shown to induce optimal insulin secretion activity in converted Panc-1 
cells after treatment of GLP-1 (Hui et al., 2001). The RNA was collected and real-time 
RT-PCR for the insulin gene was performed. It was shown that the level of insulin 




Figure 4.5 Expression of Glucagon-like peptide 1 receptor (GLP1R) and Epidermal 
growth factor receptor (EGFR). GLP1R is expressed abundantly in human pancreatic 
cells (HPC) but is only weakly detected in HepG2 cells. EGFR is massively expressed 
in both HPC and HepG2 cells, -ve: no template control.
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Figure 4.6 GLP1R is upregulated during transdifferentiation. Real-time analysis 
examined GLP1R mRNA expression. A sharp increase is detected between the 3rd 
and 5th day after transfection of Xlhbox8Vp16. The calibrator used is TTR-Vp16 
transfected HepG2 cells and the results are presented as mean + S.D.
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Insulin mRNA expression 
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Figure 4.7 Time-dependent upregulation of insulin mRNA in transdifferentiated cells 
following GLP-1 treatment. The HepG2 cells were transfected with the 
TTR-Xlhbox8vp16 construct and maintained in culture for 5 days. 10nM GLP-1 is then 
added for 12, 36 and 60 hours. Insulin mRNA was examined by real-time RT-PCR. In 
comparison to the untreated cells, GLP-1 treated cells express higher levels of insulin 
mRNA. The calibrator used is 5-day TTR-Xlhbox8Vp16 transfected HepG2 cells.
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4.B.2 Effect of betacellulin
4.B.2.1 Physiological effect of betacellulin on pancreatic p 
cells
Betacellulin (BTC) was first characterised in the conditioned medium of a cell line 
derived from a mouse pancreatic (3 cell tumour(Shing et al., 1993). It belongs to a 
member of the epidermal growth factor (EGF) family and it is highly expressed in the 
pancreas, liver, kidney and small intestine (Dunbar and Goddard, 2000; Seno et al., 
1996). Structurally, BTC possesses six cysteine consensus motifs that form three 
intramolecular disulfide bonds (Dunbar and Goddard, 2000). BTC binds to the EGF 
receptor (EGFR) including the homodimers of EGFR / erbB1 and erbB4 or 
heterodimers of various erbB receptors to mediate intracellular signalling (Graber et 
al., 1999; Huotari et al., 2002; Ishiyama et al., 1998; Sundaresan et al., 1998).
Several studies have shown that BTC stimulates the growth and differentiation of 
pancreatic cells both in vitro and in vivo and is therefore regarded as a mitogen for 
pancreatic (3 cells (Huotari et al., 1998). The most compelling evidence for this comes 
from studies on cell lines. Conversion of pancreatic exocrine-derived AR42J cells to 
insulin producing cells can be induced by culture with BTC and activin A, a member of 
the transforming growth factor (3 (TGF-|3) family (Mashima et al., 1996). Both the 
pancreatic a cell line, a-TC1.6 and the intestinal epithelial cell line IEC-6 can be 
transformed into insulin-producing cells by BTC treatment in the presence of Pdx-1 
(Watada et al., 1996b; Yoshida et al., 2002). More recently, the insulinotropic effect of 
BTC on pancreatic islet cells was demonstrated in vitro. For instance, Demeterco et al. 
showed that BTC caused proliferation in human foetal pancreatic tissues as 
previously observed in AR42J cells(Demeterco et al., 2000). BTC activated the
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regeneration and neogenesis of (3 cells and sequentially improved hyperglycaemia in 
alloxan or streptozotocin diabetic mice and in 90% pancreatectomised rats (Li et al., 
2001; Li et al., 2003a; Yamamoto et al., 2000). These data confirm that pancreatic (3 
cells are sensitive to BTC.
4.B.2.2 Betacellulin up-regulates insulin mRNA expression
The responsiveness of transdifferentiated HepG2 cells to BTC treatment was 
examined using RT-PCR for insulin mRNA. In order for BTC to elicit a response, it is 
necessary that the EGFR is expressed and this was shown to be the case in HepG2 
cells (Figure 4.5). To determine the effect of BTC on transdifferentiated cells HepG2 
cells were transfected with Xlhbox8Vp16 and then treated for 60 hours with 10 ng/ml 
BTC. There was a dramatic increase (about 25-fold) in expression of insulin mRNA 
compared to calibrators (Figure 4.8). The effect of BTC on transdifferentiated cells is 
much greater than that of GLP-1. This observation implies that transdifferentiated 
cells behave in the same manner as normal pancreatic cells and are actively 
responsive to BTC.
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Insulin mRNA expression 
TTR-X8Vp16 -> HepG2 5days •> 10ng/ml Betacellulin
Untreated




Calibrator:5-days cultured TTR-X8Vp16 treated HepG2
Figure 4.8 Time-dependent upregulation of insulin mRNA in transdifferentiated cells 
after betacellulin treatment. The HepG2 cells were transfected with the 
TTR-Xlhbox8vp16 construct and maintained in culture for 5 days. 10ng/ml betacellulin 
was then added for 12, 36, and 60 hours. Insulin mRNA was detected by real-time 
RT-PCR. In comparison to the untreated cells, GLP-1 treated cells express higher 
levels of insulin mRNA. The calibrator used is 5-day TTR-Xlhbox8Vp16 transfected 
HepG2 cells.
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4.B.3 Glucose-stimulated insulin release (GSIR) 
in transdifferentiated cells
In terms of (3 cell function, the most important characteristic property is the ability 
to secrete insulin in response to an elevation of external glucose (discussed in section 
1.C.1.2). In order to determine whether the transdifferentiated cells can perform this 
essential function, an ultrasensitive insulin ELISA kit was used. Although the 
proportion of insulin-positive cells as a fraction of the total cells in the transfected 
HepG2 cell system was low, it was possible to demonstrate glucose-stimulated insulin 
release. The insulin was detected in the medium of 5-day Xlhbox8Vp16-transfected 
cells after a challenge with 25 mM glucose. The results showed that there is a 
reproducible and significant increase of insulin secretion. No increase in GSIR was 
seen for transfected cells exposed to low glucose and for control (TTR-Vp16) 
transfectants, either exposed to low or high glucose (Figure 4.9).
4.C Discussion
The data presented in this chapter shows that the transdifferentiated cells display 
several functions of pancreatic p cells. These include expression of PC1/3 and 
C-peptide, indicative of processing of proinsulin; response to physiological stimuli 
such as GLP-1 and betacellulin; and release of insulin in response to glucose. These 
results indicate that transdifferentiated cells can respond in a similar fashion to normal 
pancreatic (3 cells. One question that remains unanswered is whether 
transdifferentiated cells show biphasic insulin secretion. However, due to the limited 
number of transdifferentiated cells, this was not possible to perform. Additionally, the 
presence of insulin in the serum of the culture media makes it more difficult to 
measure and interpret whether biphasic insulin secretion exists in transdifferentiated
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cells.
Transdifferentiated cells might provide a treatment for diabetes (Meivar-Levy and 
Ferber, 2003). However, in order for the therapeutic potential of transdifferentiated 
cells to be useful, a number of criteria must be fulfilled (Weir, 2004). For example, the 
surrogate p cells must exhibit all specific functional properties that p cells normally 
exhibit. In addition, transdifferentiated p cells should also have the repopulation 
potential to satisfy the demands of transplantation for curing diabetic patients. One of 
the practicable methods to achieve this future goal is to establish a stable cell line 
expressing the master switch gene, i.e. Xlhbox8Vp16. However, there was not time to 
do this in the present work. Moreover, although HepG2 cells have prolonged 
proliferation capacity, they also show carcinogenic properties. The introduction of an 
immortalising gene, e.g. telomerase catalytic subunit hTERT (Poole et al., 2001), into 
normal cells to expand the life span, or using the cells of foetal origin might be a way 
to develop a long-term non-carcinogenic stable p-cell-like cell line. Recently, it has 
been shown that foetal liver progenitor cell lines expressing Pdx1 exhibit pancreatic 




























Glucose stimulated insulin secretion in transdifferentiated cells
1.6
TTR-Vp16 TTR-X8Vp16 TTR-Vp16 TTR-X8Vp16 TTR-X8Vp16
transfected transfected transfected transfected transfected
HepG2(5days) HepG2(5days) HepG2(5days)+12hrs HepG2(5days)*12hrs HepG2(5days)+12hrs
25mM glucose 5.5mM glucose 25mM glucose












W-C L i In vitro  tra n s d iffe re n tia t io n  o f liv e r in to  fu n c tio n a l p a n c re a tic -lik e  ce lls
Figure 4.9 Transdifferentiated (3-cells secrete insulin in response to glucose. Control 
cells (TTR-Vp16 transfected cells and cultured for 5 days) or transdifferentiated cells 
(cells transfected with TTR-Xlhbox8Vp16 and cultured for 5 days) were treated with 
physiological (5.5mM) or higher concentrations (25mM) of glucose for 12 hours. The 
medium is collected and the secreted insulin is detected using an insulin ELISA kit. 
Following treatment with high concentrations of glucose, transdifferentiated cells 
significantly release more insulin compared with the control cells. The data are 
represented as mean ± S.D. from 3 independent experiments.
169
W-C L I In vitro  tra n s d iffe re n tia tio n  o f liv e r in to  fu n c tio n a l p an c re a tic -lik e  ce ils
Chapter 5. 
Establishment of a culture 
system for embryonic liver
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Overview
The results presented in Chapters 3 and 4 demonstrated that it is possible to 
induce the transdifferentiation of HepG2 cells to pancreatic cell types by 
overexpression of the Xlhbox8Vp16 transgene. More specifically, it was shown that 
the pancreatic cells (i) express markers characteristic of (3 cells, (ii) are functional, and 
(iii) that the transgene need not remain active in the long term (this is known as the hit 
and run hypothesis). However, HepG2 cells do not exhibit an entirely normal hepatic 
phenotype. For instance, HepG2 cells lack some of the liver enriched transcription 
factors (e.g. C/EBPa) and some hepatic proteins (e.g. multidrug resistant protein 
(MRP)) (Figure 3.1). Therefore, the question arises whether transdifferentiation can 
be induced in primary cultures of liver cells using the Xlhbox8Vp16 reagent?
To address this problem, we decided to establish a reliable and well-defined in 
vitro culture system for primary liver cells. In this chapter, the results from the first 
model based on culture of embryonic liver are presented. It was chosen to examine 
embryonic liver because the tissue may exhibit greater plasticity compared to the 
adult. In addition, development of an in vitro culture system for embryonic liver may 
provide a useful tool to study normal liver development.
5.A Isolation of embryonic liver cells
The embryonic liver originates from the epithelium of the anterior endoderm (see 
section 1.A.2). During development, the liver is surrounded by a mass of 
mesenchymal cells and signals such as BMPs and FGFs, are secreted from the 
mesenchymal cells. These signals are essential for the initiation, expansion and 
maturation of hepatocytes. Based on the importance of mesenchymal cells around the 
fetal liver as well as previous experience in culturing of embryonic pancreatic tissues
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in the laboratory (Percival and Slack, 1999), direct isolation of whole hepatic epithelial 
region from E11.5 embryo was carried out (shown in Figure 2.1). The project was 
designed as shown in Figure 5.1.
Liver buds cultured in Basal medium (+20%FBS)
Mechanical removal of 
mesenchymal cells
Liver buds cultured in selective medium KSFM
TransfectionIntroduction 
of 9ene of 
interest into 
liver cells






Repression of mesenchymal cells
Optimal culture condition
Combination
Figure 5.1 Procedure for the in vitro culture of embryonic liver.
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5.A.1 Liver cells cultured in BME with 20% FBS 
medium
The initial experiments on embryonic liver culture were performed in basal 
medium containing Earle’s salt and 20 % FBS. Following isolation, the cells attached 
and began to spread out on the fibronectin-coated coverslips by 24 hrs (Figure 5.2). 
We examined the expression of three hepatic markers for either embryonic or mature 
liver cells to detect the differentiation status of the cells during different periods of 
culture. The markers used were a-fetoprotein (AFP, to detect immature hepatoblasts) 
(Abelev and Eraiser, 1999), cytokeratin 8 (CK8) (to detect epithelial cell types) and 
glutamine synthetase (GS, to detect mature hepatocytes) (Bennett et al., 1987; Ku et 
al., 2001; Omary et al., 2002; Smith and Campbell, 1988). Results indicated that AFP 
expressing cells gradually decreased after 7 days of culture compared to those in 
culture for only 2 or 5 days. In contrast, the number of GS-expressing cells increased 
when the cells were cultured for longer periods (the GS protein accumulation begins 
normally in mouse hepatocytes at about E15 (Notenboom et al., 1997)). CK8 was 
detected on the 3rd day of culture and expression was maintained throughout the 
remaining culture period up to 7 days (Figure 5.3). This evidence suggests that the 
BME culture system may be a useful tool in the study of the liver development in vitro.
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Liver buds isolated from  E11.5 m ouse em bryos
C ultured in B M E +20% FB S  for 24 hours
Figure 5.2 A transmitted light image of mouse embryonic liver tissues cultured for 
24hrs in basal medium with Earle’s salts in the presence of 20% FBS. The liver 
tissues are isolated from E11.5 mouse embryos and cultured on a fibronectin-coated 
coverslip. A representative image is shown. Scale bar = 50 pm








2 days 4 days 7 days
Figure 5.3 Time course analysis of liver markers in embryonic liver tissues. Liver 
tissues were isolated from E11.5 mouse embryos and cultured in BME (with 20% FBS) 
for 2, 4 and 7 days on fibronectin-coated coverslips and immunostained for 
a-fetoprotein (A-C), cytokeratin 8 (D-F) and glutamine synthetase (G-l). Scale bar = 
20 pm
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5.A.2 Transfection of hepatic epithelial cells is 
prevented by mesenchymal cells
To induce transdifferentiation of embryonic liver cells to pancreatic-like cells 
efficient delivery of the XlhboxVp16 DNA into hepatic epithelial cells is required. 
Among the various gene delivery methods including transfection, electroporation or 
viral infection, it has been considered that adenoviral infection is the most efficient 
(Barnett et al., 2002). Adenovirus has a typical morphology with an icosahedral capsid 
consisting of 3 major proteins including hexon, penton base and a knobbed fibre. The 
virus genome is linear, double- strained DNA ending with a terminal protein attached 
to the inverted terminal repeats (Figure 5.4)(Russell, 2000). Adenoviral infection is 
mediated through the high-affinity conjugation of the fibre knob with the widely 
distributed cellular receptor called the coxsackievirus and adenovirus receptor 
(CAR)(Bergelson et al., 1997) and the binding between the arginine-glycine-aspartic 
acid (RGD) residue of penton base and integrins av|33 or avp5 (Wickham et al., 
1993).
The titre of the adenoviral vector used to infect embryonic liver cells was first 
tested in order to calculate the optimal infection conditions. As shown in Figure 5.5, 
using adenovirus encoding CMV-GFP DNA sequence, 10® virus particles were 
sufficient to obtain a good infection based on GFP expression. However, the GFP was 
mainly present in the overlying mesenchymal cells rather than in the deeper epithelial 
region. To confirm this observation, and to exclude the possibility that the problem 
was virus-dependent, the embryonic liver cultures were infected with another 
adenoviral vector containing CMV-LacZ DNA. After infection, it was co-stained for 
(3-galactosidase, the protein product of the LacZ gene, and E-cadherin (the epithelial 
marker) in the infected cells. If the virus only infected mesenchymal cells, no
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(3-galactosidase/E-cadherin coexpressing cells should be found. Using the Z-series 
function on the confocal microscope, it was shown that the hepatic epithelial cells did 
not receive any adenoviral particles (Figure 5.6). This means that under BME culture 
conditions, epithelial infection is prevented by the overlying mesenchymal cells.
5.A.3 Mechanical removal of mesenchymal cells 
from liver culture
To improve the infection efficiency of BME cultured liver tissue, the mesenchyme 
must be removed from the epithelium so that the virus can reach onto the epithelial 
cells. The removal of the mesenchyme was carried out after the liver tissue had been 
in culture for 24 hours. The reason for doing it this way was because immediately after 
isolation the epithelium and mesenchyme are difficult to distinguish. However, after 
culture, the mesenchyme forms a layer over the underlying epithelium that in theory 
can be peeled off. The mesenchyme was removed by mechanical operation using fine 
forceps. Although mesenchymal and epithelial cells appeared to be successfully 
separated (Figure 5.7), the infection efficiency was only slightly improved compared to 
the situation when the mesenchyme and epithelium were not separated (Figure 5.8). 
This observation suggested that the mechanical removal is not sufficient to completely 
separate all the mesenchymal cells from the epithelium.
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Figure 5.4 Diagrammatic representation of the structure of adenovirus. Reproduced 
from Barnett et al, 2002.
2x10A8 PFU 2x10A7 PFU 2x10A6 PFU
Ad CMV-eGFP infection on 1-day cultured E11.5 embryonic liver cells
Figure 5.5 Adenoviral infection of 24-hour cultured liver tissues. Liver tissues were 
isolated from E11.5 mouse embryos and infected with the titres of Ad CMV-eGFP 
indicated. The images were taken on the following day after infection. PFU, plaque 
forming units.
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Figure 5.6 Infection of adenovirus CMV-LacZ onto isolated embryonic liver tissues 
cultured in BME and 20%FBS. (A) Diagrammatic representation of the infection 
procedure. The embryonic liver tissues were isolated from E11.5 mouse embryos and 
infected with 108 PFU virus particles for 1 hour. The liver tissue was then maintained 
in fresh BME and 20% FBS for a further 24 hours. A-l to A-IV shows images taken 
through different layers of the tissue using the Z-series collection facility on the LSM 
510 confocal microscope. (B,C) the absence of infected adenoviral vector in the 
epithelial cells of embryonic liver tissues. The cells are stained with p-galactosidase 
(green) and E-cadherin (red). Scale bar = 20 pm
178
IV-C Li In vitro transdifferentiation of liver into functional pancreatic-like cells
•^•Mesenchymal cells 
4 1  Epitheium ceils
Figure 5.7 Schematic showing the removal of mesenchymal cells from cultured 
embryonic liver tissues. Isolated liver tissues (from E11.5 mouse embryos) were 
cultured in BME and 20% FBS for 24 hours after isolation. The mesenchymal cells 
were removed using sharp forceps to expose the underlying epithelial cells.
vi <v
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B-1
B-3 B-2
Mesenchymal cell (+) 
Mesenchymal cell (•)
Ad CMV-eGFP -> E11.5 liver buds (GFP E-cadherin)
Figure 5.8 Adenoviral infection of cultured embryonic liver tissues either with (A) or 
without (B) mesenchymal tissue. The cultured embryonic liver cells were isolated from 
E11.5 mouse embryos and cultured for 24 hours in BME and 20% FBS. On the 
following day, the mesenchymal cells were mechanically removed (as shown in Figure 
5.7) and the epithelium was then infected with 108 PFU of Ad CMV-eGFP. E-cadherin 
(red) and GFP (green) was detected by immunofluorescence staining. Scale bar = 20 
pm
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5.B Culture of embryonic liver cells in 
selective medium
5.B.1 Keratinocyte serum free medium (KSFM)
Certain media can selectively favour the growth of specific cell types, such as 
epithelial cells. Using selective medium might improve the viral infection of a gene 
product into embryonic hepatic epithelial cells. Several groups had previously used 
KSFM for culturing a wide range of epithelia, such as oral, oesophageal, corneal, 
foreskin, bronchial and gingival epithelial cells (Andl et al., 2003; Chen et al., 2002; 
Duits et al., 2003; Kremer et al., 1999; Lin et al., 2005; Vallette et al., 1998). Therefore, 
it was decided to test whether KSFM can maintain hepatic epithelial cells and at the 
same time, repress the growth of mesenchymal cells.
5.B.2 Repression of mesenchymal cells in KSFM 
medium
There are two kinds of commercially available KSFM that differ in the 
concentration of Ca2+. One contains no Ca2+ (OmM) and the other contains a low 
concentration Ca2+ (0.9mM). The low concentration form is favourable for the growth 
of epidermal cells (Hennings et al., 1980). The two media were tested to determine 
their ability to maintain the hepatic epithelial phenotype in isolated embryonic liver. It 
was examined the expression of albumin, E-cadherin and smooth muscle actin as 
hepatic, epithelial and mesenchymal cell types, respectively. The results showed that 
both media actively inhibit mesenchymal cell growth based on lack of smooth muscle 
actin expression. However, loss of E-cadherin expression in cells cultured in KSFM
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without Ca2+ confirmed that they do require Ca2+ in low amounts to preserve the 
epithelial phenotype in an in vitro culture system (Figure 5.9 & Figure 5.10). It was 
shown that the growth of the mesenchymal cells in BME medium is much greater than 
the cells cultured in KSFM medium (Figure 5.11 & Figure 5.12).
Not only does the KSFM inhibit the growth of mesenchymal cells but also inhibits 
the time-dependent migration of the mesenchymal cells out from the central area 
(Figure 5.13). Therefore, based on the maintenance of epithelial and hepatic 
properties and the repression of mesenchymal phenotype, KSFM medium with low 
Ca2+ was used for all subsequent experiments.
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Figure 5.9 Expression of liver markers in KSFM without Ca2+. Liver tissues were 
immunostained for albumin (A-C), E-cadherin (D-F) and smooth muscle actin (G-l). 
The liver tissues were isolated from E11.5 mouse embryos and cultured in KSFM 
without Ca2+ for 5, 7 and 9 days on fibronectin-coating coverslips. Scale bar = 20 pm
Liver buds isolated from E11.5 embryos 
Cultured in Keratinocyte-SFM (without Calcium)
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Figure 5.10 Expression of liver markers in KSFM with Ca2\  Immunofluorescence 
staining of albumin (A-C), E-cadherin (D-F) and smooth muscle actin (G-l) on cultured 
embryonic liver. The liver tissues were isolated from E11.5 mouse embryos and 
cultured in KSFM with 0.9mM Ca2+ for 5, 7 and 9 days on fibronectin-coating 
coverslips. Scale bar = 20 pm
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Smooth muscle actin staining for 
the embryonic liver tissues
BME+20%FBS Keratinocyte-SFM
Figure 5.11 Expression of smooth muscle actin (SMA) in isolated liver cultured with 
BME or KSFM medium. Liver tissue was isolated and cultured for 24hrs in either BME 
(plus 20% FBS) or KSFM medium. The SMA was expressed in tissue cultured in BME 
medium but not in KSFM medium. Scale bar = 20 pm
Re-growth of mesenchymal cells after cultured in BME + 20% FBS
1 day 3 days 5 days
Figure 5.12 Growth of mesenchymal cells in cultured embryonic liver. Embryonic 
livers were isolated from E11.5 mouse embryo and attached in BME and 20% FBS for 
24 hours. The mesenchymal cells were removed using sharp forceps and the 
remaining tissue was then cultured in BME and 20% FBS for a further 5 days. A 
sub-population of mesenchymal cells remain and continue to grow and cover the 
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Figure 5.13 Repression of mesenchymal cell growth under KSFM culture conditions. 
The growth of mesenchymal cells is suppressed and moved from the hepatic 
epithelium during 14-days culture in KSFM medium. The epithelial cells are detected 
with E-cadherin (red) and mesenchymal cells by smooth muscle actin (green) 
immunostaining. Scale bar = 100 pm
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5.B.3 Optimal culture conditions in KSFM 
medium
Liver cells cultured in KSFM spread less than when cultured in BME medium 
(Figure 5.14). This might lead to a higher rate of cell death if the epithelial cells in the 
centre of the tissue do not receive KSFM. A live-dead cell assay confirmed that there 
was a higher proportion of dead cells in the centre of the tissue compared to the 
surrounding area (Figure 5.15). Therefore, to balance cell viability and the efficiency 
of gene introduction, tests were performed to define the optimal culture conditions for 
maintenance of epithelial integrity and inhibition of mesenchymal growth. For example, 
to maintain cell viability, various concentrations of serum was supplemented to the 
KSFM medium. In this experiment, although the cell viability was improved and the 
epithelial / hepatic phenotypes were maintained, the mesenchymal cells expanded 
when more than 5% serum was added to the culture medium (Figure 5.15N). 
Supplementation of KSFM with a lower concentration of serum (0.5%, 1% and 2.5%) 
maintained cell viability and the epithelial/hepatic properties. When liver tissue was 
cultured with KSFM and 1% serum, no growth of the mesenchymal cells was 
observed (Figure 5.16). As a result, the KSFM + 1% serum was chosen as the 
“optimal” condition for the remaining experiments. However, the cells did not migrate 
out and remained massed in the centre of the culture dish.
In order to introduce genes by virus infection a flat culture is necessary. 
Because the BME medium promotes spreading better than the KSFM, sequential 
addition of BME (with 20% serum) and KSFM (with 1% serum) was then tested. The 
aim of this was to achieve the best culture condition for cell growth and ectopic gene 
expression in epithelial cells. The results suggested that hepatic mesenchymal cells 
could only be repressed when incubated in KSFM medium for 8 days whereas the
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epithelial phenotype was conserved when the cells were incubated in the BME 
environment for less than 3 days (Figure 5.17& Figure 5.18). Based on these results, 
the best combination culture condition chosen was: culture in BME (plus 20% serum) 
for 2-3 days followed by incubation in KSFM (plus 1% serum) for another 8 days 
(Figure 5.19).
Following this procedure, the efficiency of gene delivery was assessed both by 
transfection of plasmid DNA and by infection with adenovirus. GFP or DsRed was 
detected to examine the efficiency of gene delivery into embryonic liver tissues. 
Although the final culture condition showed the maintenance of the hepatic and 
epithelial phenotype and reduced mesenchymal contamination (Figure 5.20), the 
transfection (Figure 5.21) or infection efficiency (Figure 5.20D) into epithelial cells was 
still extremely low.
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Liver buds isolated from E11.5 embryos
with fibronectiin coating without fibronectiin coating
Cultured in Keratinocyte-SFM 24 hours
Figure 5.14 Transmitted light images of embryonic liver tissues isolated from E11.5 
mouse embryos and cultured for 24hrs in KSFM media. The livers were cultured on 
coverslips coated with (A,B) or without (C,D) fibronectin. Scale bar = 50 pm
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E11.5 liver buds cultured in KSFM containing various concentration serum -  14 days
Live-bead .




KSFM+0%FBS KSFM+5%FBS KSFM+10%FBS KSFM+20%FBS
Figure 5.15 The effect of FBS in KSFM on 14-day cultured embryonic liver tissue. 
The liver tissues were isolated from E11.5 mouse embryos and cultured in KSFM 
supplemented with 0%, 5%, 10% and 20% of FBS. The cell viability (A-D) and the 
expression of albumin (E-H), E-cadherin (l-L) and smooth muscle actin (M-P) was 
then examined. Scale bar = 20 pm
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E11.5 liver buds culture in KSFM containing various concentration serum >14 days
KSFM + 0.5% FBS KSFM + 1% FBS KSFM ♦ 2.5% FBS
Figure 5.16 The effect of low concentration of FBS in KSFM on 14-day cultured 
embryonic liver cells. The liver tissues are isolated from E11.5 mouse embryos and 
cultured in KSFM supplemented with 0%, 1% and 2.5% of FBS. The cell viability (A-C) 
and the expression of albumin (D-F), E-cadherin (G-l) and smooth muscle actin (J-L) 
was then examined. Scale bar = 20 pm
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B2 -> K8 B3 -> K7 B4 -> K6 B5 -> K5 B6 -> K4
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Figure 5.17 Incubation period test for the combination of BME and KSFM medium-1. 
Liver tissues were isolated from E11.5 mouse embryos and cultured in BME and 20% 
FBS and then transferred into KSFM plus 1% FBS for different time periods (total 
culture time was 10 days). The expression of albumin (A-E), E-cadherin (F-J) and 
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Figure 5.18 Incubation period test for the combination of BME and KSFM medium-2. 
Liver tissues were isolated from E11.5 mouse embryos and cultured in BME plus 20% 
FBS and then transferred into KSFM with 1% FBS for 8 days. The expression of 
albumin (A-E), E-cadherin (F-J) and smooth muscle actin (K-O) was examined by 
immunofluorescence staining.
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BME culture for 2-3 days KSFM culture for 7-10 days Infection of Maintain in BME for
adenoviral vector another 5 days
Epithelial cells mSmooth muscle actin +ve cells •  Adenoviral particles
Figure 5.19 A working model of gene delivery into embryonic liver cells using KSFM 
culture medium.
E11.5 liver cultured in BME 3days -> KSFM 8 days
E-cadherin Smooth muscle actin
E p ith e liu m
A  I B
Ad CMV-eGFP infection (1 days)
Figure 5.20 Examination of liver, epithelial and virus infection using optimal culture 
condition in embryonic liver tissues. The examination of E-cadherin (A), smooth 
muscle actin (B), albumin (C) (green; DAPI stating was shown in blue) and adenoviral 
infection efficiency (D) in cultured embryonic liver tissue. Livers were cultured in BME 
plus 20% FBS for 3 days and then the media was changed to KSFM with 1% FBS for 
a further 8 days. In (D), Ad CMV-eGFP infection efficiency of the epithelium was 
assessed by staining for E-cadherin (red) and GFP (green).
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CMV-DsRed-> CMV-nGFP->
B3K8 cultured liver buds B3K8 cultured liver buds
AFP IDsRed AFP nGFP
Figure 5.21 Transfection of embryonic liver cultures. The embryonic liver cells from 
E11.5 embryos were cultured with the same procedure as described in Figure 5.20 
and then transfected with 2pg plasmid DNAs of CMV-DsRed (A,B) or CMV-nGFP 
(C,D). The detection of AFP (green) and DsRed (red) (A,B) or GFP (green) and AFP 
(red) (C,D) was performed after 24 hours of transfection. Scale bar = 10 pm
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5.C Discussion
Embryonic cells may possess greater cellular plasticity than differentiated cells. 
Based on this idea it might be easier to direct embryonic cells to a new cell fate (Efrat, 
2002). In liver, several markers for progenitor cells were found in the last few years. 
They include serum protein a 1-fetoprotein and the intermediate filament protein CK14 
(Shafritz and Dabeva, 2002).
We tried to build a suitable embryonic liver culture model to test whether (i) 
ectopic genetic expression is possible and (ii) Pdx1 can convert liver to pancreas. 
Although the embryonic liver tissues can be cultured in BME and KSFM medium it is 
not possible to add genes to the cultures with the methods available. It suggested that 
it is very difficult to clearly separate the epithelial from the mesenchymal cells in 
embryonic liver tissue and, on the other hand, again confirms the importance of 
mesenchymal cells for liver development (Cascio and Zaret, 1991). To further refine 
the current system, the combination of mechanical manipulation and the utilisation of 
selective culture medium might be considered.
In brief, the results from this chapter shows that the embryonic liver cells seemed 
to be unsuitable to culture in either BME or KSFM culture medium. However, the fact 
that the growth of mesenchymal cells was inhibited under KSFM culture conditions 
provides an alternative means to enrich the epithelial cell culture from other 
hepatic-like cells. Trials on the inoculation of adult hepatocytes in KSFM are 
discussed in the next chapter.
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Chapter 6. 
Long-term culture of rat 
hepatocytes & conversion 
into pancreatic-like cells
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Overview
In Chapter 5, a culture system for mouse embryonic liver tissue was produced 
but this requires further refinement. In the present chapter, we sought to extend 
further the use of KSFM culture medium to primary adult rat hepatocytes. Specifically, 
we aim to develop a suitable in vitro culture system for long-term culture of primary 
hepatocytes. First, a broad introduction to the principles underlying isolation and 
culture of hepatocytes from adult rodents and the current obstacles to the long-term 
maintenance of mature hepatocytes will be introduced. Afterwards, results will be 
presented showing that KSFM can maintain the expression of liver proteins in rat 
hepatocytes for up to 28 days. In addition, functional experiments on hepatocytes 
cultured in KSFM will be performed to confirm that the function of specific pathways is 
maintained in long-term cultured hepatocytes. Finally, the question of cell plasticity 
between liver and pancreas was addressed using this culture system and adenoviral 
infection technique. Preliminary results suggested the partial transdifferentiation of 
differentiated liver cells into pancreatic cells.
6.A Introduction
6.A.1 Isolation of adult hepatocytes
The liver has a multitude of functions including the regulation of carbohydrate, fat 
and protein metabolism, the detoxification of endo- and xenobiotics, and the synthesis 
and secretion of plasma proteins and bile. The materials for studying liver functions 
include isolated perfused liver (Berry et al., 1992), liver slices (Parrish et al., 1995) or 
freshly isolated and cultured hepatocytes (Mitaka, 1998) (Table 6.1). Among them, the 
isolation and culture of hepatocytes from adult animals is the most common method to
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be used. The technique for isolation of hepatocytes now widely used is based on the 
two-step collagenase perfusion technique first developed by Berry and Friend (Berry 
and Friend, 1969). As well as enzymatic digestion, different non-enzymatic 
mechanical separation methods were used to obtain liver cells (Schreiber and 
Schreiber, 1973). These include liver homogenisation, trituration of liver samples, and 
filtration of the tissue through fine sieves. However marked cellular damage was 
observed under all conditions. Besides vigorous physical breakdown of the liver, a 
range of digestive enzymes were tested for their potential to acquire intact cells. For 
example, trypsin, pronase and lysozyme were all used to disperse liver tissue into a 
single cell suspension (Howard et al., 1967; Seglen, 1976) but these enzymes did not 
produce large numbers of viable hepatocytes. By the late 1980s collagenase was 
used as a successful dissociating agent (Berry and Friend, 1969; Klaunig et al., 
1981).
To date, the two-step collagenase perfusion technique is the method of choice for 
the isolation of large numbers of viable hepatocytes from adult animals. In the first 
step, a calcium-free medium containing a calcium chelator is perfused through the 
liver. Removal of calcium ions (by EDTA, EGTA or citrate) from epithelial cells results 
in the rapid destruction of intercellular junctions and therefore loosening of the cell-cell 
contacts(Troyanovsky, 2005). The second step is the introduction of the enzyme 
collagenase into the liver lobes. The procedure is carried out in situ using the animals’ 
own circulatory system to perfuse the liver via the portal vein or vena cava (retrograde 
perfusion). It has previously been shown that the two-step collagenase isolation 
procedure can yield a high percentage of viable liver cells. Seglen proposed several 
experiments to assess the importance of the following factors for hepatocyte isolation 
(Seglen, 1976).
(A) Ca2+; Ca2+ plays a dual role in the hepatocyte isolation protocol. On the one
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hand, removal of Ca2+ is essential to disrupt the Ca2+-dependent E-cadherin 
molecules between adjacent hepatocytes and hence improve both the quantity and 
quality of dispersed hepatocytes. The presence of Ca2+ is also required for the activity 
of collagenase (1-5 mM of Ca2+ is sufficient to sustain collagenase activity for 
liberation of hepatocytes) (Berry et al., 1997; Takahashi and Seifter, 1970). Regarding 
these properties of Ca2+, both the concentration and timing of re-introduction of Ca2+ 
back into liver during the hepatocyte preparation process are critical for obtaining 
intact cells. Seglen demonstrated that Ca2+ must first be removed from the tissue by 
pre-perfusion with EGTA or EDTA containing medium then added back into the 
perfusion medium with collagenase to obtain a high quantity of intact, viable cells 
(Seglen, 1976).
(B) Concentration and quality o f collagenase: Collagenase is a key element 
for hepatocyte isolation. It is therefore necessary that the user tests the activity of 
each batch of collagenase. Different batches of collagenase exhibit differing 
efficiencies during preparation of hepatocytes (Howard et al., 1973). Seglen showed 
that crude collagenase and purified collagenase displayed similar activity on liver cell 
dispersion in the presence of same concentration of calcium ions (Seglen, 1976). In 
addition, to obtain the best quality and quantity of dispersed hepatocytes, Klaunig et al 
suggested using 100U/ml of type I collagenase as the concentration of choice for 
mouse hepatocyte preparation(Klaunig et al., 1981).
(C) pH and buffering: The pH value of the perfusion medium should be kept at 
approximately pH 7.4. The detection of a rapid drop in pH during perfusion is due 
either to the enzymatic breakdown of glucose in the medium or the generation of 
bicarbonate from the dissolution of carbon dioxide in water. Therefore a strong 
buffering system is essential to ensure healthy cells. Several buffering agents have 
been suggested to maintain the pH. Among the buffers, the addition of HEPES into
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the perfusion medium has proved to be the simplest and most practical (Seglen, 
1976).
(D) Other factors: In addition to the points raised above, the production of isolated 
hepatocytes can also be affected by other factors, such as the perfusion flow rate 
(optimum of 5-10ml/minute for mouse, 25-30 ml/minute for rat) or the force of 
centrifugation following isolation (optimum of 50-100 g for liver cell isolation).
After the liberation of hepatocytes, monitoring of cell viability should be performed. 
Several techniques for viability testing have been suggested and most depend on an 
intact cell membrane. Examples include trypan blue exclusion, measurement of ATP 
content (Olinga et al., 1998), detection of the reduction of the tetrazolium salt 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (so called MTT test) 
(Denizot and Lang, 1986), monitoring of leaking lactate dehydrogenase or detection 
of cell-specific biomarkers such as aminotransferase (AST and ALT) or total bilirubin 
(Behrsing et al., 2003).
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2. Acquirement of large 
number of hepatocytes
3. Similar response to in 
vivo pharmacological
and toxicological effect
1. Relatively quick and easy 
to prepare 
2. Preservation of liver 
architecture and includes 
ail liver cell types 
3. Possibility for 
cryopreservation
1. Extended survival periods 
2. Standard preparation 
protocol 
3. Possibility for lengthy and 
complex experiments
Cons
1. Disruption of 
intercellular contacts & 
cell communications 
2. Loss of cell polarity and 
shape
3. Damage to receptors
4. Short survival periods
(-few hours)
1. Short survival period (-
few days)
2. impaired preservation of 
metabolizing enzymes 
(e.g. cytochrome P450)
3. Slower metabolising rate
for certain metabolites
1. Contamination by non- 
hepatic cells 




3. Time consuming (e.g. 
concentration of additives 
in the medium should be 
tested prior to experiment)
Table 6.1 Comparison of in vitro systems for studying liver function (Berry et al., 1992; 
Cervenkova et al., 2001; Denizot and Lang, 1986; Sidelmann et al., 1996)
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6.A.2 Limitations of currqw ent in vitro 
hepatocyte culture systems
Hepatocytes in suspension show rapid loss of their differentiation status after 
plating out onto the culture dish (Agius, 1987). Dedifferentiation is reflected not only in 
decreased liver-specific functions, but there is also an alteration of morphology: the 
cells flatten, depolarize, and lose many of the surface characteristics of normal 
hepatocytes in vivo. The mechanisms responsible for loss of differentiated properties 
presumably include downregulation of transcription factors involved in liver specific 
gene expression (Padgham et al., 1993). The loss of differentiated functions has been 
attributed to the change in environmental conditions (extracellular matrix, hormonal 
conditions) following cell isolation (Padgham and Paine, 1993) and is most apparent 
in the rapid decline of total cytochrome P450s (CYPs), particularly the CYP3A1 
isoform (Padgham et al., 1993). Therefore, after a standard hepatocyte isolation 
protocol was established, attempts were made to produce suitable culture conditions 
for hepatocytes. Studies of liver function are generally confined to the first few days of 
culture but this precludes longer-term studies. Conventional approaches to 
maintaining the differentiated properties of isolated hepatocytes in culture include 
supplementation of the medium with hormones such as dexamethasone (Agius et al., 
1986; Enat et al., 1984), co-factors such as nicotinamide, pyruvate, DMSO and 
phenobarbital (LeCluyse et al., 1996; Waxman et al., 1990); the application of 
extracellular matrix components (Bissell et al., 1987; Dunn et al., 1989; 
Gomez-Lechon et al., 1998) and co-culture with non-parenchymal epithelial cell-types 
(Agius, 1988; Rogiers and Vercruysse, 1993). Recently, Mitaka has compiled an 
extensive review on the development of conditions for maintenance of hepatocytes in 
culture (Mitaka, 1998). Although most groups declared that they had successfully
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found a suitable medium for human or rodent hepatocyte culture, only a limited 
number of liver-specific functions were demonstrated in individual studies. So, there is 
still no consensus on the best conditions for culturing isolated hepatocytes (Table 6.2) 
and this will ultimately depend on the experimental procedures to be performed on the 
hepatocytes.





0.2% BSA, 20mM HEPES, 0.5mg/L insulin, 10‘7M dexamethasone, 5.5mM 
galactose, 30mg/L proline, 20mM NaHC03, 5mg/L transferrin, 0.2mg/L 
CuS04.5H20 , 0.5mg/L FeS04.4H20 , 0.75mg/L ZnS04.7H20 , 0.05mg/L MnS04, 





2g/L BSA, 2.25g/L glucose, 2g/L galactose, 0.1 g/L ornithine, 0.03g/L proline, 
0.305g/L nicotinamide, 0.544 mg/L ZnCI2, 0.75mg/LZnSO4.7H2O, 0.2mg/L 
CuS0 4.5H20, 0.025mg/L MnS04, 146.1 mg/L glutamine, 1g/L ITS, 10'7M Dex, 







0.25% bicarbonate, 15mM HEPES, 65.5ju M ethanolamine, 100^g/m l trnaferrin, 
0.6g/L insulin, 10‘7M dexamethasone, 10nM glucagon, 32.25mg/L proline, 7.18// 










1g/L albumin, 5.5mM galactose, 0.5mM glutamine, 0.3mM ornithine, 0.13 mM 
proline, 5mM HEPES, 2.5ng/ml Na-selenite, 2.5//g/ml transferrin, 0.2mM ZnCI2, 






10%FBS, 20mM HEPES, 10mM nicotinamide, 1mM ascorbic acid-2-phosphate, 









10mM nicotinamide, 30mg/L proline, 1mM ascorbic acid 2-phosphate, 0.5//g/ml 






2%DMSO, 1 / /  M [+]-alpha-tocopherol, 25ng/ml EGF
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DMEM 20%FBS, 0.1 f j. M dexamethasone, antibiotics
Abbreviations - DMEM: Dulbecco's Modified Eagle's Medium; L-15: Leibovitz L-15 
Medium; MEM: Minimum essential medium; WE: Williams' Medium E; KSFM: 
Keratinocyte-stimulating factor medium, ITS: Insulin-transferrin-selenium mixture; 
EGF: Epidermal growth factor; HGF: Hepatocyte growth factor; BSA: Bovine serum 
albumin; FBS: Foetal bovine serum
Table 6.2 Summary of media used for hepatocyte culture (selected publications from 
1995-2005). Antibiotics referred to were penicillin and streptomycin.
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6.B Development of a serum-free culture 
system for the maintenance of hepatic 
differentiation phenotype
6.B.1 Preservation of hepatic markers in KSFM 
medium
Despite numerous attempts, it is difficult to maintain hepatocytes in a 
well-differentiated state for more than a few days. Therefore it was sought to develop 
a protocol for maintenance of hepatic functions in vitro by addition of a simple, 
well-defined medium. Based on the previous observation in embryonic liver culture 
(see Chapter 5) and the use of KSFM in the culture of epithelial cells by several 
groups (Andl et al., 2003; Chen et al., 2002; Vallette et al., 1998). The potential of 
KSFM as a medium for the culture of primary hepatocyte cultures was then tested.
Adult rat hepatocytes isolated by the collagenase perfusion technique were 
plated either on glass coverslips or on tissue culture plastic (see chapter 2 for further 
details). The cells were allowed to attach in Williams’ Medium E (WE) containing 10% 
serum and maintained for 6-10 hours before changing to serum-free defined WE or 
KSFM medium (see transmitted images in Figure 6.1). Initial results based on 
immunofluorescence detection and Western blotting were encouraging. For the same 
culture period (up to 72 hours), albumin protein expression was preserved in cells 
maintained in KSFM but not in WE medium (Figure 6.2). A similar result was also 
observed for transferrin expression (Figure 6.3).
The expression of hepatic proteins other than albumin and transferrin was 
compared between WE and KSFM culture medium with the indicated supplements
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(see section 2.B.2.3). The liver proteins included serum proteins a 1-antitrypsin (Figure 
6.4), haptoglobin (Figure 6.5), liver enriched transcription factors C/EBPa (Figure 6.6), 
C/EBP|3 (Figure 6.7), HNF4a (Figure 6.8), RXRa (Figure 6.9), enzymes associated 
with ammonia detoxification: glutamine synthetase (GS) and carbamylphosphate 
synthetase (CPS) (Figure 6.10), the Phase II metabolising enzyme 
UDP-glucuronosyltransferase (UGT) (Figure 6.7) and the epithelial marker E-cadherin 
(Figure 6.11). The results showed that all the proteins examined were maintained in 
KSFM-cultured conditions in comparison to WE culture media. Connexin 32 (Cx32) 
and connexin 26 (Cx26) are the two main gap junction proteins expressed in 
hepatocytes(Kumar and Gilula, 1986; Nicholson et al., 1987). Gap junction 
intracellular communication plays an important role in regulating cell survival and 
apoptosis (Krysko et al., 2005), cell differentiation and proliferation (Cheng et al., 2004) 
and tumourigenesis (Luebeck et al., 2005). Therefore, the expression of Cx32 was 
also examined. The expression of Cx32 was only detected in hepatocytes cultured in 
KSFM with EGF, BPE in the absence and presence of dexamethasone (Figure 6.12).
Western blotting for several hepatic proteins including albumin, transferrin and 
HNF4a was also carried out. The expression of proteins from hepatocytes cultured 
under different conditions for 24 and 72 hours were examined. The protein expression 
was sustained in KSFM culture medium, the best in KDS condition, compared to 
those WE medium (Figure 6.13). This result confirmed in semi-quantitative terms, the 
immunostaining results.
Based on the above observations, it was investigated whether KSFM could 
prevent de-differentiation of cultured hepatocytes.The expression of vimentin, a 
cytoskeletal de-differentiation marker (Blaheta et al., 1998), after 72 hrs of culture was 
examined. Vimentin was expressed in rat hepatocytes cultured in WS and WDS but 
not in cells cultured in KS and KDS (Figure 6.14a). It is worth noting that two different
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groups of vimentin positive cells were found in WS cultured cells after 72 hours: 
individual vimentin-positive cells were found scattered (Figure 6.14b) as well as in 
groups (Figure 6.14c). Following inoculation of the cells, some attached as individuals 
whereas others attached in groups and both undergo de-differentiation after culture in 
WS for 3 days. Altogether, these observations suggested that KSFM may play a role 
in the preservation of the differentiation state of the isolated rat hepatocytes.
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24 hours 72 hours 24 hours 72 hours
Figure 6.1 Transmitted light images of isolated rat hepatocytes maintained in culture 
for 24 or 72 hours in either WE or KSFM medium with the indicated supplements. 
Scale bar = 10 pm. For abbreviations, see section 2.B.2.3.
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Immunostaining for albumin
Figure 6.2 Albumin expression in isolated rat hepatocytes cultured for 72 hours in 
different culture media. The preservation of albumin is observed in hepatocytes 
cultured in KSFM medium. Scale bar = 20 pm. For abbreviations, see section 2.B.2.3.
24 hours 48 hours 72 hours 24 hours 48 hours 72 hours
Immunostaining for transferrin
Figure 6.3 Transferrin expression in isolated rat hepatocytes cultured for 24, 48 and 
72 hours in different culture media. Scale bar = 20 pm. For abbreviations, see section
2.B.2.3.
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24 hours 72 hours 24 hours 72 hours
Immunostaining for a1-antitrypsin
Figure 6.4 a 1-antitrypsin expression in isolated rat hepatocytes cultured for 24 and 72
hours in different culture media. Scale bar = 20 pm.
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24 hours 72 hours 24 hours 72 hours
Immunostaining for haptoglobin
Figure 6.5 Haptoglobin expression in isolated rat hepatocytes cultured for 24 and 72
hours in different culture media. Scale bar = 20 pm.
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Figure 6.6 C/EBPa expression in isolated rat hepatocytes cultured for 24 and 72
hours in different culture media. Scale bar = 20 pm.
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24 hours 72 hours 24 hours 72 hours
Immunostaining for UGT/C/EBPp
Figure 6.7 Expression of C/EBP(3 (green) and UGT (red) in isolated rat hepatocytes
cultured in different culture media for 24 and 72 hours. Scale bar = 20 pm.
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24 hours 72 hours 24 hours 72 hours
Immunostaining for HNF-4a
Figure 6.8 HNF4a expression in isolated rat hepatocytes cultured in different culture
media for 24 and 72 hours. Scale bar = 20 pm.
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24 hours 72 hours 24 hours 72 hours
Immunostaining for RXRa
Figure 6.9 RXRa expression in isolated rat hepatocytes cultured in different culture
media for 24 and 72 hours. Scale bar = 20 pm.
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24 hours 72 hours 24 hours 72 hours
Immunostaining for CPS/GS
Figure 6.10 Glutamine synthetase (GS, green) and carbamoylphosphate synthetase
(CPS, red) expression in isolated rat hepatocytes cultured in different culture media
for 24 and 72 hours. Scale bar = 20 pm.
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24 hours 72 hours 24 hours 72 hours
Immunostaining for E-cadherin
Figure 6.11 E-cadherin expression in isolated rat hepatocytes cultured in different
culture media for 24 and 72 hours. Scale bar = 20 pm.
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24 hours 72 hours 24 hours 72 hours
Immunostaining for connexin 32
Figure 6.12 Connexin 32 expression in isolated rat hepatocytes cultured in different
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Figure 6.13 Western blotting analysis for albumin, transferrin and HNF4a in 24-hour 
and 72-hour cultured rat hepatocytes. 10pg total protein was loaded per lane, 
a-tubulin was used as an internal loading control.
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24 hours 72 hours
W D S
24 hours 72 hours
Figure 6.14 Vimentin expression in isolated rat hepatocytes cultured in different 
media for 24 and 72 hours (A). In 72-hour WS cultured rat hepatocytes. Scattered 
de-differentiated hepatocytes (B) and groups of vimentin positive cells (C) were 
observed. Scale bar = 20 pm.
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6.B.2 Long-term preservation of differentiated 
rat hepatoctyes in KSFM culture medium
Although the results for three days were encouraging, it was important to 
determine whether KSFM media can maintain the hepatic phenotype for longer 
culture periods. In order to find out the optimal culture conditions, the survival of 
hepatocytes was examined under different culture conditions. Equal numbers of cells 
were seeded and cultured in six different KSFM culture conditions. The cell number, 
detected by DAPI staining of cell nuclei, at 24 hours of culture was set as 100% and 
the relative percentage of cell numbers at 1 week / 2 weeks / 3 weeks were 
determined (Figure 6.15). As cells cultured in KDS exhibited the best survival rates it 
















K KD KS KB KE KDS
□  24hrs EJ1wk « 2 w k s  m 3wks
Figure 6.15 Time course for the percentage of surviving hepatocytes cultured in 
KSFM medium. The histogram describes the percentage of hepatocytes (based on 
DAPI-positive remaining from the 24 hour culture point). The data were obtained from 
at least 6 random fields for each culture and presented as mean ± S.D.. Abbreviations: 
K-Keratinocyte serum free medium; D-dexamethasone; S-supplemented with both 
EGF and BPE; B-bovine pituitary gland extract and E - recombinant human epidermal 
growth factor.
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A number of liver specific markers were examined in KDS cultured rat 
hepatocytes using RT-PCR, Western blotting and immunostaining. For RT-PCR, the 
primers were designed for a number of enzymes including Phase I detoxification 
enzymes cytochrome P450s (Cyp2B12, Cyp3A1, Cyp7A1 and Cyp reductase), 
rate-limiting enzymes involved in amino acid metabolism such as tyrosine 
aminotransferase (TAT)(Yeoh et al., 1979) and tryptophan 2,3-dioxygenase 
(TdO)(Moore et al., 1986) and CPS. All these transcripts were highly expressed in 
KDS cultured rat hepatocytes up to 3 weeks and some (e.g. CPS, Cyp3A1, TAT and 
TdO) were still present at 4 weeks (Figure 6.16). Using Western blotting, hepatic 
proteins including albumin, transferrin, UGT, the acute phase protein haptoglobin and 
liver-enriched transcription factor HNF1a and HNF4a were detected and showed 
steady expression for up to 4 weeks (Figure 6.17). Furthermore, the expression of 
several liver-specific proteins such as apolipoprotein B (ApoB), transferrin, albumin, 
Cyp2E1 was also detected by immunostaining. The results indicated that these 
proteins could be maintained for 2 weeks (Figure 6.18), 3 weeks (Figure 6.19) and 4 
weeks (Figure 6.20) under KDS culture conditions. In addition, C/EBPa, C/EBP(3, 
RXRa and HNF4a were maintained for at least 3 weeks.
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Figure 6.16 RT-PCR examination of hepatic mRNA expression in long-term KDS 
cultured rat hepatocytes. The expression of carbamoylphosphate synthetase I (CPS1), 
cytochrome reductase, tyrosine aminotransferase (TAT), tryptophan di-2,3-oxygenase 
(TdO), UDP-glucuronosyltransferase 1a (UGT1a) and three cytochrome P450 genes 
(Cyp2B12, Cyp3A1, Cyp7A1) are investigated. RT(-): no template control. Pre and 
Post represent the mRNAs extracted from normal liver or freshly isolated hepatocytes, 
respectively.
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Figure 6.17 Time-course protein expression in KDS cultured rat hepatoctyes. 
Western blotting of albumin, transferrin, haptoglobin, UGT, HNF-1aand HNF-4a in 
hepatocytes cultured for different time periods (24hours to 4 weeks) in KDS cultured 
rat hepatoctyes. Pre and Post in (A) and (B) represent the proteins extracted from 
normal liver or freshly isolated hepatocytes, respectively.
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UGT/C/EBP j  C/EBP a Cyp2E l/H NF-4a
Figure 6.18 Protein expression in 1-week and 2-weeks KDS cultured rat hepatoctyes. 
Immunofluorescence staining for the expression of C/EBPp (green) and UGT (red) 
(A,B), C/EBPa (C,D) and HNF4a (green) and Cyp2E1 (red) in 1-week and 2-week 
KDS cultured rat hepatocytes. Scale bar = 20 pm.
Album in ApoB Connexin 32
C/EBPp RXRcr
Figure 6.19 Protein expression in 3-weeks KDS cultured rat hepatoctyes. 
Immunofluorescence staining for albumin, ApoB, Connexin 32, Cyp2E1, UGT, 
C/EBPa, C/EBP3, HNF4a and RXR in rat hepatocytes cultured for 3 weeks in KDS. 
Scale bar = 20 pm.
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Figure 6.20 Protein expression in 4-weeks KDS cultured rat hepatoctyes. 
Immunofluorescence staining for albumin, Connexin 32 (indicated by arrows), 
Cyp2E1 and haptoglobin rat hepatocytes cultured for 4 weeks in KDS media. Scale 
bar = 20 pm.
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6.B.3 Functional analysis of KSFM cultured rat 
hepatoctyes
6.B.3.1 Lipid and glycogen storage in KDS cultured rat 
hepatocytes
To test whether hepatocytes cultured under KDS conditions maintained their 
functional capacity, their potential to store lipid and to oxidise glucose into glycogen 
was examined. Oil red O is one of the Sudan dyes used for the detection of general 
lipids(Bayliss and Adams, 1972). Oil red O was used to stain the lipid droplets in 
hepatocytes. By this means, the lipids were seen to be present in the hepatocytes 
cultured with KDS up to 4 weeks after isolation (Fig 6.21). The examination of 
glycogen in the KDS cultured hepatocytes was performed using Periodic acid- Schiff 
(PAS) staining (Lazaro et al., 2003). The results showed that glycogen storage could 
also be maintained in the hepatocytes cultured with KDS for up to 4 weeks after the 
induction of the culture medium containing 25mM glucose (Figure 6.22).
6.B.3.2 Active urea cycle in KDS cultured rat hepatocytes
The urea cycle is an essential metabolic process for the removal of ammonia 
formed by the breakdown of many nitrogenous compounds in liver (Morris, 2002). In 
brief, arginine from the diet or from protein breakdown is cleaved by the cytosolic 
enzyme arginase, generating urea and ornithine. Ornithine in the cytosol is 
transported to the mitochondrial matrix, where ornithine transcarbamoylase catalyses 
the transformation of ornithine to citrulline. The citrulline is then transported to the 
cytoplasm, and converted to argininosuccinate by argininosuccinate synthetase,. 
Then arginine and fumarate are produced from argininosuccinate by the cytosolic
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enzyme argininosuccinate lyase (also called argininosuccinase) and, in the final step 
of the cycle, arginase cleaves urea from arginine, regenerating cytosolic ornithine, 
which can be transported to the mitochondrial matrix for another round of urea 
synthesis.
The activity of ureagenesis in the KDS cultured rat hepatocytes was examined by 
two separate assays, the urea assay and the arginase assay. Assays were performed 
after 24 hours, 1 week, 2 weeks, 3 weeks and 4 weeks of culture using either the 
detection of secreted urea (urea assay), or by measurement of arginase activity 
(arginase assay). Arginase activity was detected at each time point while the level of 
urea production remained stable (between 1600 pg and 2100 pg urea per dish of cells) 
(Figure 6.23). For the urea assay, the culture medium was changed 24 hours prior to 
the assay and the results suggested that secreted urea was slightly reduced after 4 
weeks culture (Figure 6.24). Although it is impossible to interpret these results with in 
vivo data, stabilisation of urea cycle activity suggested that the urea cycle is active for 
more than 2 weeks under KDS culture conditions.
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Oil red O staining for KDS cultured hepatocytes
Figure 6.21 Lipid storage in rat hepatocytes cultured in KDS medium. Lipid droplets 
were stained in rat hepatocytes by oil red O staining at (A) 24-hours (B) 1-week (C)
2-weeks (D) 4-weeks of culture. Scale bar = 20 pm.
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PAS staining for KDS cultured hepatocytes
Figure 6.22 Glycogen storage in rat hepatocytes cultured in KDS medium using the 
PAS assay. Glycogen was stained in rat hepatocytes at (A) 1-week (B) 2-week (C)
3-week (D) 4-weeks of culture. Scale bar = 20 pm.
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Figure 6.23 Arginase activities in cultured rat hepatocytes. The activity of arginase 
was determined using the procedure described in section 2.B.10.2. The data are 
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Figure 6.24 Urea secretion cultured rat hepatocytes. Rat hepatocytes were cultured 
for different time points (24-hours to 4-weeks) in KDS media. The media were 
collected and the urea concentration determined using the procedure described in 
section 2.B. 10.1. The data are represented as mean ± S.D. and from at least 4 
individual dishes.
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6.B.4 Hepatic metabolising enzymes are induced 
by phenobarbital treatment in KDS cultured 
hepatocytes
“Xenobiotic” is the term used to describe a foreign particle or molecule that is 
potentially dangerous or toxic (Waxman et al., 1990). Phenobarbital, one common 
xenobiotic, is used as an inducer of Phase I and II metabolising enzymes in liver 
(Waxman et al., 1990). Following treatment by phenobarbital, the transcription of 
phase I (cytochrome P450s) and phase II (UGT) detoxification enzymes is activated. 
It is through the binding of CAR-RXR (CAR, constitutive active receptor; RXR, 
9-c/s-retinoic acid receptor) heterodimers with the cis-acting element (DR4 motifs, 
such as NR1 and NR2 domain on the enhancer of Cyp2b10 gene) of the genes 
(Kakizaki et al., 2003; Swales and Negishi, 2004). To examine the effect of 
phenobarbital on Phase I and II metabolising enzymes in KDS cultured rat 
hepatocytes, the expression of Cyp2B12, Cyp3A1, Cyp7A1 and UGT were enhanced 
by real-time RT-PCR analysis. Rat hepatocytes were cultured for 1 week in KDS and 
then treated with and without phenobarbital for 3, 5 or 7 days (i.e. in total for 10,12 or 
14 days). All the Phase I and Phase II genes examined were upregulated 2-10-fold in 
phenobarbital-treated cells compared with control cells (Figure 6.25). For longer-term 
effects, the KDS cultured hepatoctyes were incubated for 1,2,3 and 4 weeks and then 
treated with 10pM phenobarbital for a further 3 days. KDS cultured hepatocytes 
respond to phenobarbital treatment. The UGT and cytochrome P450s (Cyp2B12, 
Cyp3A1 and Cyp7A1) (Figure 6.26) were upregulated for at least 2 weeks. However, 
the response to phenobarbital after 3 and 4-weeks was lower compared to treatment 
after 2 weeks. The reduced response after 3 or 4 weeks might be due to lower cell 
viability. Approximately 50% of cells detached between 2 and 3 weeks of culture
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(Figure 6.15). The results suggest that KDS cultured rat hepatocytes are able to 









UGT Cyp2B1/2 Cyp3A1 Cyp7A1
□ 0 days 3 days □  6 days □ 7days
Figure 6.25 Phenobarbital-induced expression of liver metabolising enzymes. 
Hepatocytes were cultured with KDS for 7 days and then the medium was changed to 
KDS supplemented with and without 10 pM phenobarbital for another 3, 5 and 7 days. 
The expression of UGT, Cyp2B12, Cyp3A1 and Cyp7A1 was performed by real-time 
RT-PCR. The results were displayed as the ratio of (Cone. [targe{ gene (treated)] / Cone.
[reference gene (trea ted )])-(C o n e , [target gene (untreated)] /  COHC. [reference gene (untreated)])- T h e  C alibra tor is
the mRNAfrom adult rat liver.
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Figure 6.26 Induction of Phase I or II metabolising enzymes in response to 
phenobarbital treatment of long-term KDS cultured rat hepatocytes. The experimental 
procedure and the result are the same as described in Figure legends of Figure 6.25.
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6.B.5 Effect of EGF and BPE on hepatic gene 
expression in transdifferentiated hepatocytes
It was then examined the effect of supplements (rhEGF+BPE) on the hepatic 
phenotype in transdifferentiated hepatocytes (TD hepatocytes) derived from the 
pancreatic cell line AR42J-B13 (B13). Hepatocytes are induced from B13 cells 
following treatment with 1pM dexamethasone(Shen et al., 2000). TD hepatocytes 
express a number of hepatic properties similar to normal hepatocytes(Burke et al., 
2006; Kurash et al., 2004; Tosh et al., 2002a; Tosh et al., 2002b). It is interesting to 
know whether TD hepatocytes also respond to the supplements used for KSFM 
culture. TD hepatocytes were treated as shown in Figure 6.27. The expression of 
UGT and several liver mRNAs including serum protein albumin and a1-antitrypsin, 
cytochrome P450 enzyme Cyp7A1 and hepatic enzyme TAT was analysed using 
immunostaining and real-time RT-PCR. In cells cultured with supplements (either in 
the presence or absence of dexamethasone after 7 days) the number of UGT positive 
cells and UGT expression in TD hepatoctyes was enhanced (Figure 6.28). 
Furthermore, the hepatic genes albumin, a 1-antitrypsin, Cyp7A1, HNF4a and TAT 
were upregulated in the cells incubated with supplements (Figure 6.29). These data 
confirmed that addition of EGF and BPE can enhance the hepatic phenotype in both 
cultured rat hepatocytes and in TD hepatocytes.
! v
Dexamethasone 





































W-C L i In vitro  transdifferentia tion  of liver into functional pancreatic-like cells
Figure 6.27 Scheme for investigating the effect of KSFM on tansdifferentiated 
hepatocytes induced from pancreatic AR42J-B13 cells.
Figure 6.28 Immunostaining of UGT expression in transdifferentiated hepatocytes. 
Hepatocytes were induced by culturing AR42J-B13 cells for 14-days with or without 
1pM dexamethasone or 5ng/ml rhEGF and 50pg/ml PGE. Three typical fields are 
shown for each culture condition. Scale bar = 20|um.
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Calibrator: Fresh rat liver cDNA
Figure 6.29 The effect of rhEGF and BPE on hepatic mRNA expression in cultured 
transdifferentiated hepatocytes. The expression of a 1-antitrypsin, AAT; 
Carbamoylphosphate synthetase, CPS; tyrosine aminotransferase, TAT and 
UDP-glucuronosyltransferase, UGT; was performed by RT-PCR analysis, w/o Dex: 
culture in medium without containing dexamethasone; with Dex: medium containing 
dexamethasone. The numbers presented is log value of ratio of mRNA ceii cultured with
rhEGF and BPE / mRNA ceil cultured without rhEGF and BPE-
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6.C Conversion of hepatocytes to (3-like 
cells
Using rat hepatocytes maintained in KSFM media we sought to investigate 
whether it may be possible to induce the transdifferentiation to pancreatic cell types. 
Adenoviral infection was chosen since it more efficient compared to other transfection 
systems e.g. transfection (for further details see section 3.G). Tests of the infectious 
titre of adenoviral vector on the rat hepatocytes were first performed. Different titres of 
adenovirus containing expressing CMV-EGFP were infected into KDS cultured rat 
hepatocytes and then the cells were cultured for 2, 4 and 6 days. The infection 
efficiency was determined by the percentage of GFP positive cells at each time point. 
There is a balance between maintaining healthy cells (Figure 6.30) while at the same 
time ensuring the best infection efficiency (Figure 6.31).
Based on the preliminary results, it can be concluded that a multiplicity of 
infection (MOI) of 10-20 is optimal for virus infection in rat hepatocytes. Using an MOI 
of 20 for the TTR-Xlhbox8Vp16 adenovirus, insulin-expressing cells, either with or 
without co-expression of the hepatic marker albumin, were detected on the 5th day 
after infection (Figure 6.32). However, the transdifferentiation efficiency was still very 
low and it suggested that Xlhbox8Vp16 alone might not be sufficient to convert all 
hepatocytes into pancreatic-like cells.
Based on the notion of regulatory network for pancreas development (see Figure
1.1) (Edlund, 1998; Wilson et al., 2003), we hypothesised that perhaps the 
combination of several pancreatic specific transcription factors can increase the 
transdifferentiation efficiency (and in particular for (3-cell generation). The different 
transcription factors (with a total viral titre of 20 MOI) were introduced onto KDS 
cultured rat hepatocytes and the gene expression for pancreatic (3 cells was then
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analysed (Figure 6.33). These transcription factors included: Xlhbox8Vp16, Ngn3, 
Nkx2.2 and Nkx6.1. Following infection, the mRNAs were extracted and RT-PCR 
analysis performed for the expression of several p-specific genes including 
chromogranin A (ChA), GLP1 receptor (GLP-1r), islet amyloid polypeptide (IAPP), 
insulin, potassium channel subunit (Kir6.2), sulphonylurea receptor (SUR) and rat 
Pdx1. The results showed some reprogramming from a hepatic towards a pancreatic 
(3 cell phenotype after 5 days, (3-cell specific genes were expressed to a higher level in 
rat hepatocytes infected with 3 or 4 transcription factors compared with those infected 
with only 1 or 2 transcription factors (Figure 6.34B). It is also worth noting that after 2 
days of adenovirus infection, no insulin is detected but by 5 days the hormone is 
expressed. This suggests that the timing between day 2 and 5 is critical for 
reprogramming of liver cells to induce pancreatic genes (Figure 6.34A).
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Figure 6.30 Titration of adenoviral vectors in KDS cultured rat hepatocytes. 24-hours 
KDS cultured rat hepatocytes were infected with different titres of Ad CMV-EGFP. The 
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Virus infectious concentration
Figure 6.31 Quantitative examination of GFP positive cells in Ad CMV-EGFP infected 
KDS cultured rat hepatocytes. The procedure is the same as described in Figure 6.30. 
The percentage of GFP positive cells was determined from 6 random fields of infected 
cultures. The data are represented with mean + S.D.
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Ad TTR-Xlhbox8Vp16 -> rat hepatocytes for 5 days
b k b HI
Albumin/Insulin
Figure 6.32 Insulin expression in cultured rat hepatocytes. Rat hepatocytes were 
cultured with KDS for 3 days and subsequently infected with 20 MOI Ad 
TTR-Xlhbox8Vp16. After a further 5-days of culture in KDS medium, the expression of 
insulin (green) and albumin (red) were analysed using immunoflourescence staining. 
Insulin is found expressed in cells either without (A) or with (B) albumin. Scale bar = 
20 pm.
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Cultured in KDS for 3 days
Ad TTR-X8Vpl6 V V V V V V
Ad CMV-Nkx2.2 V V V V V V V V
Ad CM V- H A -Nkx6.1 - eGFP V V V V V V V
Ad CWV-HA-moNgn3-eSFP V V V V V V V
(P S. Top up to same titer of virus by adding Ad null (total viral titer = MOI))
I
Maintain in KDS for another 5 days and RT-PCR examination of p specific markers
Figure 6.33 Schematic representation of the procedure to investigate pancreatic (3 
activity in KDS cultured rat hepatocytes infected with selective combinations of 
adenoviruses. The adenoviruses encode pancreatic specific transcription factors.
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Figure 6.34 RT-PCR analysis of pancreatic (3 specific mRNAs in transdifferentiated 
pancreatic-like cells induced by the infection of various adenoviral vectors encoded 
pancreatic transcription factors after (A) 2 days and (B) 5 days after infection. The 
transcription factors were detected using RT-PCR referring to the infection 
combinations. Chr A, chromogranin A; GLP-1r, glucagon-like peptide 1 receptor; IAPP, 
islet amyloid polyeptide; Kir6.2, potassium channel subunit; SUR, sulphonylurea 
receptor. Neurogenin3 (Ngn3), Nkx2.2 and Nkx6.1 are all from mouse origin. (+): 
mRNAfrom rat insulinoma RIN-m5F cells; (-): no template control. Sample 1-16 are 
referred to the cells infected with different combinations of viruses encoding various 
transcription factors.
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6.D Discussion
Much effort has been devoted to developing conditions suitable for in vitro culture 
of rodent or human hepatocytes. Although numerous culture media have previously 
been presented, it has been very difficult to find one for sustaining the differentiated 
state of hepatocytes (Block et al.f 1996; Runge et al., 2000). Only short-term cultures 
has been accomplished by most groups (i.e. less than 7 days). The present work 
showed for the first time that KSFM medium with dexamethasone, rhEGF and BPE is 
able to maintain the differentiated properties of hepatocytes for up to 28 days. This 
statement is based on the expression of liver specific proteins (including liver-enriched 
transcription factors), the ability to induce drug metabolising enzymes, store lipid and 
produce urea.
The main benefit of KSFM culture media is that it is relatively simple in 
comparison with the culture conditions reported from other groups. In previous studies, 
supplements were added into culture medium in hepatocyte culture for different 
experimental purposes. They contained growth factors (EGF and hepatocyte growth 
factor) (Miyazaki et al., 1998), differentiation-promoting chemicals (nicotinamide and 
DMSO) (Mitaka, 1998), metal ions (ferrous iron, copper, manganese or zinc) (Kojima 
et al., 1996), and hormones/co-factors (insulin-transferrin-selenium mixture, 
dexamethasone and ethanolamine) (Sasaki et al., 1997; Shelly et al., 1989). 
Nevertheless, it is difficult to ascertain the concentration of these additives in the 
medium due to the different descriptions from individual groups. In contrast, 
commercially available supplements and dexamethasone are the only two 
components required to supplement the KSFM culture medium. It is also worth noting 
that hepatocytes were directly plated out on the culture dishes or glass coverslips 
without any extracellular matrix support materials such as rat tail collagen (Rana et al.,
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1994), collagen/matrigel sandwich configuration (Kang et al., 2004), bone marrow 
stromal cells (Mizuguchi et al., 2001) or co-culture with feeder fibroblasts cells 
(Washizu et al., 2001). This simplifies the preparation procedure and supplies a stable 
system for future use.
Another interesting observation from this investigation is the potential mitogenic 
effect of BPE on culture rat hepatocytes. Among the supplements used in the KSFM 
medium, EGF has been found to induce DNA synthesis in cultured hepatocytes 
(Richman et al., 1976). In contrast, BPE is rarely mentioned to be essential for 
hepatocyte growth. In our system BPE did have an ability to support cell growth and 
differentiation but further investigations remain to be performed to determine the 
function of each component of the BPE.
Liver-enriched transcription factors such as HNF1a, HNF4a and C/EBPa are 
important in the control of hepatic differentiation (Costa et al., 2003). In addition, 
C/EBPp has been shown to be a master regulator for the formation of 
transdifferentiated hepatocytes from pancreatic-derived cells (Kurash et al., 2004; 
Shen et al., 2000; Tosh et al., 2002b). When I examined the expression of the liver 
enriched transcription factors I found that HNF4a, C/EBP(3 and C/EBPa expression 
were reduced within 3 days of culture with WE medium. This observation suggests 
that loss of HNF4a, C/EBP(3 and C/EBPa transcription factors is the immediate cause 
of the loss of differentiated hepatic phenotype.
Recently, it was suggested that loss of expression of connexin proteins might be 
a prognostic marker for hepatocellular carcinoma (Sheen et al., 2004). The authors 
stated that the presence of connexin proteins in liver is associated with normal liver 
function. The induction of Cx32 and Cx26 proteins in DMSO-containing primary 
mouse hepatocyte cultures was also observed and confirmed the importance of 
connexin proteins in differentiating hepatoctyes (Stoehr and Isom, 2003).
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A partial pancreatic phenotype can be induced following overexpression of (3-cell 
transcription factors in cultured hepatocytes (Figure 6.34). The partial 
transdifferentiation of hepatocytes to pancreatic cells is also shown in recently 
published results from elsewhere. Kaneto et al has shown that Pdx1Vp16 in 
combination with NeuroD or Ngn3, enhances insulin biosynthesis (by the detection of 
insulin mRNA expression and the activity of insulin promoter) in liver-derived 
transdifferentiated cells (Kaneto et al., 2005). The data also demonstrated the 
enhanced expression of various pancreas-related factors including islet specific 
glucokinase, SUR1 and Kir6.2 in the PdX1Vp16/NeuroD or Pdx1Vp16/Ngn3 
co-expressing cells. Interestingly, the gene expression of other pancreatic markers for 
exocrine (elastase) and endocrine (glucagon, somatostatin and pancreatic 
polypeptide) cells is also increased (Kaneto et al., 2005). Using the soluble factors 
(SFs; EGF and nicotinamide) to promote the transdifferentiation efficiency, Sapir et al 
generated functional pancreatic cells from isolated fetal human liver cells containing 
Pdx1 transgene (Sapir et al., 2005). The results indicated that the expression of 
pancreatic genes including endogenous human Pdx1 was 10-104 times greater in the 
presence of EGF and nicotinamide in contrast to those without treating EGF and 
nicotinamide. Furthermore, these transdifferentiated cells were also able to ameliorate 
hyperglycemia following implantation into non-obese diabetic SCID mice. In addition 
to EGF and nicotinamide, the effect of other soluble factors including activin A, 
betacellulin, Exendin-4 and Hepatocyte growth factors (HGFs) has recently been 
shown to be able to promote the pancreatic differentiation states of human 
liver-derived insulin-producing cells (Zalzman et al., 2005).
In summary, it has been described the development of a simple, novel culture 
system for rat hepatocytes and show that the differentiated phenotype as well as 
several hepatic biochemical activities can be maintained over extended periods of
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culture (up to 28 days). This finding may provide a standard system for the in vitro 
culture of liver cells and could pave the way for bioengineering applications to make 
an artificial liver system. In addition, it is also encouraging to note that several 
pancreatic (3 cell markers can be induced when the hepatoctyes were infected with 
adenoviruses containing pancreatic transcription factors. This observation not only 
provides a powerful tool to investigate the transdifferentiation between liver and 
pancreas but also reveals the possibility to directly examine the exact position of 
individual transcription factors in the pancreatic regulatory network. Lastly, once the 
standard protocol to generate surrogate pancreatic p cells is established, it might be 
possible to test their therapeutic potential for curing diabetes.
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Chapter 7 .  
Discussion & future 
directions
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7.A Summary
From the results presented in previous chapters, it was shown that Xlhbox8Vp16 
is able to transdifferentiate two different types of liver cells (the human hepatoma cell 
line HepG2 or primary cultures of adult rat hepatocytes) into pancreatic cells 
(Chapters 3 and 6). The transdifferentiated cells express many pancreatic markers 
and functional properties, including glucose-sensitive insulin secretion (Chapters 3, 4 
and 6). In addition, a novel culture system, using the defined media KSFM, for 
maintaining the differentiated properties of hepatocytes was discovered and it was 
shown that KSFM is able to maintain the hepatic differentiation properties for up to 28 
days (Chapter 6).
7.B Is de-differentiation a prerequisite for 
transdifferentiation?
The ability to convert one cell type to another has enormous therapeutic potential 
for the treatment and cure of degenerative disorders such as diabetes and 
Parkinson’s disease(Ball and Barber, 2003; Burke and Tosh, 2005; Lindvall et al., 
2004). For example, the conversion of embryonic stem cells, pancreatic ductal (or 
exocrine cells) or, as shown here and in several other studies, liver cells, into 
pancreatic cells may make it possible to carry out many more pancreatic islet grafts on 
patients with severe diabetes (Baeyens et al., 2005; Hussain and Theise, 2004; 
Lardon and Bouwens, 2005; Nakajima-Nagata et al., 2004; Ramiya et al., 2000; 
Serup et al., 2001; Vaca et al., 2005) Transdifferentiation may occur through a 
mechanism that involves de-differentiation and re-differentiation (Bonner-Weir and 
Weir, 2005; Bouwens, 1998; Tsonis, 2000; Weir, 2004). For example, in chick 
embryos, transdifferentiation of retinal pigmented epithelial cells (PECs) to lens cells
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involves de-differentiation to an intermediate phenotype before re-differentiation. 
Intermediate cells do not express markers for PECs or iris cell(Agata et al., 1993). 
Furthermore, in both amphibian heart and limb regeneration, muscle de-differentiation 
is commonly observed (Tsonis, 2000). More recently, Means et al. suggested that 
pancreatic epithelial explants undergo spontaneous acinar-to-ductal metaplasia in 
response to EGFR signalling. The authors concluded that this change in epithelial 
character is associated with the appearance of the nestin-positive transitional cells 
(Means et al., 2005). Nestin is expressed in the mesenchymal cells of the developing 
mouse pancreas (Selander and Edlund, 2002) as well as in exocrine cell types 
(Delacour et al., 2004) and is regarded by some as a marker of pancreatic progenitors. 
These findings imply that de-differentiation is an essential step to transdifferentiation 
in some cases. Although it is possible to induce pancreatic transdifferentiation from 
adult rat hepatocytes maintained in KSFM, it may be possible to enhance 
transdifferentiation if a different medium were used. Rather than using KSFM as a 
culture medium (since it maintains the hepatic phenotype extremely well), an 
alternative medium should be considered (e.g. one that does not sustain hepatic 
differentiation (e.g. Williams’ Medium E).
7.C Enrichment of transdifferentiated 
pancreatic cells
Although some transdifferentiated pancreatic cells from HepG2 cells showed 
expression of the mitotic marker, phosphohistone H3, the incidence of 
transdifferentiated cells was still low. The reason for the low rate of transdifferentiated 
pancreatic cells is not known. One idea might be because the transdifferentiated cells 
are damaged following enforced expression of the transgene. However, dead cells
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were extremely rare after transfection of TTR-Xlhbox8Vp16 into HepG2 cells (Figure
7.1). There might be another reason -  the cells are damaged because the cells are 
forced to express the transgene at high level. This idea is supported by the 
observation that transgenic mice generated by crossing Alb-Cre mice with mice 
carrying a transgene cassette composed of the chicken beta-actin gene (CAG) 
promoter and a floxed linked DNA sequence (CAT) linked to Pdx1 cDNA (Miyatsuka et 
al., 2003). Animals generated by this cross express pancreatic exocrine (elastase-1 
and chymotrypsinogen 1B) and endocrine cell types (insulin, glucagon, somatostatin, 
and pancreatic polypeptide) were all found in the liver. However, the liver tissue 
displayed abnormal lobular structures and multiple cystic lesions. Based on the same 
idea, the low efficiency of transdifferentiation in the HepG2 model might be due to the 
catalytic activity of digestive enzymes produced by exocrine cells. To reduce the 
contamination of exocrine cells, endocrine specific transcription factors (such as Ngn3) 
rather than the general pancreatic transcription factors (such as Pdx1) might be used 
to direct transdifferentiation of liver cells into a restricted endocrine cell lineage. In 
order to isolate specific types of pancreatic cells, a reporter system could be used to 
sort individual cell populations. For example, to separate a pure population of 
pancreatic (3 cells two different approaches can be taken. GFP under the control of the 
insulin promoter can either be incorporated into the transgene or alternatively be 
transfected into HepG2 cells and then transdifferentiation is induced by ectopic 
expression of Xlhbox8Vp16. The GFP-expressing cells can be sorted by 
fluorescence-activated cell sorting (FACS) (Meyer et al., 1998). It has been recently 
shown that the sorted |3 cells from MIP-GFP transgenic mice (mice that express GFP 
under the control of the mouse insulin I gene promoter (MIP)) displayed normal [3-cell 
properties, e.g. intracellular calcium mobilisation in response to high glucose (Hara et 
al., 2003). Once the cells are purified, it may be possible to culture them in vitro and
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expand the population using known (3-cell mitogens, e.g. betacellulin.







Live-Dead assay in TTR-(Xlhbox8)Vp16 transfected HepG2 cells
Figure 7.1 Cell viability in cultured TTR-Vp16 (A-C) and TTR-Xlhbox8vp16 (D-F) 
transfected HepG2 cells. The cell viability was examined using a live-dead assay in 
3-day (A,D), 5-day (B, E) and 7-day (C,F) hepatocytes after transfection. Scale bar = 
20 pm.
7.D High through-put screening for 
transdifferentiation using transgenic 
animals
Results from both the present investigation as well as other studies suggest Pdx1 
is a master-switch gene since it can create pancreatic-like cells from non-pancreatic 
cells (Song et al., 1999). It will be of interest to generate transgenic animals carrying 
Pdx1 transgene under the control of a ubiquitous promoter (i.e. CMV promoter) to 
screen the possibility of conversion of non-pancreatic cell types into pancreatic cells.
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In addition, once information on the role of pancreatic regulatory factors in pancreas 
development is elucidated the delivery of specific transcription factors at specific time 
points to mimic normal pancreas development (see Figure 1.1) should be carried out. 
It may not only be able to increase conversion efficiency but also provide more direct 
evidence to elucidate the role of the transcription factors in pancreas development. 
For instance, a transgenic mouse has recently been generated in which a pancreatic 
endocrine-specific enhancer drives the expression of a tamoxifen (TM)-inducible Cre 
recombinase/estrogen receptor fusion protein (Zhang et al., 2005). In these mice, 
Pdx1 can be deleted at any time point and therefore make it possible to investigate 
the impact of Pdx1 on pancreas development. The same strategy can also be applied 
to different pancreatic transcription factors (such as Hlxb9) whose loss of function 
mutation leads to pancreatic agenesis during the early pancreas development (see 
section 1.A.3.3).
7.E Improvements for the embryonic liver 
culture system
In Chapter 5, it was shown that KSFM can effectively inhibit the growth of 
mesenchymal cells in the embryonic liver culture system thereby making it possible to 
introduce the gene of interest into embryonic liver tissues. However, the poor growth 
of hepatic epithelium resulting from the lack of mesenchymal signals did lead to 
increasing cell death (Figure 5.15). To obtain the optimal condition between gene 
delivery efficiency and epithelial cell viability, using KSFM medium containing growth 
factors (see section 1 .A.2) is shown to be able to rescue the epithelium phenotype 
without affecting the gene delivery efficiency. Nevertheless, a recent study from Serls 
et al indicated that response thresholds to FGFs emanating from the cardiac
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mesoderm are involved in patterning the adjacent foregut endoderm into either liver or 
lung. This idea was supported by the observation that the hepatic protein albumin was 
induced when ventral foregut endoderm explants were exposed to low concentration 
(5 ng/ml) of Fgf1 and Fgf2 but, in contrast, the early lung-specific protein Nkx2.1 was 
activated when treated with high-concentration (greater than 50 ng/ml) of Fgf1 and 
Fgf2 (Serls et al., 2005). Furthermore, the temporal expression of Fgf receptor 4 
present within the endoderm implies that signaling through Fgfr4 may be involved in 
specifying lung versus liver (Serls et al., 2005). This notion suggested the necessity to 
examine the concentration and time point when adding the growth factors into the 
cultured embryonic liver cells in order to maintain the hepatic epithelial phenotype.
7.F Can KSFM maintain liver differentiation 
in hepatocytes from different species?
Xenobiotic-induced enzyme alteration varies in hepatocytes derived from 
different animals (e.g. human vs rat) as well as differences within species (strain 
differences, human polymorphisms) (Cottrell et al., 1996). It is therefore important to 
examine whether the effect of KSFM is species specific or whether it can be used to 
maintain differentiation in hepatocytes of different origins. One encouraging 
preliminary result is an observation using mouse hepatocytes. Mouse hepatocytes 
were isolated by the same protocol as described for rat hepatocytes (collagenase 
perfusion procedure, described in section 2.B.2.3). The expression of albumin was 
detected after 72hrs based on immunostaining. In comparison, in hepatocytes 
cultured in Williams’ Medium E, albumin expression is lost by 72 hrs (Figure 7.2). 
Further investigations are needed to examine both the maintenance of other hepatic 
markers as well as the liver functional properties of KSFM cultured mouse
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hepatocytes.
Figure 7.2 Albumin expression in adult mouse hepatocytes cultured in different 
culture medium for 72 hours. Albumin expression is maintained in hepatocytes 
cultured in KSFM medium. Scale bar = 20 pm. For abbreviations, see section 2.B.2.3.
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Appendix 1 Bacterial strain Plasmids
1.A Bacteria strains
Bacteria stra ins Genotype Supplier
E.Coli XL-1 Blue
recA1 endA1 gyrA96 thi-1 hsdR17 






F'traD36 laclq A(lacZ)M15 pro A+B+ 
/ e14- (M crA -) A(lac-proAB)thi 
gyrA96 (N a lr) endA1 hsdR17(rk- 





(lacZYA-argF)U 169 deoR, recA1 
endA1 hsdR17(rk- mk+ phoAsupE44 
A - thi-1 gyrA96 relA1
Promega, uk
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1.B Reagents for the preparation of
competent cells and plasmids
Reagents Composition Supplier
Luria-Bertani (LB) broth Dissovled 1 tablet in 50 ml distilled water
Sigma, UKLB agar Dissovled 1 tablet in 50 ml distilled water
Ampicillin 50mg/ml stock, store in -20° C
Restriction enzymes + 
buffers




T4 ligase Stock= 400000u/ml
New England 
Biolabs, UK
Calf intestinal alkaline 
phosphatase (CIP)
Stock= '\u/ fi\ Promega, UK
DNA Polymerase I, 
Large (Klenow) 
Fragment
retain 3'-*- 5' exonuclease activity 
lack of 5'-> 3' exonuclease activity
New England 
Biolabs, UK
10X DNA loading dye 10X diluted for further use Fermentas
DNA markers (1 kb DNA 
ladder)
1 mg/ml stock, mix 50 fi g with in 50 / / 1 








Ethidium Bromide Stock=0.5mg/ml Sigma, UK
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1.C Plasmid constructs
The DNA vectors used in this project were mainly constructed in 2 expression 
vector: pCS2+ and pcDNA3. Before the description of the experimental 
constructs, these 2 backbones were presented first.




Sett (S tfO ) ,,
(»S> Kpn I (377)
amp





A-150228There is an ATG upstream 
of the Xba I site
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1. pCS2-nGFP
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2. pCS2-TTR-Xlhbox8Vp16; Elastase-GFP
This construct was made by Dr. Marko E.Horb and all the details was 
described in the Experimental Procedures section in (Horb et al., 2003). The 
map is shown as followed.
■ ^CL C/5  CO C/
Elastase
SV40 pnlyA SV40 poly A V40 polypromoterVP16XlhboxSpromoter
Insert EI-GFP
pCMV - > pTTR
SM01 (WO)M M 3(2«)
F e ly ! la k c i \;  
NoO/tagl (Kir DUl
SkZ 
H t r l / K t t l  (3 5 4 )  
B*tXl 
Nrit
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3. pCS2-TTR-Vp16; Elastase-GFP
This construct was made by Dr. Marko E.Horb for the control transfection 
experiment. The Xlhbox8 region was removed by cutting with Cla I and 
reiinearisea using T4 ligase. The map is shown as followed.
m
GFP
T T R  promoter Xlhbox8 VP16
Cut (Cla I) and 
religation
SP6













p ro m o te r GFP
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4. pCS2-TTR-Xlhbox8Vp16
The construct was constructed by removing Elastase-GFP portion in 
pCS2-TTR-Xlhbox8Vp16; Elastase-GFP with Not I enzyme and relegating 
using T4 ligase. The map is shown as followed.
o
o j  1 a Z  S A.73 -
00 Z  XCfl <
GFP V40 poly>
T T R  promoter
a — OQ U
T7
T T R  promoter Xlhbox8 VP16
Xlhbox8 VP16
Cut (Not I) and 
religation
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5. pCS2-TTR-Vp16
This control construct was made by removing Xlhbox8 part in 
pCS2-TTR-Xlhbox8Vp16 with Not I enzyme and relegating using T4 ligase. 
The map is shown as followed.
T7
T T R  promoter Xlhbox8 VP16




T T R  promoter VP16
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6. pCS2-Vp16-N
This construct was provided by Dr. DS Kesseler (Department of cell and 
Developmental Biology, University of Pennsylvania, USA). The details of the 
vector was shown below.
Plasmid Name VP16-N 
Other Names 
Constructed by Dan Kessler 
Vector (name and size) pCS2+ (4095 b.p.) 




Designed for the fusion of DNA-binding domains to the 
C-terminus. N-terminal fusions can also be constructed 
using the BamHI site in the pCS2+ polylinker. Injection into 
embryos has no effect.
a n  Reference DS Kessler unpublished, 1996
TRANSCRIPTION
For sense transcripts :








5' Junction of pCS2+ and VP16: 
pCS2+ MCS
Ligations can be made in all three frames:
BamHI (blunt):
GAT CCC ATC GAT 





GGATCCCATCGAT ATG ACC GGATCC CTG TCG ACG GCC CCC 
M T G  S L  S T A  P
BamHI Clal
3' Junctign of VP16 and pCS2+: 
VP16 pCS2+ MCS
Xhol Xbal
GAG TAC GGT GGG CTC GAG CCT CTA GAA CTA TAG TGA 




BamHI Imunq bean nudeasel:
CC ATC GAT 
I D






CTC GAG CCT CTA G 
L E P L
Xbal (muno bean nucleasfll
CTC GAG CCT 
L E P
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7. pCS2-Pdx1Vp16
The construct was composed by Dr. Marko E Horb. It was made by putting 
Pdx1 cDNA (generated by PCR using primers designed for making Pdx1 cDNA 
from pcDNA3-IPF1 plasmid, see below) into pCS2+-VP16-N vector digested 
with Hind III and Cla I.
VP16 (1681-1923)
BamHI Cla I Xhol Xbal
Pdx1 cDNA
Hind I I I Cla I
Ape l
IPFl








Junction of Pdxl and VP16:
Pdxl_____________________ VP16___________________
— Clal   BamHI ___Sail------
CCC TCC AGC ATC GAT ATG ACC GGA TCC CTG TCG ACG 
P S S  I D M T G S  L S T
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8. pcDNA3-nGFP
The construct was made by Dr. David Tosh. The nuclear GFP was cut from 
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9. pcDNA3-TTR-nGFP
The plasmid was made by Dr. David Tosh. The TTR promoter (from Dr. Robert 
Costa, Department of Biochemistry and Molecular Genetics, University of 
illinois at Chicago) was cut with EcoRi (blunt) / Hind III and cloned into 
pcDNA3 excised by Bgl II (blunt) / Hind III. See (Beck and Slack, 1999) for 
reference.
. 'i?  f ’ b W l <
^  — 1— ~ i
— 3  Kb ^
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10.pcDNA3-Pdx1
The plasmid was cloned by Dr. Chia-Ning Shen. Briefly, the IPF1/Pdx1 
transcript and was excised using EcoRI/Xbal from an original vector 
pKK4-IPF1 (kindly provided by Dr. Ulf Ahlgren) and the pcDNA3 vector was 
also cut with EcoRI/Xbal. The 2 fragments were then ligated with T4 ligase. 
The map is shown below.
Apa I 
N acl EcoRI Pst I Xba I
I P F 1
a . A
Pvul
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11. pcDN A3-Pdx1 Vp16
The plasmid was constructed by Dr. Marko E Horb. The Pdx1Vp16 DNA was 
cut with Hind Ill/Xbal from pCS2+-Pdx1Vp16 and cloned into pcDNA3 digested 
with Hind Ill/Xbal.
•s a  ■ « o 
X  ^  CD 03 W
VP 16Pdxl
Junction of Pdxl and VP 16: 
Pdxl VP16
 CM   RamHT ----- Sail--------
CCC TCC AGC ATC GAT ATG ACC GGA TCC CTG TCG ACG 
P S S  I D M T G S  L S T
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12. pcDNA3-CMV-Xlhbox8Vp16; Elastase-GFP
The construct was made by Dr. Marko E Horb. The Xlhbox8vp16; EI-GFP 
fragment was cut out from pCS2-TTR-Xlhbox8Vp16; Elastase-GFP with Kpn I 
and cloned into pcDNA3 vector cut with Kpn I also.
c / 5 X C O C Q U a . i 2 o O Z X X <
CD U  ffl c/3 (/) <
X X  Z i £ «
U  CQ c/5 III Z XCQ Z
E lu ta s e
promoter GFPVP16\ lh b o x 8CMV
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13.pDsRed-N1 (purchased from clontech)
pDsRed1-N1 Vector Information
GenBank Accession #: Submission in progress
591 SOI
GCTAGCG 

















611 621 631 641
\C  TCA GAT CTC GAG CTC AAG CTT CGA ATT CTG CAGTCGAC 
BglII XhoI y . H i n dill





GGAT CCA  CCG GTC GCC ACC ATG GTG 
BamHI
Sac II Xma I Sma I
Restriction Map and Multiple Cloning Site (MCS) of pDsRed1-N1 Vector. Unique restriction sites are in bold. The Not 
I site follows the DsRedl stop codon.
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14. pcDNA3-CMV-DsRed
The plasmid was made by cutting pDsRed-N1 with Bam HI and Not I to excise 
the DsRed portion and then cloning this part into the pcDNA3 vector digested 












S91 SOI 611 621 631 641
GCTAG CG CTA  CCG GAC TCA GAT CTC GAG CTC AAG CTT CG A A TT C TG CAG TC G A C
Nhal EctAl III Bgl II Xho I A , Hirri III EcoRl Sal IS»cl Aeel
G GTA CCG Cfi 
Kpn I \  H 
AsplW I \
Sac II









There is ail ATG upstream 
of the Xba I site Bsml
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15. pcDNA3-CMV-Xlhbox8Vp16; CMV-DsRed
The plasmid was construct by replacing Elastase-GFP protion with 
CMV-DsRed (digested with Bgl II / Xho I then blunt by Klenow fragment) in 
pcDNA3-CMV-Xlhbox8Vp16; EI-GFP plasmid. The pcDNA3-CMV- 
Xlhbox8Vp16; EI-GFP was treated with Not I to remove the EI-GFP part and 
then blunt by Klenow fragment. The 2 blunt-end DNA pieces were then ligated 









H 0z I Xbal I
* *
Ndel




• There is an ATG upstream 
of the Xba ! site B s m l
i  _ *s 2. s 2£0 U Ui W
— — *it S/ Sta Q£ ^  _StSsSs8 aii-S 
e / > X O O B a . W f f l Z X > <
I _ — > _
85  -•9 01 <  t/5 i .






















































X lhboi8 VP16 |-
T7M ElajUst
promoter SV«(thA
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Appendix 2 List of Suppliers
Abeam Cambridge, Uk
ABgene Surrey, UK
Acris Antibodies Middlesex, UK
Amersham Bioscience Buckinghamshire, UK
Baxter Healthcare Ltd. Newbury, UK
BD Bioscience San Diego, CA, USA
BD Transduction Laboratories San Diego, CA, USA
Beckman Buckinghamshire, UK
Becton and Dickinson Oxford, UK
BIOCHROM AG Berlin, Germany
Biomeda Foster city, CA, USA
Bio-Rad Laboratories Herts, UK
Calbiochem Nottingham, UK
Cambridge Biosciences Cambridge, UK
Chemicon International Temecula, CA, USA
Clontech Palo Alto, CA, USA
Cypex Ltd. Dundee, UK
DakoCytomation Ely, UK
Ethicon Endo-Surgery Bracknell, UK
European Collection of Cell Cultures Salisbury, UK
Fermentas Sunderland, UK
Fisher Scientifics Loughbotough, UK
Fisons scientific apparatus Loughborough, UK
Gibco™/lnvitrogen Life Technologies Paisley, UK
Go re-Tex Newark, USA
ISTCP New Jersey, USA
Jencons (Scientific) Ltd Bedfordshire, UK
Leica Milton Keynes, UK
Mercodia AB Sweden
Millipore Corporation Bedford, MA, USA
Molecular Probes Leiden, The Netherlands
MP Biomedicals UK London, UK
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New England Biolabs Hertfordshire, UK
Novagene Madison, Wl, USA
Pall Corporation Pansacola, FL, USA
Perkin Elmer Cambridgeshire, UK
Pierce Biotrchnologies Inc. Rockford, IL, USA
Promega Madison, Wl, USA
Qiagen Crawley, UK
Raymond A LAMB limited East sussex, UK
Roche (Boehringer Mannheim) Lewes, UK
Santa Cruz Biotechnology Wiltshire, UK
Scientific Laboratory Supplies Ltd. Nottingham, UK
Sigma Poole, UK
TERUMO MEDICAL CORPORATION Merseyside, UK
Triple Red Limited Buckinghamshire, UK
Upstate Biotechnologies Dundee, UK
Vector Laboratories Burlingame, CA, USA
VWR International Dorset, UK
Worthington Biochemical Corporation Lakewood, NJ, USA
Zeiss Hertfordshire, UK
Zymed Laboratories Inc. Cambridge, UK
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